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 The skin epidermis develops from a single uniform layer of multipotent 
cells during embryogenesis.  Morphogenesis of hair follicles is initiated when a 
series of reciprocal interactions between this undifferentiated ectoderm and its 
underlying mesenchyme leads to a localized invagination of epithelial cells.  As 
hair follicle development proceeds, stem cells are specified and set aside to fuel 
the postnatal hair cycle and repair the epidermis after injury.  Although many 
signaling pathways have been identified by genetic studies to be essential for the 
induction of hair follicle morphogenesis and differentiation, little is known about 
the downstream genetic targets and molecular mechanisms in specifying a hair cell 
fate and establishing the stem cell niche.  To define how the embryonic epithelium 
is able to integrate signals to direct, maintain, and regulate the hair cell lineage, I 
developed a strategy to isolate and transcriptionally profile embryonic hair 
progenitors and interfollicular epidermis in mice.  This screen not only 
substantiated genes previously implicated in hair and epidermal development, but 
also uncovered genes that could be important in orchestrating lineage specification 
of multipotent skin progenitors.  Many of these uncharacterized genes were also 
differentially expressed in the stem cells of postnatal hair follicles, suggesting that 
embryonic hair progenitors may directly give rise to and reflect functional 
attributes of adult stem cells.  To test this premise, I evaluated the role of 
transcription factor Lhx2 in skin development.  Expressed specifically by both 
embryonic hair progenitors and postnatal follicle stem cells, Lhx2 functions to 
establish hair follicle stem cells and maintain their undifferentiated, quiescent 
state.  Loss of Lhx2 reduces hair follicle number and causes stem cells to 
precociously differentiate, whereas gain of Lhx2 inhibits differentiation and 
promotes a hair follicle stem cell fate.  Thus, Lhx2 appears to be a molecular link 
between the specification of embryonic hair progenitors and adult multipotent 
stem cells.  Further characterization into genes that regulate hair follicle 
morphogenesis is expected to expand our understanding of how stem cells are 
established and maintained, and the potential mechanisms by which they are 
disrupted in skin disease.
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 Mechanisms to regulate cell lineage occur throughout the life of 
multicellular organisms.  Beginning in the early embryo, pluripotent cells of the 
inner cell mass must restrict their lineage and differentiate into the myriad of cell 
types that make up an organism.  Lineage restriction continues in adult life as 
somatic stem cells balance cell proliferation and differentiation to maintain 
homeostasis and repair tissues after injury.  Control of these processes relies on 
extrinsic cues from the environment which ultimately direct intrinsic genetic 
programs within cells (Fuchs et al., 2004; Li and Xie, 2005).  Disruption of these 
regulatory mechanisms not only causes developmental defects, but also the 
pathogenesis of diseases such as cancer (Reya et al., 2001).  Although progress has 
been made towards understanding the external signals that control cell fate 
decisions, questions still remain regarding the downstream molecular factors that 
integrate these signals to modulate cell specification.
 As a continuously self-renewing tissue composed of multiple cell types, the 
skin is an excellent model system to address the mechanisms of cell lineage 
determination.  Epithelial stem cells have been identified and their progeny follow 
well defined spatial and temporal programs of differentiation to replenish aged or 
damaged cells (Niemann and Watt, 2002; Gambardella and Barrandon, 2003).  The 
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accessibility of the skin and the existence of molecular markers to identify specific 
cell lineages allows for tractable manipulation and phenotypic analysis of 
function.
Architecture of skin
 Mammalian skin consists of a stratified squamous epidermis and an 
underlying dermis of connective tissue, separated by a basement membrane of 
extracellular matrix (Figure 1.1).  Although there is variation between body sites, 
the major appendage of the skin is the hair follicle.  Skin epithelial cells are also 
referred to as keratinocytes, named for the keratin intermediate filaments that are 
abundantly expressed in each cell.
 Epithelial cells between hair follicles, also known as the interfollicular 
epidermis, is comprised of four distinct layers which function to provide a 
protective barrier against dehydration, infection, and mechanical stress.  Attached 
to the basement membrane are mitotically active cells known as the basal layer. 
Cells of the basal layer give rise to differentiating spinous cells by withdrawing 
from the cell cycle through oriented cell divisions and detaching from the 
basement membrane (Lechler and Fuchs, 2005).  Moving outwards towards the 
skin surface and altering their gene expression, the spinous layer becomes the 
granular layer by expressing structural proteins necessary to produce the final 
2
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Figure 1.1  Skin and its appendages.  Mammalian skin consists of the epidermis 
and its appendages, hair follicles and sweat glands, separated from the underlying 
dermis by a basement membrane of extracellular matrix.  The interfollicular 
epidermis is a stratified squamous epithelium composed of four cell layers. 
Attached to the basement membrane is the proliferative basal layer.  Cells 
committed to epidermal differentiation detach from the basement membrane, 
move outwards towards the skin surface, and undergo an ordered progression of 
molecular and metabolic changes to form the spinous layer, granular layer, and 
stratum corneum.  The hair follicle is composed of concentric rings of cell layers. 
The outermost layer of the hair follicle, the outer root sheath, is contiguous with 
the basal layer of epidermis.  At the base of the follicle are highly proliferative 
matrix cells associated with the dermal papilla.  Cells committed to hair 
differentiation leave the matrix compartment, move upwards towards the skin 
surface, and acquire a specific hair lineage, including the inner root sheath and hair 
shaft (medulla, cortex, cuticle).  Figure from Fuchs and Raghavan, 2002.
terminally differentiated layer, the stratum corneum, consisting of highly cross-
linked proteins and extruded lipids (Fuchs and Raghavan, 2002; Dai and Segre, 
2004).
 An analogous differentiation program takes place in the hair follicle. 
Contiguous with the interfollicular basal layer is the outer root sheath which 
extends down to the base of the follicle, where highly proliferative cells known as 
the matrix reside closely associated with the dermal papilla.  Specific hair lineages 
with unique biochemical and molecular properties arise from matrix cells as they 
move upward in concentric rings of cells to differentiate and form the different 
layers of the hair follicle, including from outside in, the three layers of the inner 
root sheath (Henle, Huxley, cuticle) and the three layers of the hair shaft (cuticle, 
cortex, medulla).  The hair shaft which penetrates the skin is the visible part of the 
hair follicle.
Hair follicle morphogenesis
 The skin epidermis develops during embryogenesis from a single uniform 
layer of multipotent ectoderm through interactions with the mesenchymally 
derived dermis.  Cells of this proliferative basal layer can differentiate into one of 
two major lineages: epidermal or hair (Figure 1.2).  To serve its function as a 
protective barrier, cells directed towards the epidermal lineage begin a program of 
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terminal differentiation by detaching from the basement membrane, moving 
outward toward the skin surface, and undergoing molecular and metabolic changes 
to create a keratinized, stratified squamous cell layer (Fuchs and Raghavan, 2002; 
Dai and Segre, 2004).
 Undifferentiated cells of the basal layer not only undergo epidermal 
stratification, but upon a mesenchymal cue, they can give rise to hair follicles 
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Figure 1.2  Key signals regulating hair morphogenesis.  During embryogenesis, 
cells from a single uniform layer of ectoderm differentiate into two main cell 
lineages.  They can either divide and stratify to form an epithelial barrier, or upon 
receiving a Wnt signal, they can invaginate into the dermis to form a hair follicle. 
Following placode induction, reciprocal signaling between the ectoderm and the 
underlying mesenchyme through Noggin and Shh is necessary for proper hair 
follicle organization and development.  The hair follicle continues to grow 
downwards and progenitor cells of the matrix differentiate into various lineages 
that constitute a mature follicle.  During this morphogenetic process, stem cells 
residing in the bulge are specified and set aside for postnatal hair cycles and 
epidermal repair.  Abbreviations: Bu, bulge; ORS, outer root sheath; IRS, inner 
root sheath; HS, hair shaft; Mx, matrix; DC, dermal condensate; DP, dermal 
papilla.
(Hardy, 1992).  In response to this inductive signal, embryonic hair morphogenesis 
begins with a localized thickening of epidermal cells in the basal layer and a 
subsequent bud-like invagination into the dermis.  Known as a hair placode or hair 
germ, these progenitor cells send a reciprocal signal back to the underlying 
mesenchymal cells to organize into a dermal condensate, a tight cluster of 
precursor cells of the dermal papilla.  As the hair follicle continues to develop by 
growing further down into the dermis, a group of rapidly proliferating follicular 
cells called the matrix surrounds the dermal papilla, forming the hair bulb.  Cells 
losing contact with the hair bulb become the outer root sheath, contiguous with the 
interfollicular epidermis.  The close association between the matrix and dermal 
papilla within the hair bulb likely results in another exchange of epithelial-
mesenchymal signals to begin terminal hair differentiation.  Matrix cells move 
upward and adopt specific hair lineages through changes in gene expression to 
form the concentric layers of the hair follicle, including the inner root sheath and 
hair shaft. (Paus et al., 1999)
 This period of active hair growth and differentiation known as anagen 
continues until the proliferative capacity of matrix cells is exhausted.  A regressive 
period of catagen ensues where the lower portion of the hair follicle undergoes 
apoptosis and the dermal papilla is brought upwards towards a region of the hair 
follicle known as the bulge.  The hair follicle then enters a resting period of 
6
telogen, until an inductive signal, possibly from the dermal papilla, instructs cells 
of the bulge to proliferate and differentiate into a new anagen hair follicle.  Hair 
growth continues in this cyclical fashion throughout life, and many of the same 
mechanisms of embryonic hair morphogenesis are reiterated with each initiation of 
anagen from the bulge cells (Figure 1.3). (Muller-Rover et al., 2001; Stenn and 
Paus, 2001)
Hair follicle stem cells
 Several lines of evidence indicate that the hair follicle bulge is the niche 
and reservoir of epithelial stem cells (Cotsarelis, 2006).  Located at the base of the 
permanent portion of the adult hair follicle, cells of the bulge are generally slow 
cycling and quiescent, imparting them with “label-retaining” attributes after a 
short nucleotide analog pulse and extended chase period (Cotsarelis et al., 1990; 
Morris and Potten, 1999).  When isolated and placed in culture, bulge cells 
become highly clonogenic, suggesting that they possess the ability to self-renew 
(Kobayashi et al., 1993; Rochat et al., 1994).
 The label retaining cells of the bulge also give rise to all the epithelial 
lineages of the skin, including the interfollicular epidermis.  Using two different 
labeling techniques, cells of the bulge were found to contribute to hair follicles 
during anagen induction and to epidermis during wound healing (Taylor et al., 
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Figure 1.3  Hair follicle morphogenesis and cycling.  Schematic diagram of 
different stages of follicular morphogenesis and the hair cycle.  Hair follicles are 
specified from the epidermis only during embryogenesis and enter the postnatal 
hair cycle, where follicles go through stages of growth (anagen), regression 
(catagen) and rest (telogen).  Note that only the lower portion of the hair follicle 
below the bulge is regenerated with each hair cycle.  Figure from Paus and 
Cotsarelis, 2004.
2000; Tumbar et al., 2004).  Transplantation experiments in which a labeled bulge 
was grafted onto an unlabeled hair follicle also revealed the bulge’s ability to 
differentiate into multiple cell lineages (Oshima et al., 2001).  The recent 
identification of bulge specific markers have enabled the isolation and purification 
of bulge cells, providing the means to definitively demonstrate through clonal 
analysis that bulge cells exhibit the two fundamental properties of all stem cells: 
self-renewal and multipotency (Trempus et al., 2003; Morris et al., 2004; Blanpain 
et al., 2004; Claudinot et al., 2005).  In sum, epithelial stem cells reside in the hair 
follicle bulge and are endowed with the proliferative capacity and potency to fuel 
the hair cycle and regenerate damaged epidermis.
 The bulge acquires its distinctive morphology and expresses specific 
molecular markers after the initial morphogenetic cycle of hair development.  As a 
consequence, the existence of epidermal stem cells prior to the first postnatal 
telogen is uncertain and awaits the identification of markers which can label these 
putative cells during hair follicle morphogenesis.  Thus, the origin of epidermal 
stem cells and establishment of the bulge niche during development remains to be 
determined.
 Clues into the origin of adult bulge stem cells may lie within the embryonic 
hair placode, which possesses many salient features in common with these cells. 
Although committed to a follicular cell fate, the hair placode remains 
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undifferentiated, yet capable of differentiating into all the lineages of the hair 
follicle (Levy et al., 2005).  Likewise, under normal homeostatic conditions, bulge 
cells contribute primarily to hair follicle lineages and not the interfollicular 
epidermis (Ito et al., 2005).  The morphologic features of hair renewal during 
anagen induction from postnatal bulge cells also mirrors the induction of hair 
placodes from embryonic ectoderm during development, where reciprocal 
epithelial-mesenchymal signaling leads to downgrowth, proliferation, and 
differentiation (Fuchs et al., 2001).  Thus, mechanisms regulating hair 
morphogenesis serve as a paradigm for studying stem cell activation and cell 
lineage determination.
Signaling during hair follicle morphogenesis
 Studies using genetically engineered mice implicate several key signals in 
the induction of hair follicle morphogenesis (Nakamura et al., 2001; Millar, 2002; 
Botchkarev and Paus, 2003; Schmidt-Ullrich and Paus, 2005).  Reflecting the 
morphological and functional similarities between embryonic hair placodes and 
bulge stem cells, many of these signaling pathways also direct and specify a hair 
fate during postnatal anagen induction.  Misregulation or disruption of these 
pathways leads to abnormal hair development and pathogenesis of skin disease. 
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Wnt signaling
 Of the different signaling pathways involved in hair follicle morphogenesis, 
Wnt/β-catenin signaling is absolutely essential for the specification and 
maintenance of the hair cell lineage (Alonso and Fuchs, 2003).  Initially identified 
as a component of adherens junctions, excess β-catenin is normally targeted for 
proteosome-mediated degradation.  Upon receipt of a Wnt signal through Frizzled 
receptors, the degradation of β-catenin is inhibited, resulting in its cytoplasmic 
accumulation and nuclear translocation where it can partner with members of the 
Lef/Tcf family of DNA binding proteins to function as a transcription factor 
complex (Logan and Nusse, 2004).  Mutations in different components of the Wnt/
β-catenin signaling pathway can result in constitutive activation and the 
pathogenesis of various epithelial malignancies (Polakis, 2000).
 Genetic studies demonstrate the importance of Wnt/β-catenin signaling in 
hair morphogenesis.  By following the activation of this pathway using transgenic 
mice that express a β-catenin/Lef1 responsive β-galactosidase reporter 
(TOPGAL), hair placodes were positively marked coinciding with nuclear β-
catenin and Lef1 expression (Figure 1.4A-C; DasGupta and Fuchs, 1999). 
Conditional loss of β-catenin or transgenic expression of a Wnt signaling inhibitor 
within the epidermis completely abrogates all signs of hair morphogenesis (Figure 
1.4D; Huelsken et al., 2001; Andl, et al., 2002), and mice mutant for Lef1 exhibit a 
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marked reduction in the number of hair follicles (van Genderen et al., 1994). 
Conversely, overexpression of a constitutively active form of β-catenin in the 
epidermis induces de novo hair follicles in postnatal epithelia, suggesting that 
activated β-catenin is sufficient to direct a hair cell fate (Gat et al., 1998).  Since 
hair follicles are specified entirely during embryogenesis, the presence of de novo 
12
Figure 1.4  Wnt signaling during hair morphogenesis.  (A-B)  Back skin from 
E17.5 TOPGAL embryos were stained for β-galactosidase activity and sectioned 
(DasGupta and Fuchs, 1999).  Hair placodes and a few cells at the leading front of 
invaginating hair germs express the TOPGAL reporter, indicative of active Wnt 
signaling.  The positive staining of larger hair follicles in (A) is from 
differentiating precortical cells of more mature guard hairs.  (C-D) Early hair 
progenitors express P-cadherin and Lef1, the nuclear partner of stabilized β-
catenin.  In the absence of epithelial β-catenin, hair follicles are not induced as 
evident by the lack of P-cadherin staining (Huelsken et al., 2001).  K14-Cre was 
used to ablate β-catenin from the skin epithelium (Vasioukhin et al., 1999).  Thus, 
Wnt signaling is absolutely necessary to initiate hair follicle morphogenesis. 
Immunofluorescence images are color-coded according to secondary antibodies 
used.
follicles further suggests that β-catenin may impart multipotency to interfollicular 
epidermal cells.
 Active β-catenin complexes are also found in precortex cells as they 
differentiate to form the hair shaft.  Consistent with this role in terminal hair 
differentiation, Lef1 binding sites are present in several hair specific keratin genes 
and the hair shafts Lef1 knockout mice are poorly keratinized (Zhou et al., 1995; 
Kratochwil et al., 1996).
 Wnt signaling is also active in the bulge stem cells particularly at the onset 
of a new hair cycle.  Transient expression of a stabilized β-catenin in the epidermis 
can initiate a new anagen follicle (van Mater et al., 2003; Lo Celso et al., 2004), 
whereas sustained expression leads to precocious stem cell activation (Lowry et 
al., 2005) and eventually pilomatricomas, hair follicle tumors composed of 
undifferentiated matrix cells (Gat et al., 1998; Chan et al., 1999).  Finally, 
postnatal loss of β-catenin in the bulge results in the formation of epithelial cysts 
instead of the normal induction of new hair cycles, suggesting that in the absence 
of β-catenin, stem cells are directed toward an epidermal cell fate rather than a 
hair cell fate (Huelsken et al., 2001; Lowry et al., 2005).
 Although the source of the Wnt signal remains elusive, Wnt/β-catenin 
signaling is clearly necessary to induce the hair cell lineage during morphogenesis 
and activate bulge stem cells during postnatal hair cycles.
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Shh signaling
 Absent in β-catenin null epidermis, sonic hedgehog (Shh) lies downstream 
of Wnt signaling during hair follicle morphogenesis (Callahan and Oro, 2001). 
Shh signals by binding to its receptor Patched (Ptch) thereby antagonizing its 
inhibition of Smoothened (Smo).  This allows Smo to activate downstream target 
genes through the Gli family of transcription factors (Lum and Beachy, 2004).
 Expressed in the hair placodes and germs during morphogenesis, Shh is 
required to promote epidermal proliferation and subsequent downgrowth once hair 
follicles are induced (Figure 1.5A-B; St-Jacques et al., 1998; Chiang et al., 1999). 
In the absence of Shh, developing follicles are arrested as hair germs and the 
underlying mesenchyme fails to aggregate and organize into a dermal condensate 
(Figure 1.5C-D).  Among the Gli family members, only Gli2 null mice exhibit the 
same phenotype as Shh nulls, but transgenic expression of Gli2 in the epidermis of 
Shh knockouts is unable to completely rescue the arrested hair germs (Mill et al., 
2003), suggesting that Shh has Gli2 independent effects and/or a cell non-
autonomous role within the dermis.  In line with this possibility, loss of Shh is 
unable to properly organize mesenchymal cells expressing a platelet derived 
growth factor (PDGF) receptor, which could prevent hair germs that express a 
PDGF ligand from signaling back to the mesenchyme for further development 
14
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Figure 1.5  Shh signaling during hair morphogenesis.  (A-B) Shh is expressed 
in hair placodes and germs.  Back skin sections from E17.5 embryos were probed 
with Shh cRNA, then immunostained for β4-integrin.  The Shh in situ 
hybridization signal in (A) was pseudo-colored and overlayed with the β4-integrin 
image (B).  (C-D) Although hair follicles are induced in Shh null embryos, they 
fail to develop a dermal condensate and are unable to develop beyond the hair 
germ stage (St-Jacques et al., 1998; Chiang et al., 1999).  Alkaline phosphatase 
(AP) is a marker of the dermal condensate.  (E-F) The arrested hair germs of Shh 
knockout embryos continue to exhibit activated Wnt signaling as determined by 
TOPGAL reporter expression.  Thus, Wnt signaling lies upstream of Shh to initiate 
hair follicle morphogenesis, but Shh signaling is subsequently required to organize 
the dermal condensate and promote hair downgrowth.
(Karlsson et al., 1999).  Since Shh signaling effectors are expressed in both the 
epidermis and dermal condensates of hair follicles, it is still unclear which 
compartment is responsive to and requires Shh signaling.
 Shh signaling also regulates the adult hair cycle.  During the telogen to 
anagen transition, Shh target genes are expressed in the both the developing hair 
follicle and dermal papilla (Oro and Higgins, 2003).  Exogenous Shh or a small 
molecule agonist can trigger this transition, while mice treated with antibodies 
against Shh or a known antagonist cyclopamine can block this transition (Paladini 
et al., 2005; Sato et al., 1999; Wang et al., 2000; Silva-Vargas et al., 2005). 
Interestingly, anagen does appear to initiate despite blocking Shh, but like 
embryonic hair germs, the follicles do not progress beyond small bulb-like 
structures (Wang et al., 2000).
 Consistent with a role in promoting proliferation during development, 
activating mutations in the Shh signaling pathway lead to hair derived 
tumorigenesis, particularly basal cell carcinoma (BCC) (Daya-Grosjean and 
Couve-Privat, 2005).  Germline mutations in Ptch1 cause basal cell nevus 
syndrome, an autosomal dominant predisposition to multiple cancers especially 
BCC (Hahn et al., 1996; Johnson et al., 1996).  Spontaneous BCC also has 
inactivating patched and activating smoothened mutations (Gailani et al., 1996; 
Xie et al., 1998).  In addition, mouse models overexpressing Shh, Smo, Gli1 and 
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Gli2 lend further support that misregulation of Shh signaling is sufficient to induce 
tumors (Oro et al., 1997; Fan et al., 1997; Xie et al., 1998; Nilsson et al., 2000; 
Grachtchouk et al., 2000).  Tumors arising from constitutive Shh signaling also 
express hair follicle bulge markers, suggesting that they result from an 
inappropriate expansion of undifferentiated hair progenitor cells (Jih et al., 1999). 
Recently, a study showed that BCC cells isolated from regressing tumors could 
completely reconstitute a new hair follicle when combined with inductive dermal 
cells, providing evidence that BCC represents “an aberrant form of hair follicle 
organogenesis” (Hutchin et al., 2005).
Bmp signaling
 In contrast to Wnt and Shh, bone morphogenetic protein (Bmp) signaling 
appears to inhibit hair follicle morphogenesis (Botchkarev and Sharov, 2004). 
Belonging to the transforming growth factor-β  (Tgf-β) superfamily, Bmp ligands 
signal by binding two serine/threonine kinase receptors which result in the 
activation of the Smad family of intracellular messengers.  Specifically, Bmps 
signal through Smad-1/5/8 while Tgf-βs signal though Smad-2/3.  These activated 
Smad proteins then associate with Smad4, translocate into the nucleus, and 
mediate gene transcription (Shi and Massague, 2003).
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 Bmp signaling in skin development begins as early as gastrulation when 
prospective ectoderm cells are specified to be epidermal, rather than neural 
(Hemmati-Brivanlou and Melton, 1997).  As evident by phosphorylated 
Smad-1/5/8, active Bmp signaling continues within the epidermis as it 
differentiates.  However, these activated Smad complexes are not present in the 
developing hair follicles despite the strong expression of Bmp ligands and 
receptors (Figure 1.6A-C).  Similar to neural induction, Bmp signaling must be 
inhibited by antagonists such as Noggin for proper specification of hair follicles 
during embryogenesis.
 Noggin is expressed in the dermal condensates beneath developing hair 
placodes and likely exerts its effects on the epithelium (Figure 1.6D).  Mutant 
mice lacking Noggin have fewer hair follicles and retarded hair development 
(Botchkarev et al., 1999).  Although Bmp signaling is dispensable for hair follicle 
induction, it is required later for proper hair shaft and inner root sheath 
differentiation (Figure 1.6E-F).  Inhibition of Bmp signaling during hair 
differentiation leads to reduced expression of several molecular factors required 
for lineage commitment and terminal differentiation (Kulessa et al., 2000; 
Kobielak et al., 2003; Andl et al., 2004; Yuhki et al., 2004).  Interestingly, Lef1 
and Shh were enhanced in these mutant follicles lacking Bmp signaling. 
Likewise, expression of Lef1 in the embryonic hair germ is dependent on 
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Figure 1.6  Bmp signaling during hair morphogenesis.  (A-B) Bmp ligands are 
expressed at sites of hair follicle morphogenesis.  By in situ hybridization, Bmp2 
is primarily localized in hair placodes, while Bmp4 is present in both the placodes 
and underlying dermal condensates.  (C)  However, Bmp signaling is not active in 
early hair progenitors.  Phosphorylated Smad1/5/8 (pSmad) is excluded from hair 
placodes and germs, but is prominent in the differentiating epidermis.  (D) Bmp 
inhibition during hair morphogenesis is likely mediated by Noggin.  Heterozygous 
noggin embryos were stained for β-galactosidase activity to detect endogenous 
Noggin expression in dermal condensates (Botchkarev et al., 1999).  (E-F) Bmp 
signaling is required for terminal hair differentiation.  Active Bmp signaling is 
present in precursors of the inner root sheath and hair shaft.  Absence of Bmp 
signaling, as exemplified by the Bmp receptor-1a (BmpR1a) conditional null, 
results in the loss of AE15 immunoreactivity, which marks the inner root sheath 
trichohyalin.  Thus, inhibition of Bmp signaling is necessary to initiate hair 
morphogenesis, but active signaling is required for terminal hair differentiation.
inhibition of Bmp signaling by Noggin (Botchkarev et al., 1999; Jamora et al., 
2003), and studies on feather induction in chick embryos support the notion that 
Bmps downregulate Shh to mediate lateral inhibition of epithelial placode fate 
(Jung et al., 1998; Noramly and Morgan, 1998).
 Similar to its role in hair morphogenesis, inhibition of Bmp signaling is 
necessary for the activation of anagen during the postnatal hair cycle.  The telogen 
to anagen transition is associated with an upregulation of Noggin expression and 
can be stimulated by exogenous Noggin, while Bmp treatment blocks anagen entry 
(Botchkarev et al., 2001).  In line with this observation, transgenic expression of 
Noggin results in faster anagen entry (Plikus et al., 2004).  Noggin also increases 
Shh expression during postnatal hair induction (Botchkarev et al., 2001).
 In short, Bmp signaling inhibits the specification and/or activation of hair 
follicle progenitors during both embryogenesis and postnatal hair renewal, but 
promotes their terminal differentiation into various cell lineages.  Bmp signaling 
also appears to intersect with both the Wnt and Shh signaling pathways to control 
hair follicle morphogenesis. 
Other signaling pathways
 Several other signaling factors are expressed in early hair germs, including 
members of the transforming growth factor-β (Tgf-β), fibroblast growth factor 
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(Fgf), and ectodysplasin (Eda) family.  Through mouse and human genetics, all are 
implicated in different aspects of hair follicle induction and differentiation (Foitzik 
et al., 1999; Petiot et al., 2003; Laurikkala et al., 2002).
Specific aims
 With the simultaneous expression of multiple extrinsic factors, the hair 
placode can be considered a signaling center that must integrate and translate both 
stimulatory and inhibitory inputs into a program of gene expression that specifies a 
hair cell fate from embryonic ectoderm.  However, little is known about the 
molecular machinery that coordinates these signaling pathways to orchestrate hair 
follicle induction and morphogenesis.  Reflecting their morphological similarities, 
these same signals direct the activation of adult stem cells to initiate new rounds of 
hair growth.  When altered, these normal developmental processes can lead to 
diseases such as cancer.  Thus identifying and characterizing genes involved in 
early hair placode development will extend our understanding of the downstream 
intrinsic mechanisms that regulate cell lineage commitment of multipotent 
progenitors during morphogenesis and postnatally.  It will also shed light into 
potential avenues of development that can be disrupted during the pathogenesis of 
skin disease.
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 The study of hair morphogenesis is also anticipated to have broader 
implications that extend beyond the hair follicle.  Many organs such as teeth, 
mammary glands, lungs, and kidneys develop like hair follicles, utilizing a process 
of “budding morphogenesis”  (Hogan 1999; Pispa and Thesleff, 2003).  Despite 
their diversity in final form and function, the same signaling pathways used in hair 
morphogenesis modulate the epithelial-mesenchymal inductive interactions in the 
initial development of these organs.  Thus, analyzing the gene expression profile 
during hair morphogenesis can reveal how organs utilize basic cellular functions 
such as proliferation, cell fate determination, differentiation, and migration 
involving changes in shape, polarity, and adhesion to coordinate placode 
development.  At the same time, unique factors which lie downstream of these 
evolutionary conserved pathways may be uncovered that lend specificity to hair 
follicle determination and morphogenesis.
 To define the molecular mechanisms regulating hair follicle morphogenesis, 
I initially developed a strategy to isolate and transcriptionally profile embryonic 
hair placodes and interfollicular epidermis in mice.  By comparing the gene 
expression profiles of these two cell populations, genetic changes that occur when 
the hair follicle lineage is specified from the undifferentiated ectoderm were 
unveiled.  In addition to substantiating genes previously documented in hair and 
epidermal development, this screen revealed insights into the embryonic origins of 
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the adult hair follicle stem cell niche.  To validate this approach to identify genes 
that specify hair follicle progenitors and regulate their functional properties during 
development, I characterized the transcription factor Lhx2.  I demonstrate that 
Lhx2 is expressed specifically in both embryonic hair progenitors and adult stem 
cells, and appears to link the induction of hair follicle morphogenesis to the 
establishment and maintenance of stem cells.
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CHAPTER 2
ISOLATION AND ANALYSIS OF
EMBRYONIC HAIR PROGENITORS
 Hair follicle morphogenesis involves a temporal series of reciprocal 
interactions between the ectoderm and its underlying mesenchyme (Figure 1.2). 
In response to an inductive Wnt and an inhibitory Bmp signal (Noggin), small hair 
placodes bud from the epithelium, giving rise to larger hair germs.  In the presence 
of the mitogen Shh, these hair germs develop further and grow downward to form 
a mature follicle that actively produces hair.  Although the molecular details of bud 
formation are still poorly defined, the general features of this process are repeated 
at the start of each postnatal hair cycle when multipotent stem cells in the hair 
follicle bulge become activated to initiate a new round of hair growth.  In addition, 
the early epithelial remodeling to form the hair germ shares many features with the 
development of other epithelial tissues and organs, including feathers, teeth, and 
mammary glands.  Understanding how tissues form buds that then progress along 
different lineages is predicated on elucidating the molecular mechanisms that 
funnel these early signaling pathways into a transcriptional program that drives 
morphogenesis.
 To examine the genetic changes that occur during epithelial bud formation, 
I developed a method to isolate and purify embryonic hair progenitors along with 
interfollicular epidermal cells.  The gene expression profiles of these two cell 
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populations were compared and analyzed to reveal transcriptional differences that 
occur as ectodermal cells commit to a hair follicle lineage and undergo 
morphogenesis.  Apart from a number of genes with previously documented roles 
in hair development, the embryonic hair progenitors differentially expressed 
several genes in common with the postnatal hair follicle bulge, suggesting 
functional similarities to those of adult stem cells.  Interestingly, a presumptive 
bulge was identified in developing follicles by the presence of label retaining cells 
which were initially labeled during embryonic hair induction.  As the 
morphogenetic hair cycle completed, these slow cycling cells persisted as bulge 
stem cells in adult hair follicles.
Results
Isolation of embryonic hair progenitors
 The murine hair coat is composed of several different hair types that are 
initiated during embryonic development at different times (Mann, 1962).  The 
largest hair follicles known as tylotrich, guard, or primary hairs begin 
morphogenesis at embryonic day E13.5.  Relatively few in number, these follicles 
eventually from the hair overcoat and can be recognized during embryogenesis by 
a raised area of epidermis.  The undercoat is composed of the awl, auchene, and 
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zigzag hair follicles, otherwise known as nontylotrich or secondary hair follicles. 
These hair types comprise the vast majority, between 90-95%, of total hair 
follicles and are indistinguishable from each other during early morphogenesis. 
Initiation of nontylotrich hair follicles begins around embryonic day E15.5 and 
continues in waves until a few days postnatal.  Although the initial timing of 
morphogenesis in all hair follicles is not synchronous, each follicle follows the 
same program of development in approximately the same length of time.
 To determine an ideal stage of development to isolate early hair 
progenitors, the dorsal skin of mouse embryos at various ages was evaluated for P-
cadherin expression, a calcium dependent cell adhesion molecule upregulated at 
sites of hair follicle morphogenesis (Hardy and Vielkind, 1996; Jamora et al., 
2003).  At E13.5, P-cadherin was expressed uniformly throughout the single layer 
of epidermis as detected by immunofluorescence.  Large thickenings of the 
epidermis, corresponding to guard hair placodes, would occasionally be 
morphologically visible.  By E15.5, hair placodes were spaced throughout the 
dorsal epidermis and expressed elevated levels of P-cadherin relative to the basal 
layer of keratinocytes.  Many more P-cadherin positive hair placodes were induced 
a day later at E16.5, with some forming dermal condensates.  Although P-cadherin 
was still found along the basal layer, its expression was diminished relative to the 
developing hair follicles.  By E17.5, larger hair downgrowths were evident, 
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however recently induced hair placodes and germs strongly positive for P-cadherin 
were also present (Figure 2.1).
 Since P-cadherin is a cell surface molecule, its differential expression in 
hair placodes and germs was exploited to selectively isolate early hair progenitor 
cells from other epidermal cells with the use of fluorescence activated cell sorting 
(FACS).  To eliminate other cell types in the epidermis which might express P-
cadherin, transgenic embryos for Keratin 14-ActinGFP were utilized (Vaezi et al., 
2002).  Keratin 14 (K14) is specifically expressed in the keratinocytes of the basal 
layer of epidermis (Vassar et al., 1989), but the stability of actin causes all cells 
derived from the basal layer, including hair placodes and suprabasal keratinocytes, 
to express GFP.  To restrict analysis to the basal epidermal cells, α6-integrin or β4-
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Figure 2.1  P-cadherin expression in embryonic hair follicle progenitors.  Skin 
sections from E17.5 embryos were stained for P-cadherin and found to be up-
regulated at sites of hair follicle morphogenesis (Hardy and Vielkind, 1996).  This 
differential expression was used to isolate PCAD+ hair progenitors and PCAD− 
interfollicular basal cells by FACS.  Abbreviations: epi, epidermis; der, dermis; Pc, 
placode; HG, hair germ; HF, hair follicle.  Scale bar, 40μm.
integrin, transmembrane proteins involved in basement membrane assembly and 
adhesion, was also used as a surface marker to isolate hair follicle progenitors and 
interfollicular basal keratinocytes.
 To create of suspension of epidermal cells for FACS, embryonic skin from 
E17.5 K14-ActinGFP embryos was dissected and treated with dispase to separate 
the epidermis, including hair placodes and germs, from the underlying dermis, 
which harbored more mature hair pegs and follicles (Figure 2.2).  After 
dissociating the epidermal fraction with the divalent ion chelator EDTA, the 
embryonic “PCAD+” hair progenitors (K14-GFP+, α6-integrin+, P-cadherin+) 
were then separated from the “PCAD−” interfollicular epidermis (K14-GFP+, α6-
integrin+, P-cadherin−) on the basis of their differential surface P-cadherin 
expression (Figure 2.3).  Although P-cadherin is a calcium dependent cell 
adhesion molecule, it is resistant to EDTA treatment in the absence of trypsin 
(Figure 2.4).
 The specificity of P-cadherin to label hair placodes was tested using 
epidermal cells isolated from mutant embryos (Figure 2.5).  As expected, P-
cadherin did not stain cells isolated from P-cadherin null mice which undergo 
normal hair morphogenesis.  Epidermal cells isolated from the β-catenin 
conditional knockout, which lack all hair follicles and thus P-cadherin expression 
by immunohistochemistry, were also negative for P-cadherin by FACS analysis 
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Figure 2.2  Expression of molecules used to isolate hair follicle progenitors. 
Skin from E17.5 K14-ActinGFP embryos was dissected and treated overnight with 
dispase at 4°C.  Dispase treatment separates the hair germs, marked by P-cadherin 
expression, and the interfollicular epidermis from more mature hair follicles which 
remain in the dermis.  α6-integrin marks the epidermal cells of the basal cell layer, 
including the early hair follicle progenitors.  Abbreviations: epi, epidermis; der, 
dermis; Pc, hair placode; HG, hair germ; Peg, hair peg; HF, hair follicle.
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Figure 2.3  FACS strategy to isolate hair follicle progenitors.  Differential 
expression of P-cadherin was used to FACS isolate PCAD+ hair progenitors and 
PCAD− interfollicular basal cells from the epidermal fraction of dispase treated 
E17.5 K14-ActinGFP transgenic skin.  (A) Schematic to generate epidermal cell 
suspensions for flow cytometry.  (B-C) Single cell suspensions were gated for 
propidium iodide (PI) exclusion, keratinocyte GFP expression, and the basal cell 
marker α6-integrin.  These live basal keratinocytes were then sorted based on their 
P-cadherin expression.  Thus, the “PCAD+” hair progenitors (K14-GFP+, α6-
integrin+, P-cadherin+) can be separated from the “PCAD−” interfollicular 
epidermis (K14-GFP+, α6-integrin+, P-cadherin−).  The secondary only control 
for P-cadherin is shown in (C).
verifying that P-cadherin can specifically label hair placode cells.
 Finally, the purity of the PCAD+ and PCAD− sorted cell populations was 
evaluated with various molecular markers.  Reflecting their basal character, nearly 
all sorted cells in both populations stained positively for K5, the keratin partner of 
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Figure 2.4  P-cadherin is resistant to EDTA in isolating epidermal cells.  After 
dispase treatment of E17.5 K14-ActinGFP skin, the epidermal fraction was treated 
either with EDTA or trypsin plus EDTA.  Cell suspensions were then stained with 
P-cadherin and β4-integrin before analyzed by flow cytometry.  As a calcium 
dependent adhesion molecule, P-cadherin is destabilized without calcium, but in 
the absence of trypsin, P-cadherin remains present on the cell surface.  However, 
P-cadherin is lost when cells are treated with trypsin in the presence of divalent 
ion chelator EDTA which destabilizes and digests intercellular adhesive contacts. 
Although the presence of calcium during trypsinization can preserve P-cadherin 
expression, epidermal cells are not readily dissociated, creating cell clumps.  Thus, 
EDTA alone was used after dispase to create single cell suspensions of 
keratinocytes that maintain P-cadherin expression for FACS.  Surface integrins are 
not affected by either treatment.
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Figure 2.5  FACS analysis on mutant embryos.  The specificity of P-cadherin to 
label hair follicle progenitors was tested using epidermal cells isolated from 
mutant embryos at E17.5.  (A)  P-cadherin does not stain cells isolated from P-
cadherin knockout (Pcad KO) mice which undergo normal hair morphogenesis. 
(B) β-catenin conditional knockout mice (β-cat cKO) lack all hair follicles and 
expression for P-cadherin.  Weak positive staining is due to the slightly mosaic 
expression of K14-Cre recombinase, resulting in the induction of sporadic hair 
follicles.  Immunofluorescence images are color-coded according to the secondary 
antibodies used.
K14, and for β4-integrin, a partner of α6-integrin (Figure 2.6A).  A very small 
percentage of cells in the PCAD− fraction stained positive for K1, a keratin 
expressed in the suprabasal layers of the epidermis, but this could represent cells at 
a transitional stage of differentiation since they displayed a small and round 
morphology and often co-stained with K5 (Figure 2.7).
 Semi-quantitative reverse transcription polymerase chain reaction (RT-
PCR) for known placode markers confirmed the distinction between the two sorted 
cell populations (Figure 2.6C).  Previously demonstrated to be transcriptionally 
upregulated in hair placodes, mRNAs for P-cadherin, Bmp2, Bmp4, Shh, Wnt10b, 
and Msx2 were elevated in the PCAD+ relative to the PCAD− cells.  Keratin 5 was 
slightly repressed in PCAD+ cells by RT-PCR, similar to its expression pattern in 
skin at sites of hair follicle induction (Byrne et al., 1994).  Cells were also sorted 
from TOPGAL transgenic embryos and the specific activity of β-galactosidase, 
indicating active Wnt signaling, in PCAD+ embryonic hair progenitors was 
verified (Figure 2.6B).  Thus, the purity and inherent differences between the two 
isolated cell populations distinguished by surface P-cadherin expression was 
validated through analysis of known molecular markers.
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Figure 2.6  Expression of marker genes in sorted cell populations.  The sorted 
PCAD+ cells express known markers of hair placodes.  (A) Sorted cells were 
cytospun and stained for epidermal markers K1, K5, and β4-integrin.  A summary 
of cell counts from three independent sorts is shown.  Reflecting their basal 
character, both PCAD− and PCAD+ cells express basal layer markers.  (B)  Cells 
were sorted from TOPGAL positive and negative embryos, and β-galactosidase 
activity was assessed by chemiluminescence.  Relative activity was measured 
against wild-type PCAD− cells, which was arbitrarily set at 1.  An average of three 
independent sorts is shown.  Reflecting their active Wnt signaling, only PCAD+ 
cells from transgenic mice exhibit strong reporter activity.  (C) RNA was extracted 
from sorted cell populations and semi-quantitative RT-PCR was performed for 
known genes differentially expressed in hair placodes.  PCAD+ cells express 
higher levels of these placode genes relative to PCAD− cells.  K5 and K14 are 
known to be down-regulated, but still expressed in hair germs.
Transcriptional differences during hair morphogenesis
 The gene expression profiles of purified PCAD+ hair progenitors and 
PCAD− interfollicular basal keratinocytes were further analyzed using 
oligonucleotide microarrays to identify transcriptional changes that occur as 
epithelial cells commit to a hair cell lineage.  Two entirely independent samples 
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Figure 2.7  Cytospin analysis of sorted cell populations.  Unsorted and sorted 
cells were cytospun and immunostained for epidermal markers, K1, K5, and β4-
integrin.  Quantitation of three independent cell sorts is provided in Figure 2.6A. 
Although the PCAD− cell fraction had a minor contamination of K1 positive cells, 
these cells were small and round, unlike the large and flat, squamous-like K1 
positive cells in the unsorted total epidermal cell population.  Often co-staining 
with antibodies against K5, these cells may represent an early transitional stage of 
epidermal differentiation.  Images are color-coded according to the secondary 
antibodies used. 
were initially assessed for overall hybridization quality using various parameters 
(Table 2.1).  All arrays showed similar scaling factors and percent present calls, 
indicating that equivalent amounts of labeled RNA was hybridized.  Although 
there was some 3’ bias in the labeled RNA samples, it was also comparable across 
the hybridizations.  This consistency allowed us to make comparisons between the 
two sorted populations and cross-comparisons across replicates to generate 
transcriptional differences.
 To determine the capability and fidelity of the array data to reflect 
significant genetic differences that occur during hair morphogenesis, the presence 
of known hair placode markers in the PCAD+ samples relative to PCAD− samples 
was examined.  In general, the comparative analysis faithfully reflected a number 
of these changes, sometimes with multiple probe sets (Table 2.2).  Using fold 
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ARRAY SCALE FACTOR % PRESENT β-ACTIN 3’/5’ GAPDH 3’/5’
PCAD−_1 1.530 49.2 2.74 4.60
PCAD+_1 1.541 49.1 2.70 4.71
PCAD−_2 1.649 48.5 2.89 5.20
PCAD+_2 1.709 48.5 2.94 4.91
Table 2.1.  Microarray hybridization statistics.  Arrays were scaled to a target 
signal of 500 using default parameters in Affymetrix GeneChip Operating 
Software.  See materials and methods for details on analysis.
differences of these hair placode markers as a sensitivity gauge, a two-fold cutoff 
was assigned as a genuine difference between the two cell populations.  As a 
result, a total of 1394 probes (660 in PCAD+ and 724 in PCAD−) were 
preferentially expressed in one population relative to the other (see Appendix for 
complete list).  Semi-quantitative RT-PCR on a independent sorted sample further 
verified a set of transcriptional differences between the PCAD+ hair progenitors 
and PCAD− interfollicular epidermis identified in the microarray (Figure 2.8). 
37
GENE ↑/↓ FOLD CHANGE REFERENCE
P-cadherin ↑ 1.3, 1.2 Hardy & Vielkind, 1996
E-cadherin ↓ -1.7, -1.6 Jamora et al., 2003
Shh ↑ 14.8 St-Jacques et al., 1998
Bmp2 ↑ 2.5 Botchkarev et al., 1999
Bmp4 ↑ 4.6 Botchkarev et al., 1999
Tgf-β2 ↑ 11.5, 10.6, 8.8, 5.7 Foitzik et al., 1999
EdaR ↑ 5.4 Laurikkala et al., 2002
Wnt10b ↑ - Reddy et al., 2001
β-catenin ↑ 1.8, 1.3 Huelsken et al., 2001
Lef1 ↑ no change Zhou et al., 1995
Msx2 ↑ - Satokata et al., 2000
K5 ↓ -2.4 Byrne et al., 1994
Table 2.2  Fold changes of known hair placode markers.  Mean fold changes of 
genes were determined by comparing the PCAD+ array replicates to the PCAD− 
array replicates.  Multiple values represent independent probe sets in the 
microarray.  See materials and methods for details on analysis.
Recapitulating their in vivo genetic programs, a number of these differentially 
expressed genes have documented roles in either hair morphogenesis (PCAD+) or 
epidermal differentiation (PCAD−).
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Figure 2.8  Verification of differentially expressed genes in the microarrays. 
RNA was extracted from sorted cell populations of an independent sample and 
semi-quantitative RT-PCR was performed on a set of differentially expressed 
genes identified by the array data.  All genes tested recapitulated the expression 
changes in the microarrays.  See appendix for raw values and fold changes.
PCAD− interfollicular epidermal cells
 The PCAD− interfollicular epidermal population was typified by adhesive 
and cytoskeletal components and molecular factors implicated in differentiation 
(Table 2.3).  In particular, keratin intermediate filaments and components of the 
desmosome were prominently present.  Desmosomes are adhesive intercellular 
junctions that link keratin filaments to the cell surface and ultimately to adjacent 
cells.  At the core of the desmosome are desmocollins and desmogleins, 
desmosomal cadherins which mediate cell-cell contact through their extracellular 
domains.  The cytoplasmic tails of these proteins associate with plakoglobin, 
plakophilins, and members of the plakin family, which anchor desmosomes to the 
keratin cytoskeletal network.  Although more prominent in the suprabasal cell 
layers, desmosomes are also present in basal cells and function to maintain tissue 
integrity and strength amid the constant mechanical stress that the epidermis 
endures.  Disruption of these junctions or their associated keratins leads to skin 
fragility and blistering diseases such as pemphigus, palmoplantar keratoderma, 
epidermolysis bullosa, and epidermolytic hyperkeratosis (Kottke et al., 2006; 
Garrod et al., 2002; Leung et al., 2002; Lane and McLean, 2004; Rugg and Leigh, 
2004).
 The PCAD− cells also expressed higher levels of other junctional proteins 




Cldn1 Furuse et al., 2002 BmpR1b Botchkarev & Sharov, 2004
Col17a1 McGrath et al., 1995 Dll1
Dsc2 Garrod et al., 2002 Dtx2
Dsg1a Garrod et al., 2002 Jag1
Evpl Maatta et al., 2001 Krtdap Oomizu et al., 2000
Eppk1 Fujiwara et al., 2001 Notch3
Jup Bierkamp et al., 1996 Sprr2a Cabral et al., 2001
Krt1-10 Cheng et al., 1992 Sfn Herron/Li et al., 2005
Krt1-14 Coulombe et al., 1991 Sbsn Park et al., 2002
Krt1-15 Lloyd et al., 1995
Krt1-16 McLean et al., 1995 TRANSCRIPTION FACTORS
Krt2-1 Chipev et al., 1992 Esr1 Thornton, 2002
Krt2-5 Lane et al., 1992 Foxn1 Brissette et al., 1996
Krt2-6a Wong et al., 2000 Grhl1 Tao et al., 2005
Krt2-6b Wong et al., 2000 Grhl3 Ting et al., 2005
Ocln Saitou et al., 2000 Klf4 Segre et al., 1999
Ppl Aho et al., 2004 Klf5 Ohnishi et al., 2000
Pkp1 McGrath et al., 1997 Myc Arnold & Watt, 2001
Ovol1 Nair et al., 2006
Pou3f1 Andersen et al., 1997
Stat1
Tcfap2e Tummala et al., 2003
Table 2.3  Selected genes in PCAD− fraction.  Genes upregulated ≥2-fold in the 
PCAD− cell population relative to the PCAD+ cell population with established 
roles in epidermal development are listed.  See appendix for raw values.
attachment of basal keratinocytes to its underlying basement membrane.  BPAG2 
is a target of the autoimmune disease bullous pemphigoid, a blistering disease 
similar to junctional epidermolysis bullosa (McGrath et al., 1995).  Tight junction 
proteins, claudin and occludin, were also upregulated in the PCAD− cells.  Tight 
junctions were initially thought not to play a major role in stratified epithelia, but 
claudin-1 null mice are born with an epidermal barrier defect resulting in 
progressive water loss and dehydration (Furuse et al., 2002).
 Components of two signaling pathways implicated in epidermal 
differentiation, Notch and Bmp, were also preferentially expressed in the PCAD− 
cells.  In human epidermis, the receptor Notch3 and ligands Delta1 and Jagged1 
are expressed throughout the basal layer, with Delta1 enriched in epidermal stem 
cells (Thelu et al., 2002; Lowell et al., 2000).  Although these specific components 
have not been functionally characterized, Notch signaling has been demonstrated 
to affect the proliferative and differentiation status of epidermal keratinocytes. 
Loss of Notch1 results in epidermal hyperplasia, inhibition of early differentiation 
markers, and increased susceptibility to skin tumorigenesis (Rangarajan et al., 
2001; Nicolas et al., 2003).
 Bmp signaling also plays a critical role in interfollicular epidermal 
differentiation.  Bmps and their antagonists are expressed spatiotemporally 
throughout epidermal development (Botchkarev, 2003).  Beginning in gastrulation, 
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Bmps induce the epidermal lineage by inhibiting neural cell fate (Hemmati-
Brivanlou and Melton, 1997).  Several studies have demonstrated using cultured 
keratinocytes that Bmp signaling also inhibits proliferation and promotes 
differentiation.  However, conditional ablation of the BmpR1A receptor in vivo has 
no effect on the interfollicular epidermis.  Notably, the PCAD− cells expressed 
higher levels of BmpR1B.  Thus confirmation of Bmp signaling in epidermal 
differentiation awaits further genetic studies.
 Lending support to a role for Bmps in epidermal differentiation are the 
evolutionary conserved grainyhead family of transcription factors, of which Grhl1 
and Grhl3 are enriched in the PCAD− cells.  Originally identified in Drosophila to 
modulate cuticle formation, grainyheads are expressed in an epithelial-restricted 
pattern across species.  In Xenopus, Grhl1 expression in the epidermis is Bmp4 
dependent and loss of Grhl1 inhibits key epidermal structural genes resulting in 
severe terminal differentiation defects (Tao et al., 2005).  Similarly, Grhl3 null 
mice exhibit defective skin barrier function accompanied by reduced expression of 
transglutaminase, an enzyme that crosslinks structural components to form the 
water-impermeable cornified layer of epidermis (Ting et al., 2005).
 Other transcription factors that regulate epidermal differentiation were also 
increased in the PCAD− interfollicular cell population.  Expressed in proliferative 
basal cells as they transition into terminal differentiation, inactivation or 
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misregulation of these factors leads to abnormal programs of epidermal 
differentiation.  Consistent with its expression pattern and oncogenic role, c-Myc 
overexpression drives proliferation and promotes epidermal cell fate at the 
expense of hair follicles (Waikel et al., 2001; Arnold and Watt, 2001).  c-Myc 
expression is regulated in part by Ovol1 which represses c-Myc to restrict the 
proliferative potential of differentiating epidermal progenitor cells (Nair et al., 
2006).  Pou3f1, also known as Tst1/Oct6/SCIP, also appears to function at the 
transition to differentiation since loss of Pou3f1 fails to suppress basal keratin 
genes in the suprabasal cell layers (Andersen et al., 1997).  Likewise, 
keratinocytes lacking Foxn1 retain basal markers, but have a greater propensity to 
differentiate, suggesting a role at the initiation of differentiation (Brissette et al., 
1996; Baxter and Brissette, 2002).  Finally, acquisition of a functional barrier 
during epidermal differentiation requires Klf4 (Segre et al., 1999).
 Additional factors linked to epidermal stratification were also differentially 
expressed in the PCAD− cells.  Stratifin, also known as 14-3-3σ, mediates cell 
cycle arrest and terminal differentiation in epidermis.  Mutations in stratifin found 
in the repeated-epilation (Er) mouse mutant results in a hyperplastic epidermis and 
a failure of terminal differentiation (Herron et al., 2005; Li et al., 2005).  Although 
not completely characterized, suprabasin and Sprr2 are implicated as cornified 
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envelope precursor proteins and potential substrates of transglutaminase activity 
(Park et al., 2002; Cabral et al., 2001).
PCAD+ hair progenitor cells
 The PCAD+ hair progenitor population featured several signaling 
morphogens and transcription factors involved in hair morphogenesis (Table 2.4). 
Hair placode markers such as Bmp2, Bmp4, Edar, Shh, and Tgf-β2 were 
differentially expressed as previously described.  Despite the importance of Wnt 
signaling in hair morphogenesis, only one wnt ligand, Wnt5a, and one frizzled 
receptor, Fzd7, was identified in the PCAD+ hair progenitors.  Fzd7 expression 
has been reported to be upregulated in hair placodes (Reddy et al., 2004), but 
finding Wnt5a is perplexing in light of a study that found Wnt5a expression 
downstream of Shh in dermal condensates (Reddy et al., 2001).  In fact, the PCAD
+ cells expressed several Wnt inhibitory genes such as Wif1, which binds and 
sequesters Wnt ligands, and members of the dickkopf family, which inhibit the 
Wnt coreceptor Lrp6 (Mao et al., 2002).  The function of these negative regulators 
during hair development remains to be determined, but there appears to be a 





Bmp2 Botchkarev et al., 1999 Cutl1 Ellis et al., 2001
Bmp4 Botchkarev et al., 1999 Gli1 St-Jacques et al., 1998
Dkk3 Hoxc13 Godwin & Capecchi, 1998
Dkk4 Nmyc1 Mill et al., 2005
Edar Laurikkala et al., 2002 Prdm1 Horsley et al., 2006
Fgfr1 Peters et al., 1992 Sox9 Vidal et al., 2005
Fzd7 Reddy et al., 2004 Trps1 Malik et al., 2002
Hhip Vdr Li/Yoshizawa et al., 1997
Inhbb
Ptch2 St-Jacques et al., 1998 Bnc1 Weiner & Green, 1998
Pdgfa Karlsson et al., 1999 Bnc2 Romano et al., 2004
Pdgfrl Egr2 Gambardella et al., 2000
Sgk Myb Ess et al., 1999
Shh St-Jacques et al., 1998 Sox13 Roose et al., 1998
Tgfa Luetteke/Mann et al., 1993 Tbx1 Zoupa et al., 2006
Tgfb2 Foitzik et al., 1999
Tgfb3 Foitzik et al., 1999
Wnt5a Reddy et al., 2001
Wif1
Table 2.4  Selected genes in PCAD+ fraction.  Genes upregulated ≥2-fold in the 
PCAD+ cell population relative to the PCAD− cell population with established 
roles in hair follicle development are listed.  See appendix for raw values.
 Indicating active sonic hedgehog signaling in hair placodes, Shh ligand and 
its downstream transcriptional targets Ptch2, Gli1, and Hhip were expressed in the 
PCAD+ cells.  However, Ptch2 and Hhip are also negative regulators of Shh 
signaling, suggesting that feedback mechanisms might exist to restrict the level, 
location, and timing of Shh signaling during hair morphogenesis.
 Several members of the transforming growth factor-β (Tgf-β) family of 
signaling molecules were also preferentially expressed in the PCAD+ hair 
progenitor cells.  Among the three Tgf-β isoforms, only Tgf-β2 has been 
demonstrated to regulate proliferation in hair germs and mice lacking Tgf-β2 have 
fewer follicles and a delay in development (Foitzik et al., 1999; Jamora et al., 
2005).  This block in morphogenesis at the germ stage, similar to the Shh null, 
could also be secondary to defects in the dermal condensate since Tgf-β2 is 
sufficient to induce dermal condensations during feather bud development (Ting-
Berreth and Chuong, 1996).  Related family members Bmp2 and Bmp4 are also 
known to be expressed in the hair placodes, but unlike Tgf-β2, inhibition of their 
activity by Noggin is essential for proper hair morphogenesis (Botchkarev et al., 
1999; Jamora et al., 2003).  Inhbb is a subunit of the dimeric activins and inhibins. 
Loss of Inhbb does not affect development, but Inhba null mice have whisker and 
tooth defects (Schrewe et al., 1994; Matzuk et al., 1995).
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 Another positive regulator of hair morphogenesis, ectodysplasin receptor 
Edar, was upregulated in the PCAD+ cells.  A member of the tumor necrosis factor 
receptor family, Edar is mutated in humans with autosomal hypohidrotic 
ectodermal dysplasia who present with decreased hair follicles and abnormal teeth 
and sweat glands.  A similar phenotype is manifested in X-linked anhidrotic 
ectodermal dysplasia where mutations are found in the Edar ligand, Eda.  Identical 
phenotypes also exist in the corresponding Edar and Eda mouse mutants, downless 
and tabby, which lack particular hair follicle types and exhibit tooth and sweat 
gland defects (Headon and Overbeek, 1999; Laurikkala et al., 2002).  Components 
downstream of Edar, particularly the NF-κB pathway, have also been identified to 
affect the development of ectodermal appendages (Botchkarev and Fessing, 2005; 
Schmidt-Ullrich, et al., 2006).
 The PCAD+ hair progenitor genes also contained components of tyrosine 
kinase receptor signaling pathways.  Transforming growth factor-α (Tgf-α) signals 
through the receptor Egfr to mediate proliferation and survival via activation of the 
Mapk or Akt pathway.  In the hair follicle, Tgf-α may function in regulating 
orientation and shape because the Tgf-α mutation in the waved-1 mouse is 
characterized by curly whiskers and a wavy hair coat (Luetteke et al., 1993; Mann 
et al., 1993).  Similarly, loss of Fgfr2-IIIb, a fibroblast growth factor receptor also 
known as keratinocyte growth factor receptor, results not only in fewer but also 
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misaligned hair follicles (Li et al., 2001; Petiot et al., 2003).  Fgfr2 is expressed 
throughout the basal layer of the epidermis during development, but a role for 
Fgfr1 found to be upregulated in the PCAD+ hair progenitors and the underlying 
dermal condensates remains to be established (Peters et al., 1992).  A function for 
Sgk1, an intracellular kinase similar to Akt, in hair morphogenesis is also 
unknown, but Sgk3 knockout mice display abnormal hair structures possibly due 
to reduced proliferation of hair progenitor cells and subsequently a shorter hair 
cycle (Alonso et al., 2005).  Misshapen and sparse hair along with reduced 
proliferation is also seen in Pdgfa null mice (Karlsson et al., 1999), which signals 
through the platelet-derived growth factor receptor tyrosine kinase Pdgfr.
 Transcription factors associated with genetic hair disorders were also 
differentially expressed in the PCAD+ hair progenitor cells.  Trps1 is mutated 
patients with trichorhinophalangeal syndrome, a dominantly inherited disorder 
characterized by sparse scalp hair and craniofacial abnormalities (Momeni et al., 
2000).  Mutant mice lacking the Gata domain of Trps1 display similar facial 
features, no whisker follicles, and reduced pelage hair follicles (Malik et al., 
2002).  Vitamin D receptor (Vdr) mutations cause vitamin D-dependent rickets 
type II.  Along with hypocalcemia, hyperparathyroidism, osteomalacia, and 
rickets, some patients exhibit alopecia.  In mouse Vdr mutants, hair loss after the 
initial morphogenetic hair cycle is completely penetrant (Yoshizawa et al., 1997; 
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Li et al., 1997).  Unlike the metabolic disorders, alopecia is not found in vitamin D 
deficiency, suggesting that the effects of Vdr within the hair follicle are ligand 
independent (Sakai et al., 2001; Skorija et al., 2005).  As a nuclear hormone 
receptor, Vdr heterodimerizes with other nuclear receptors such as retinoid X 
receptor (Rxr) and the corepressor hairless (Hr) on target genes (Hsieh et al., 
2003).  Interestingly, inactivation Rxr-α and Hr phenocopy loss of Vdr, 
histologically developing utricles and dermal cysts in lieu of initiating postnatal 
hair cycles (Li et al., 2001; Zarach et al., 2004).
 Although not implicated in human disease, mutations in Hoxc13 and Cutl1 
also cause postnatal hair follicle defects.  Hoxc13 is strongly expressed in the hair 
shaft and mutant mice lack external hairs attributable to brittle hair follicles 
(Godwin and Capecchi, 1998).  Reflecting its expression pattern in the inner root 
sheath progenitors, Cutl1 deficient hair follicles are structurally abnormal due to 
diminished inner root sheath differentiation (Ellis et al., 2001).  Since the hair 
follicle defects in these mutants are manifested postnatally, the expression of these 
genes has not been analyzed in embryonic skin during hair morphogenesis.
 Other transcription factors of the PCAD+ cell population have been 
demonstrated to be expressed in the hair placode during morphogenesis.  Sox9 is 
activated in the epithelium upon hair induction and its expression persists 
throughout the outer root sheath as development proceeds.  Mice with disrupted 
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Sox9 also exhibit hair fragility because of defects in the outer root sheath which 
acquire more epidermal characteristics.  Furthermore, Sox9 null hair follicles lack 
expression of several bulge markers, suggesting a role in maintaining the stem cell 
compartment (Vidal et al., 2005).  N-myc is also induced in the hair placode, 
coinciding with Shh expression (Mill et al., 2005).  A functional role for N-myc 
within early hair progenitors, as well as its intriguing inverse correlation to c-
Myc’s preferential expression in the interfollicular epidermis, awaits further 
investigation.  Similarly, expression of an assortment of additional transcription 
factors enriched in the PCAD+ cells have already been described in the developing 
hair follicle, but they have not been directly implicated in specifying hair 
progenitor cell fates, including basonuclin, Egr2/Krox20, c-Myb, Sox13, and Tbx1 
(Weiner and Green, 1998; Gambardella et al., 2000; Ess et al., 1999; Roose et al., 
1998; Zoupa et al., 2006).  Although genetic mouse mutants have been developed 
for Krox20 (Schneider-Maunoury et al., 1993; Swiatek and Gridley, 1993), c-Myb 
(Mucenski et al., 1991), and Tbx1 (Lindsay et al., 2001; Merscher et al., 2001; 
Jerome and Papaioannou, 2001), their embryonic or perinatal lethality has 
precluded any analysis of hair morphogenesis.
 Recently, Prdm1/Blimp1 was determined using conditional gene targeting 
to regulate the development of sebaceous glands, another lineage within the hair 
follicle.  Initially found to be expressed in the differentiated epidermis, inner root 
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sheath, and dermal papilla (Chang et al., 2002), Blimp1 is also expressed in a 
progenitor population that gives rise to mature sebocytes (Horsley et al., 2006). 
Since germline loss of Blimp1 is embryonic lethal before hair morphogenesis is 
induced (Vincent et al., 2005), utilizing conditional alleles to generate tissue-
specific mutants was essential in this case to evaluate the function of genes 
expressed in the hair follicle.
Comparisons with other cell populations
 The presence of physiologically significant genes within the PCAD− 
interfollicular and PCAD+ hair progenitor cell populations validated the functional 
importance of the differentially expressed genes in regulating epidermal cell fates. 
To gain further insights into the attributes of these cells, comparisons were made 
to the “molecular signatures”  of other cell populations from mature hair follicles 
and epidermis (Rendl et al, 2005 and unpublished data).  Approximately 40% of 
the 1394 differentially expressed embryonic genes were in common with either the 
interfollicular epidermis, outer root sheath, or matrix signature genes (Figure 2.9). 
Notably, the PCAD− genes composed of over 96% of the overlap with the 
interfollicular epidermis whereas the PCAD+ genes composed of around 84% and 
76% of the overlap with the outer root sheath and matrix, respectively.  Thus, the 
degree of overlap revealed similarities of the embryonic cell populations to 
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postnatal hair follicle compartments and further confirmed their intrinsic 
differences.  This comparative analysis was also extended to a transcriptional 
profile of the postnatal hair follicle bulge (Blanpain et al., 2004).  Of the 
approximately 36% shared genes in the hair germ, nearly 75% exhibited a similar 
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Figure 2.9  Comparisons to other epithelial cell lineages.  The differentially 
expressed genes in the embryonic PCAD+ and PCAD− cell populations were 
compared to the “molecular signatures” of the interfollicular epidermis (IFE), 
outer root sheath (ORS), and matrix isolated from postnatal day 5 skin (Rendl et 
al., 2005 and unpublished data).  Of the genes overlapping with each epithelial cell 
lineage, the proportion represented by the PCAD+ and PCAD− cell populations 
are color-coded in red and green, respectively.  Values in parentheses represent the 
total number of genes in each set.
differential expression pattern in the bulge (Figure 2.10), suggesting that the 
embryonic hair progenitors exhibit molecular and thus functional properties 
similar to those of adult stem cells.
 Given the importance of gene regulation in determining cell lineages not 
only in skin but throughout development, a list of all transcription factors 
differentially expressed in the PCAD+ and PCAD− cell populations was generated 
(Table 2.5).  A strong correlation also existed with these genes and the bulge stem 
cells.  Since a smaller array was used to profile the bulge, the overlap is likely an 
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Figure 2.10  Comparison to the postnatal hair follicle bulge.  The differentially 
expressed genes in the embryonic hair progenitors were compared to the 
differentially expressed genes in the postnatal hair follicle bulge during anagen 
(Blanpain et al., 2004).  Of the genes in common, the proportion of genes which 
showed the same trend in expression (up or down in the hair germ and bulge 
relative to their respective reference) is represented in red.  Values in parentheses 
represent the total number of genes in each set.
under-representation of the actual similarities between the embryonic hair 
progenitors and the adult stem cells.
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PCAD+ PCAD−
Bach2 Id4 Runx1 Aff1 Mafb Sox6
Bcl6 Isl1 Runx2 Ankrd22 Mef2c Sox7
Bnc1 Lhx2 Scmh1 Ascl2 Mllt2h Stat1
Bnc2 Lbh Six4 Ell2 Mrg1 Tcfap2e
Cutl1 Lass4 Sox2 Esr1 Msl2 Tcfcp2l1
Dach1 Mitf Sox9 Foxn1 Myc
Dlx2 Myb Sox13 Ghr Nfia
Egr2 Nap1l5 Sox21 Grhl1 Nr2f2
Egr3 Nfatc1 Sp5 Grhl3 Nrip3
Foxc1 Nfe2l3 Tbx1 Hoxa1 Ovol1
Gli1 Nmyc1 Tcf7 Irx3 Pou3f1
Gtf2ird1 Nr4a1 Tcfl5 Klf3 Ror1
Hmga2 Prdm1 Trps1 Klf4 Rora
Hoxc13 Prdm5 Vdr Klf5 Satb1
Id2 Rai14 Zfp566 Klf12 Spib
Table 2.5  Differentially expressed transcription factors.  All regulators of gene 
expression upregulated ≥2-fold in either the PCAD+ (hair progenitors) or PCAD− 
(interfollicular basal keratinocytes) relative to the other are listed.  Highlighted in 
red are genes upregulated and in blue are genes downregulated within the bulge of 
postnatal hair follicles compared against the total skin epithelial cell population.  
The gene overlap is likely underrepresented since a smaller array was used to 
profile the bulge stem cells (Blanpain et al., 2004).  See appendix for raw values.
Label retaining cells during hair morphogenesis
 The molecular similarities of the embryonic hair progenitors to bulge stem 
cells suggest that they might also share functional attributes.  One of more salient 
features of bulge stem cells is their relative quiescence, thereby gaining an ability 
to retain nucleotide label (Cotsarelis et al., 1990; Morris and Potten, 1999). 
However these studies labeled mice throughout the neonatal period as the hair 
follicle fully develops into an anagen follicle and focused on periods after the 
initial morphogenetic hair cycle.  To determine if label retaining cells exist within 
hair follicles during morphogenesis, embryos were pulsed with the nucleotide 
analog bromodeoxyuridine (BrdU) at days E16.5 and E17.5 when the majority of 
hair induction occurs, and chased for various lengths of time (Figure 2.11).  After 
two days of chase, nearly every cell throughout the epidermal basal layer 
including early hair germs retained BrdU, confirming the completeness of 
labeling.  As hair morphogenesis was followed during subsequent days, the BrdU 
label diluted out particularly in the highly proliferative matrix cells.  However, a 
group of cells located in the upper outer root sheath beneath the developing 
sebaceous gland characteristically retained BrdU.  Seen in almost every hair 
follicle, these label retaining cells persisted throughout the initial hair cycle and 
eventually resided in the adult hair follicle bulge, expressing the specific marker 
CD34 (Figure 2.11F).  Thus, this location within the upper outer root sheath of 
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developing hair follicles can be considered the presumptive bulge and likely 
originates from the embryonic hair placode.
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Figure 2.11  Label retaining cells during hair follicle morphogenesis.  Pregnant 
dams were injected with BrdU twice a day between E16.5 and E17.5, and their 
pups were analyzed for BrdU incorporation at indicated ages.  (A-E) Skin sections 
immunostained for BrdU show retention of the BrdU label in the upper outer root 
sheath beneath the sebaceous gland, which remains at the base of the postnatal 
telogen hair follicle (E).  Boxed area in (C) is magnified in (D).  (F) Epidermal 
cells were isolated from back skins of BrdU pulse-chased mice and analyzed by 
flow cytometry.  BrdU positive cells express CD34 and α6-integrin, markers of 
adult bulge stem cells (Trempus et al., 2003; Blanpain et al., 2004).  Images are 
color-coded according to the secondary antibodies used.
Discussion
 Hair follicle morphogenesis requires the interplay of several signaling 
pathways, but the molecular mechanisms that coordinate these signals into a 
transcriptional program of lineage commitment and differentiation have remained 
elusive.  To investigate changes that occur as hair follicles are induced from the 
epithelium, a strategy was developed to isolate and profile the gene expression of 
hair placodes and germs.  By comparing these cells to the interfollicular epidermis 
and other cell populations, new insights were revealed into the characteristics of 
embryonic hair progenitors.
Justification of strategy to isolate hair progenitors
 Although hair follicle induction occurs over several days during 
embryogenesis, utilizing differential P-cadherin expression at E17.5 to isolate 
early hair progenitor cells has distinct advantages.  Although the hair follicles at 
E17.5 are heterogeneous in their morphological development, dispase treatment 
separates early hair germs and interfollicular epidermis from more mature 
follicles, which have grown down and remain stuck within the dermis.  Since this 
enzymatic process is difficult to manipulate at earlier embryonic ages, a cell 
suspension derived from total skin (epidermis and dermis) prior to E17.5 would 
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include these more developed follicles, which also express P-cadherin, and hence 
be more heterogeneous.  The uniform expression of P-cadherin throughout the 
basal layer of the epidermis at even earlier ages when hair specification first begins 
precludes using this marker to selectively isolate hair progenitors.  Also 
considering that the majority of hair follicle induction occurs around E17.5, skin 
from this age is the most feasible to specifically isolate early hair progenitor cells 
from interfollicular epidermis.
 Substantiating this approach is the enriched expression of various hair 
placode markers in the sorted PCAD+ cells relative to the PCAD− cells, which is 
further supported by the microarray analysis.  In particular, a number of genes 
differentially expressed in the two cell populations are associated with diseases of 
either the hair follicle or epidermis.  Implicated in diverse cellular processes, these 
documented genes expand our current understanding of how ectoderm cells 
become committed to a hair lineage and undergo follicular morphogenesis. 
Furthermore, they lend biological significance to the expression profiles and point 
to possible functions of the many uncharacterized genes in hair morphogenesis.
Insights into hair follicle morphogenesis
 Upholding the concept as a signal integrator, the PCAD+ hair placode 
simultaneously expresses several critical morphogens, including components of 
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the Wnt, Shh, Bmp, Tgf-β, Edar and receptor tyrosine kinase signaling pathways. 
Disruption of each these pathways in genetically modified or mutant mice has 
elucidated their essential roles in various aspects of hair follicle morphogenesis.
 Initiation of hair follicle morphogenesis requires Wnt signaling, but the 
origin and specific ligand necessary to direct activation remains elusive. 
Confirming a previous study on Wnt gene expression in hair placodes, Wnt10b is 
upregulated in isolated PCAD+ cells by RT-PCR (Reddy et al., 2001).  However 
this difference is not reflected in the microarray due to probe design.  This 
technical issue aside, other Wnt ligands are preferentially expressed in either the 
PCAD+ hair progenitors (Wnt5a) or the PCAD− interfollicular epidermis (Wnt3a, 
-4, -10a, -16).  Although not all of these ligands may act through the canonical 
signaling pathway to stabilize β-catenin, the broad expression of Wnts suggests 
the need to spatially restrict their activity to initiate hair follicle induction. 
Interestingly, only the PCAD+ cells differentially express several Wnt inhibitory 
genes.  Although expression of these inhibitory factors may indicate feedback 
mechanisms to regulate the level and timing of Wnt activation within the hair 
placode, they could also as secreted inhibitors laterally restrict the extent of Wnt 
activity, thereby localizing it to sites of hair follicle induction.
 Lateral inhibition may also be the role of Bmp signaling in specifying the 
hair cell lineage and regulating placode size.  Although Bmp2 and Bmp4 are highly 
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expressed in the PCAD+ hair placode, their local inhibition by Noggin derived 
from the dermal condensates is necessary for proper hair follicle induction 
(Botchkarev et al., 1999; Jamora et al., 2003).  In contrast, excess Bmp signaling 
suppresses epidermal appendage development in a variety of systems (Botchkarev 
et al., 1999; Jung et al., 1998; Noramly and Morgan, 1998).  Thus, Bmps could 
prevent surrounding cells from adopting a hair follicle fate, and by establishing a 
morphogen gradient also regulate the spacing of hair placodes from each other.
 Other positive regulators of hair follicle induction are strongly expressed in 
the PCAD+ hair progenitors.  Edar is necessary for guard hair induction and also 
regulates aspects of zigzag hairs (Laurikkala et al., 2002).  Tgf-β2 is necessary for 
induction and subsequent growth of a majority of hair follicles (Foitzik et al., 
1999).  Since absence of either of these signals does not completely abrogate hair 
follicle induction, specifying hair placodes from embryonic ectoderm likely results 
from a competition between activators and repressors in which negative regulators 
must be counteracted for hair morphogenesis to initiate and proceed.
 The PCAD+ hair placode also expresses several signals required for 
morphogenetic events downstream of induction.  Not necessary for specifying hair 
follicles, Shh is expressed in hair placodes to promote epidermal proliferation and 
to organize the underlying mesenchyme into dermal condensates upon induction 
(St-Jacques et al., 1998; Chiang et al., 1999).  Pdgfa also promotes the 
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development of the dermal condensate (Karlsson et al., 1999).  Both Shh and 
Pdgfa may also have a role in determining the polarity and shape of the hair 
placode, because grafted skin from mutant mice null for Shh or Pdgfa have 
abnormally angled hair follicles.  Although this could be attributable to defects in 
the dermal papilla, the lack of overall orientation in Shh null hair germs and the 
asymmetric localization of Shh  expression in mature hair follicles suggest that 
these signals may govern the normal anterior to posterior direction of hair growth.
 Regulation of polarity and orientation within the hair placode is further 
supported by the expression of components of receptor tyrosine kinase signaling 
pathways in the PCAD+ cells.  Although the curly and misshapen hair phenotypes 
of mutant mice with defects in genes such as Tgf-α are manifested in adult 
follicles, the expression of these factors in hair placodes suggests that polarity cues 
are received and set up early in morphogenesis.  Since receptor tyrosine kinases 
are better known in growth and cell survival programs, links between proliferation 
and cell polarity in hair morphogenesis are intriguing, but remain to be 
determined.
 Changes in polarity and shape during morphogenesis is also dependent on 
rearrangements of cell adhesion and cytoskeletal dynamics (Jamora and Fuchs, 
2002).  Evidence of these changes occurring in the hair placode is found in the 
downregulation of intercellular and substratum adhesion molecules in the PCAD+ 
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cells relative to the PCAD− interfollicular basal keratinocytes.  Various 
components adherens junctions, desmosomes, tight junctions, and 
hemidesmosomes are all repressed in the hair placode.  This breakdown in cell-cell 
and cell-matrix contacts probably allows hair progenitors to alter their shape and 
motility to transform into a three-dimensional structure that buds from a sheet of 
epithelial cells (Hogan, 1999).  Keratinocytes with mutations in these components 
often display weakened adhesion and increased migration upon culture (Tasanen et 
al., 2004; Yin et al., 2005; Matter et al., 2005).  On the other hand, forced 
expression of E-cadherin, normally downregulated upon hair follicle induction, 
blocks invagination and hair follicle formation (Jamora et al., 2003), but complete 
loss of adhesion also prevents hair morphogenesis (Vasioukhin et al., 2001).  Thus, 
a proper balance of adhesion and motility is necessary to modulate the changes in 
polarity and shape during morphogenesis.  Since regulation of adhesion and 
cytoskeletal dynamics typically occurs at the post-transcriptional level, the 
observation of transcriptional differences in these molecules within the hair 
placode suggest that acquisition of a hair cell fate is accompanied by a different set 
of structural components which can facilitate the unique morphological properties 
of hair follicles.
 The best illustration that the hair placode adopts a distinct set of molecules 
upon induction is the differential expression of transcription factors which regulate 
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the defined genetic program for subsequent morphogenesis.  Specification of a hair 
cell lineage from the embryonic ectoderm entails a repression of epidermal 
differentiation regulators and an activation of regulators associated with hair 
follicle development.  Among the transcription factors expressed in the hair 
placode, several are implicated in hair follicle disorders.  Unexpectedly, these 
disorders are manifested later in development as specific lineages of the hair 
follicle are affected: outer root sheath (Sox9); inner root sheath (Cutl1); hair shaft 
(Hoxc13); sebaceous gland (Prdm1).  These lineage specific differentiation defects 
reflect the postnatal expression pattern of these genes, but their expression in the 
PCAD+ embryonic hair placode indicates that lineage determination may occur 
earlier in morphogenesis.  Two possibilities can be considered as to how these 
lineage specific regulators are simultaneously expressed in the hair placode. 
Consisting of early multipotent progenitor cells capable of differentiating into all 
the lineages of the hair follicle, the hair placode could co-express these critical 
factors of more committed downstream progenitors and then modulate their 
expression for specific follicular compartments to develop.  Alternatively, the hair 
placode may be a heterogeneous population of progenitor cells already committed 
to different lineages of the hair follicle, which become partitioned as specific 
follicular compartments develop.  Analysis of the expression pattern of these 
regulators at the cellular level and how they are controlled by environmental cues 
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during hair follicle induction and subsequent morphogenesis will be necessary to 
distinguish between these possibilities.  Nonetheless, the defined functions of these 
genes in determining cell fates will guide studies into the many uncharacterized 
transcription factors differentially expressed in the hair placode.
Insights into hair follicle stem cells
 In line with the multi-lineage potential of the hair placode, the gene 
expression profile of PCAD+ cells exhibits a strong similarity to the “molecular 
signatures”  of both the outer root sheath and hair matrix.  Even more striking is the 
molecular resemblance between the embryonic hair placode and the adult bulge 
stem cells, indicating that they might also share functional attributes.  Both the 
hair placode and bulge stem cells are undifferentiated, but possess the potential to 
differentiate into the diverse cell types of the entire hair follicle.  In theory, the hair 
placode also has self-renewal character by giving rise to the bulge which supplies 
cells for multiple rounds of hair growth throughout life.  However, whether the 
embryonic hair placode is composed of stem cells which persist as adult bulge 
stem cells is presently unknown.
 The presence of label retaining cells in a region of the upper outer root 
sheath of developing hair follicles is compelling evidence that a stem cell 
compartment exists prior to completion of the initial morphogenetic hair cycle. 
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Precisely located where the future bulge will develop, these label retaining cells 
remain as CD34 positive stem cells in the adult hair follicle.  In contrast to other 
studies which labeled the developing follicle once this presumptive bulge formed a 
few days postnatal, embryonic hair placodes and germs were pulsed and chased. 
This allowed the fate of labeled progenitor cells to be traced during morphogenesis 
from hair follicle induction to the presumptive bulge.
 More functional studies are necessary to demonstrate that initiation of hair 
follicle morphogenesis entails the specification of stem cells, but the persistence of 
label retaining cells clearly suggests that the hair placode contains slow cycling 
cells, a hallmark of adult bulge stem cells.  Identifying the hair placode as the 
embryonic origin of the bulge is also supported by the molecular similarities 
between them.  Further characterization into these shared genes will shed light into 




 The following mice were generous gifts: P-cadherin-/- (G. Radice, 
University of Pennsylvania); β-cateninfl/fl (R. Kemler, Max Plank, Freiburg). 
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TOPGAL and K14-ActinGFP were previously generated (DasGupta and Fuchs, 
1999; Vaezi et al., 2002).  For timed pregnancies, the morning of a vaginal plug 
was considered embryonic day E0.5.
Histology and immunofluorescence
 Tissues were embedded in OCT (Tissue-Tek) and immediately frozen on 
dry ice.  Sections of 10μm were cut with a cryostat onto glass slides, fixed in 4% 
paraformaldehyde for 8 minutes, and subjected to immunofluorescence 
microscopy.  When applicable, the MOM Basic Kit (Vector Labs) was used to 
prevent non-specific binding of mouse monoclonal antibodies.  Otherwise, 
stainings were performed in phosphate buffered saline (PBS) with 0.1% Triton 
X-100, 2.5% normal donkey serum, and 2.5% normal goat serum.  BrdU 
unmasking involved treatment with 1M HCl at 37°C for 45 minutes prior to 
blocking.  Primary antibodies were incubated overnight at 4°C and secondary 
antibodies at room temperature for 1 hour.  Slides were washed after antibody 
incubations with PBS for 5 minutes, three times.  Antibodies and dilutions used: P-
cadherin (rat, 1:100; M. Takeichi, Riken, Kobe); α6-integrin (rat, 1:100; 
Pharmingen); β4-integrin (rat, 1:100; Pharmingen); K5 (rabbit, 1:500; Fuchs lab); 
K1 (rabbit, 1:500; Fuchs lab); BrdU (rat, 1:500; Abcam); FITC (1:100; Jackson) or 
Alexa594 (1:1000; Molecular Probes) conjugated secondary antibodies.  Nuclei 
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were stained with 4’6’-diamidino-2-phenylindole (DAPI; 1:10000) in a single 
wash step after staining.  Slides were mounted with antifade.  Imaging was 
performed using Zeiss Axioskop and Axiophot microscopes equipped with Spot 
RT (Diagnostic Instruments) and Axiocam (Zeiss) digital cameras, respectively.
Isolation of hair progenitors and flow cytometry
 Back skins from E17.5 K14-ActinGFP transgenic or other genetic embryos 
were dissected using the shoulders and hips as landmarks, and treated overnight 
with dispase (Gibco, 0.4mg/mL) at 4°C, which selectively removed the epidermis, 
hair placodes, and hair germs from the rest of the skin upon mechanical 
manipulation.  The epidermal fraction was treated with versene, a solution of 
0.5mM ethylenediaminetetraacetic acid (EDTA) in phosphate buffered saline 
(PBS) with 0.1% glucose, and cell suspensions were neutralized with culture 
media (E high calcium) and strained (40μM pores; BD Biosciences).  Single cells 
were washed once and resuspended in PBS containing CaCl2 and MgCl2 (Gibco) 
with 5% fetal bovine serum at a concentration of 107 cells/mL.  Approximately 106 
cells can be obtained per embryonic back skin and typically between 5-15 
embryos were used per isolation and sort.  Cells were incubated with primary 
antibodies coupled to biotin for 30 minutes on ice, and after washing once with 
PBS, cells were stained with streptavidin and antibodies directly conjugated to 
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specific fluorophores for 30 minutes on ice.  Cells were washed once in PBS and 
resuspended in 300ng/mL propidium iodide for dead cell exclusion.  All 
centrifugation steps were performed at 300xg for 5 minutes at 4°C.  Cell sorts 
were performed on a FACSVantage SE system equipped with FACS DiVa 
software (BD Biosciences).  Epidermal cells were gated for single events and 
viability, then sorted according to their expression of K14-ActinGFP, α6-integrin, 
and P-cadherin.  Typically after gating for GFP and α6-integrin expression, the 
brightest ~5% P-cadherin positive and negative cells were sorted as PCAD+ and 
PCAD− respectively.  Cells collected for RNA were directly sorted into lysis 
buffer, otherwise cells were collected into PBS with 5% serum.  Purity of sorted 
cells was determined by post-sort FACS analysis and typically exceeded 95%. 
Flow cytometry analysis was performed on a FACSort equipped with CellQuest 
(BD Biosciences).  Antibodies and dilutions used for FACS: P-cadherin 
conjugated to biotin (1:100, Fuchs lab); α6-integrin coupled to APC or PE (1:100, 
Pharmingen); β4-integrin (1:100, Pharmingen) coupled to APC; CD34 conjugated 
to biotin (1:50, Pharmingen); streptavidin-PE (1:1000, Pharmingen); streptavidin-
APC (1:200, Pharmingen).  Cytospin analysis was performed with a Cytospin4 
unit (Thermo/Shandon) onto glass slides, and stained as described above.
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β-galactosidase activity assay
 FACS sorted cells from TOPGAL/K14-ActinGFP double transgenic and 
K14-ActinGFP single transgenic E17.5 embryos were counted and equal numbers 
of cells were analyzed using Galacto-Light (Applied Biosystems) per 
manufacturer’s directions.  Between 15,000-20,000 cells were lysed in 20μL and 
the relative activity of β-galactosidase was measured against wild-type PCAD− 
cells.
RNA isolation and semi-quantitative RT-PCR
 Total RNA from FACS sorted cells was isolated using the Absolutely RNA 
Microprep kit (Stratagene) and quantified using Ribogreen (Molecular Probes). 
Approximately 105 sorted cells yielded 1μg of total RNA.  Normalized RNA 
quantities were reverse transcribed with Superscript III using oligo-dT primers 
(Invitrogen).  Typically, 30ng of total RNA was reverse transcribed into a 20μL 
volume of cDNA, which was then diluted 12-fold.  One microliter of this working 
stock was used as template for PCR reactions: 2.5μL of 10X PCR buffer with 
MgCl2, 0.5μL of 10mM dNTPs, 0.25μL of AmpliTaq DNA polymerase (Applied 
Biosystems), 0.5μL each of forward and reverse primers at 20mM, 1μL of 
template DNA, and 19.75μL of H2O.  PCR amplification of selected genes of 
interest was performed using primers designed to produce a product spanning 
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exon/intron boundaries.  Primers were designed using PrimerSelect of Lasergene 
(DNAStar) to work at the following settings: initial denaturing at 94°C for 3 
minutes; 27-36 cycles of 20 seconds at 94°C denaturing, 30 seconds at 60°C 
annealing, and 45 seconds at 72°C extension.  Primers used:
 gapdh: 5’-cgtagacaaaatggtgaaggtcgg-3’; 5’-aagcagttggtggtgcaggatg-3’
 pcad: 5’-tgccatggtcagacaaagaaagat-3’; 5’-gcttgggtgcctgagaacgaa-3’
 shh: 5’-aaagcgcacggaaggagactt-3’; 5’-acccccatggagcaggtttt-3’
 bmp2: 5’-gaagtggcccatttagaggagaac-3’; 5’-cccggaggtgccacgat-3’
 bmp4: 5’-agtccagctatagggaagcagtttg-3’; 5’-tccactggctgatcacctcaac-3’
 wnt10b: 5’-tgccctctgtccttttccaacc-3’; 5’-tgtaaatgaaggtgagcctcgc-3’
 msx2: 5’-tcaagtggccctgtcgcttag-3’; 5’-tatgctgccctcaggcttcag-3’
 keratin5: 5’-aacattttggggtctgggtcac-3’; 5’-ggcccacagagactgcttcttt-3’
 aqp3: 5’-gctggcccacatgaaacaca-3’; 5’-tcagcccctcccaatgtctatc-3’
 cdkn1a: 5’-agcagttgcgccgtgattg-3’; 5’-aggccgaagatggggaagag-3’
 c-myb: 5’-aaccctctaggagctcatttgtgg-3’; 5’-ctaagctctattgccccctgaca-3’
 cyclinD1: 5’-gctaccgcacaacgcactttcttt-3’; 5’-gcaccccctggctccctactctc-3’
 dach1: 5’-gcggcagcacaagttcagagt-3’; 5’-agatggaaagccgggaggtagt-3’
 dusp6: 5’-ccccgggtgtcaaaagtgtc-3’; 5’-ccacgaaaatgccgtcagaat-3’
 edar: 5’-gtttagaaggcggttgggttttt-3’; 5’-aggggaatcgcagcgtcat-3’
 enc1: 5’-ctgcctgctccgcttacaaat-3’; 5’-cccccaccccttccttca-3’
 fzd7: 5’-tggctccccttcctaatttgtatc-3’; 5’-gctggcattaaaaactgctctgag-3’
 gpr49: 5’-actcgcgtgttttgatctcatcc-3’; 5’-ccccttgctaggaggcagtaagt-3’
 hoxa1: 5’-tcaccccctaacttagctggtttc-3’; 5’-cattgtgcgacatgcagaagacta-3’
 idb4: 5’-gctgagctgcgatggatgg-3’; 5’-ggttggattcacgattgctcttct-3’
 klf3: 5’-cacgggtcagacctaaagaatgtg-3’; 5’-agcaggtgagccaggtcaaca-3’
 klf4: 5’-caccggccctttcagtgc-3’; 5’-cccccgtttggtacctttagg-3’
 lbh: 5’-tggaatagcgggttagaggacag-3’; 5’-cacggcaagaccaagacagataac-3’
 msx1: 5’-ctccccagccacctctttga-3’; 5’-tcttggcctctgcatccttagtt-3’
 naked1: 5’-tagacctggcggggatagagaa-3’; 5’-agatgggcagagggggagac-3’
 n-myc: 5’-ggcgaggcagcagcagtt-3’; 5’-gttcccaggggcatcaaatg-3’
 ptch2: 5’-caccctgccccagagttttg-3’; 5’-acccattgcgtcccagtgac-3’
 runx1: 5’-gccccaaggcctcctcat-3’; 5’-ccagcggttaggcttcatacg-3’
 runx2: 5’-tcggaggaaaggcactgactg-3’; 5’-gaaagcaaatcttgggcaatagc-3’
 sox2: 5’-ctcggcagcctgattccaata-3’; 5-tactggcaagaccgttttcgtg-3’
 sox9: 5’-cggcggaggaagtcggtgaagaac-3’; 5’-ggtgggtgcggtgctgctgatg-3’
 sox13: 5’-ggtgtgggccaaggatgaacg-3’; 5’-tcccggagactgcaggtattgatg-3’
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 tcf1: 5’-caccctccccatgccaatac-3’; 5’-gcagccccacagagaaactga-3’
 tll: 5’-atgccgaccctccctcaga-3’; 5’-tacgtccccagatcttggaaaagt-3’
Microarray analysis
 Two rounds of amplification/labeling of 200ng total RNA was performed to 
obtain biotinylated cRNA for hybridization onto Affymetrix GeneChip Mouse 
Genome MOE430 2.0 oligonucleotide microarrays at the Genomics Core 
Laboratory of Memorial Sloan-Kettering Cancer Center (New York, USA).  Two 
entirely independent samples were used for data analyses.  Scanned microarray 
images were imported into GeneChip Operating Software (GCOS, Affymetrix) to 
generate signal values and present/absent calls for each probe set using the MAS 
5.0 statistical expression algorithm.  Assuming equal levels of total signal in each 
of the hybridizations, arrays were scaled to a target signal of 500 using default 
analysis parameters.  Data files were imported into GeneTraffic 3.8 (Iobion 
Informatics), and replicate hybridizations were grouped and compared using the 
Robust Multi-chip Analysis algorithm.  Genes represented with probe sets ≥2-fold 
increased in one population over the other and called present in both replicates 
were considered significant.
 For comparative analysis, the overlap of probe sets from the “molecular 
signatures”  of P5 epidermal cell lineages (Rendl, unpublished data) and from the 
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adult hair follicle bulge (Blanpain et al., 2004) with the differentially expressed 
genes in the PCAD+ and PCAD− sorted cells was determined.
BrdU label retaining experiments
 Pregnant CD-1 females were intra-peritoneally injected with 50μg/g of 5’-
bromo-2’-deoxyuridine (BrdU, Sigma) twice a day for 2 days at E16.5 and E17.5 
and analyzed for BrdU incorporation postnatally.  Back skins were processed for 
immunofluorescence as described.  For flow cytometry, back skin was dissected 
and the subcutaneous fat was scraped using a scalpel.  After treatment with trypsin 
plus EDTA (Gibco, 0.25%) at 4°C overnight, the epidermal cells were scraped and 
neutralized cell suspensions were sequentially strained (70μM, then 40μM pores; 
BD Biosciences).  Single cells were resuspended in PBS with 5% fetal bovine 
serum and stained with primary and secondary antibodies as described above. 
BrdU detection was subsequently performed using BrdU Flow Kit (Pharmingen) 




LHX2 IN HAIR FOLLICLES
 Multiple signaling pathways converge to initiate hair follicle 
morphogenesis from embryonic ectoderm and activate bulge stem cells to 
regenerate the hair follicle.  However, the molecular mechanisms that mediate the 
response to these signals and direct the transcription of effector genes are largely 
unknown.  By isolating and profiling the gene expression of hair placodes and 
interfollicular epidermis, a number of transcriptional regulators were identified 
that could orchestrate lineage determination of multipotent skin progenitors.  An 
indication of their functional similarities and possible developmental origin, the 
adult hair follicle bulge expressed several transcription factors in common with the 
embryonic hair placode.  To explore the possibility that these shared transcription 
factors govern fundamental characteristics of both embryonic hair progenitors and 
adult stem cells, I focused on one of these factors, Lhx2.
 Lhx2 belongs to the LIM-homeodomain (LIM-HD) family of transcription 
factors, which regulate patterning and cell specificity during the development of a 
variety of tissues and organs, particularly the central nervous system (Hobert and 
Westphal, 2000; Hunter and Rhodes, 2005).  Initially cloned in a screen for 
markers of early B-lymphocyte differentiation, Lhx2 is also expressed in the 
developing brain, retina, olfactory organs, liver, and limbs (Xu et al., 1993; 
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Rincon-Limas et al., 1999).  Exhibiting a functional role in these tissues, Lhx2 null 
mutant embryos lack forebrain structures, are anophthalmic, have no mature 
olfactory sensory neurons, develop liver fibrosis, and die in utero between E15.5 
and E16.5 due to impaired definitive erythropoiesis (Porter et al., 1997; Hirota and 
Mombaerts, 2004; Kolterud et al., 2004; Wandzioch et al., 2004).  On the other 
hand, forced expression of Lhx2 can immortalize multipotent hematopoietic 
progenitor cells in vitro and is associated with chronic myelogenous leukemia 
(Pinto do O et al, 1998; −2002; Richter et al., 2003; Wu et al., 1996).  Although 
Lhx2  null mice have no limb abnormalities, Lhx2 is the mammalian ortholog of 
Drosophila apterous, best known in wing imaginal discs as a selector gene for 
dorsal identity and in regulating wing outgrowth (Cohen et al., 1992).  Lhx2 
therefore appears to control the status of progenitor cells in several developmental 
contexts, particularly during organ expansion, but a possible role for Lhx2 in skin 
has not been examined.
 In this study, I assessed whether Lhx2 can regulate lineage determination in 
the skin as it does in other tissues.  Expressed in embryonic hair progenitors upon 
induction of hair morphogenesis, Lhx2 became restricted to the stem cell 
compartment as hair follicle development progressed.  By analyzing its expression 
in genetic mutant embryos defective in aspects of hair morphogenesis, Lhx2 was 
positioned downstream of signals necessary to specify hair follicle stem cells, but 
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upstream from signals required to drive stem cells to terminally differentiate. 
Finally using gain- and loss-of-function studies, Lhx2 was demonstrated to 
maintain stem cells in a undifferentiated, quiescent state.
Results
Lhx2 expression during hair morphogenesis
 Lhx2 was upregulated 18-fold in the PCAD+ population relative to the 
PCAD– population, as determined by microarray analysis.  Semi-quantitative RT-
PCR of an independent sorted sample and in situ hybridization of E17.5 embryos 
confirmed this marked differential expression in early hair progenitors (Figure 
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Figure 3.1  Differential expression of Lhx2 in embryonic hair progenitors. 
(A)  Semi-quantitative RT-PCR on sorted cell populations of an independent 
sample confirms the up-regulated expression of Lhx2 in the E17.5 PCAD+ hair 
progenitors.  Closely related family member Lhx9 is not expressed in skin.  Total 
brain mRNA was used as a positive control.  (B) In situ hybridization of 
digoxigenin-labeled Lhx2 cRNA probe in E17.5 skin verifies the localization of 
Lhx2 in early developing hair follicles.  Lhx2 images were pseudo-colored and 
overlayed onto an immunofluorescence image of β4-integrin.
3.1).  When examined by immunofluorescence, Lhx2 first appeared in early hair 
placodes, and as morphogenesis progressed, became prominent at the leading front 
of invaginating hair germs and pegs (Figure 3.2A).  As downgrowth neared 
completion and hair differentiation began, Lhx2 concentrated in the upper outer 
root sheath at the presumptive site of the developing postnatal follicle stem cell 
compartment (Figure 3.2A).  Concomitantly, expression diminished at the base of 
the follicle, where highly proliferative matrix cells give rise to the differentiating 
inner root sheath and hair shaft (Figure 3.2B).  In adult hair follicles, Lhx2 
concentrated in the bulge, and as the new hair cycle began, Lhx2 extended to the 
emerging secondary hair germs (Figures 3.2C-D).  Based on these patterns, Lhx2 
appears to function in specifying embryonic hair follicle progenitor cells that then 
persist as bulge stem cells in adult follicles.  Although the antibody used 
recognizes both Lhx2 and its closely related family member Lhx9, the latter is not 
expressed in the skin epithelia as determined by RT-PCR and microarray analysis 
(Figure 3.1). 
Lhx2 expression in genetic mutants
 To more precisely define the role of Lhx2 in hair follicle stem cell 
specification and/or maintenance, its status was examined in various genetic 
mutant embryos that are defective in different aspects of hair morphogenesis.  In 
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Figure 3.2  Lhx2 expression during hair morphogenesis and in postnatal stem 
cells.  (A-D) Back skin sections from mice at indicated ages were stained with 
antibodies as color-coded and counterstained with DAPI in blue.  Upon induction 
of hair morphogenesis, Lhx2 is expressed in epithelial cells at the leading front of 
invaginating follicles and in the postnatal bulge compartment, but is diminished in 
mature proliferative hair progenitors (Mx).  Abbreviations: Pc, placode; HG, hair 
germ; Peg, hair peg; HF, hair follicle; Bu, (presumptive) bulge; ORS, outer root 
sheath; Mx, matrix; DC, dermal condensate; DP, dermal papilla; 2°HG, secondary 
hair germ emerging at the start of the postnatal hair cycle.  Scale bars, 20μm.
the complete absence of hair follicle induction or bulge maintenance, as reflected 
in β-catenin conditionally null (cKO) skin, Lhx2 was not expressed (Figure 3.3A). 
In Shh knockout embryos where hair follicles are specified but unable to progress 
beyond the germ stage, Lhx2 expression was dramatically reduced (Figure 3.3B). 
This positioned Lhx2 downstream of Wnt and Shh, where it could play a role in 
establishing or expanding the early progenitors necessary for hair follicle 
morphogenesis. 
 Bmp signaling is not required for hair follicle induction, even though Bmp 
ligands and receptors are expressed in embryonic hair germs and in postnatal 
follicle stem cells.  Correspondingly, in BmpR1a cKO skin where a Bmp receptor 
is ablated in the epidermis, Lhx2 was normally expressed in both embryonic hair 
germs and the presumptive bulge of developing follicles (Figure 3.3C-D). 
However, Bmp signaling is required for hair differentiation and in the absence of 
BmpR1a, proliferating undifferentiated hair progenitor cells accumulate at the 
follicle base (Andl et al., 2004; Kobielak et al., 2003).  Lhx2 was noticeably 
enhanced in these follicles, with strong staining throughout the outer root sheath 
and matrix (Figure 3.3D-E).  These cells were also positive for Shh and Lef1. 
Thus, in the absence of terminal hair differentiation, cells accumulating in 




Figure 3.3  Lhx2 expression in genetic mutants of hair morphogenesis.  Skin 
sections from indicated genetic mutant mice and their wild-type littermates were 
stained with antibodies as color-coded and counterstained with DAPI in blue.  (A) 
Lhx2 is not expressed in the absence of hair follicle induction, as reflected in the 
β-catenin conditional null.  (B) Lhx2 is reduced in Shh null hair germs, where 
follicles are specified but unable to progress further.  (C-E) Lhx2 is expressed 
normally in BmpR1a conditional null hair germs and presumptive bulges, but 
persists in the lower ORS and Mx of neonatal and adult follicles.  Unable to 
undergo terminal differentiation, these Lhx2 expressing cells in the BmpR1a null 
follicles appear to be undifferentiated stem cells.  Scale bars, 40μm.
Lhx2 inhibits differentiation
 If Lhx2 governs the gene expression program of undifferentiated hair 
follicle stem cells or their early progenitors, then misexpression of Lhx2 in the 
interfollicular epidermis might result in an induction of hair follicle progenitor 
genes.  To test this possibility, K14-Lhx2 transgenic mice were engineered and two 
independent founder lines with and without a protein tag were analyzed (Figure 
3.4).  Transgenic pups from both founders failed to thrive and died at birth with 
open eyes, kinky whiskers, and some displayed a patch of erythematous skin 
beneath the chin (Figure 3.5).  Although more hair follicles were not induced, 
Lhx2 expression markedly suppressed morphological and biochemical signs of 
epidermal differentiation, and the skin failed to produce a functional lipid barrier 
(Figure 3.6).  The suprabasal keratin K1 and filaggrin, expressed in keratohyalin 
granules of terminally differentiating cells, were completely absent from 
transgenic epidermis.  Coinciding with the absence of these differentiation 
markers, the transgenic could not exclude a substrate from permeabilizing into the 
skin and converting into a blue precipitate.
 Similarly, transgenic expression of Lhx2 suppressed differentiation in the 
tongue epithelium.  Not normally expressed in the basal cells of tongue epithelia, 
ectopic Lhx2 inhibited the development and differentiation of filiform papillae 
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Figure 3.4  Design and expression of the Lhx2 transgene.  (A) Diagram of the 
K14-Lhx2 construct.  Full length murine Lhx2 cDNA with and without a C-
terminal HA epitope tag was cloned into the ~2 kB human keratin 14 promoter 
(Vasioukhin et al., 1999).  (B) Western blot of keratinocytes transfected with 
indicated constructs.  The same blot was probed with anti-Lhx2/9 and anti-HA 
antibodies.  Note the presence of endogenous Lhx9 in cultured keratinocytes. 
K14-ΔNΔCβ-catenin-HA served as a positive control for HA detection.  (C) 
Immunofluorescence analysis of transfected keratinocytes.  Cells were co-
transfected with K14-GFP and indicated Lhx2 transgenic constructs.  GFP 
expression identified transfected cells and antibodies used are color-coded in red. 
Nuclei are stained with DAPI in blue.
(Figure 3.7).  Of note, the differentiation defect in the tongue was evident at birth, 
but at this time the skin was morphologically and biochemically normal despite 
the robust expression of Lhx2 throughout the basal layer.  Abnormalities in the 
skin became evident a few days after grafting.  However, the redness seen beneath 
the chin of newborn transgenic pups (Figure 3.6) is reminiscent of the gross 
phenotype of grafted skin and is likely an area of suppressed epidermal 
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Figure 3.5  Gross phenotype of Lhx2 transgenic mice.  K14-Lhx2 transgenic 
(TG) mice are born, but fail to thrive with open eyes, abnormal whiskers, missing 
ear lobes, and a patch of erythematous skin beneath the chin.  The red skin is 
likely an area of suppressed epidermal differentiation manifested neonatally (see 
Figure 3.6).  All pictures are of newborn pups, except for the upper left of E17.5 
embryos.
differentiation.  Collectively, these findings suggest that Lhx2 can maintain 
epithelial cells in an undifferentiated state.
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Figure 3.6  Lhx2 inhibits terminal differentiation in skin.  Transgenic 
expression of Lhx2 in the interfollicular epidermis suppresses morphological and 
biochemical features of spinous, granular, and stratum corneum stages of 
epidermal differentiation.  Newborn skin sections from K14-Lhx2 transgenic (TG) 
and wild-type (WT) littermates were grafted for 8 days and processed for 
hematoxylin/eosin staining or immunofluorescence with antibodies as color-coded 
and counterstained with DAPI in blue.  Patches outlined in black denote skins 
grafted onto nude mice and subjected to a β-galactosidase substrate exclusion 
assay to test for an intact epidermal barrier.  The lack of a functional epidermal 
barrier in transgenic skin is evident by the penetration and conversion of the 
substrate into a blue precipitate.  The background absorption in the surrounding 
nude skin arises from defective hair follicle orifices.  Scale bar, 40μm.
Lhx2 promotes hair follicle stem cell fate
 In lieu of epidermal differentiation markers, the Lhx2 transgenic epidermis 
expressed genes associated with the hair follicle outer root sheath.  For example, 
keratin 17 (K17) expression, normally restricted to the outer root sheath, was 
expanded into the interfollicular epidermis (Figure 3.6).  Although K17 is also 
associated with hyperproliferative states, enhanced proliferation was not evident in 
the transgenic epithelium by Ki67 staining.  Instead, induction of Tcf3 and Sox9, 
two key transcription factors of adult hair follicle stem cells (Merrill et al., 2001; 
Vidal et al., 2005), was noticeably present in the transgenic epidermis before any 
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Figure 3.7  Lhx2 inhibits terminal differentiation in tongue.  Transgenic 
expression of Lhx2 in the tongue epithelium suppresses the development of 
filiform papillae as evidenced by the loss of differentiation markers.  Newborn 
tongue sections from K14-Lhx2 transgenic (TG) and wild-type (WT) littermates 
were immunofluorescence stained with antibodies as color-coded and 
counterstained with DAPI in blue.
overt changes in epidermal differentiation (Figure 3.8).  Nfatc1, an 
uncharacterized bulge transcription factor, was also ectopically expressed in the 
interfollicular epidermis.  Thus, Lhx2 alters the fate of epidermal cells and 
promotes the acquisition hair follicle stem cell characteristics.
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Figure 3.8  Expression of Lhx2 induces hair follicle stem cell markers.  Prior to 
overt changes in epidermal differentiation, transgenic expression of Lhx2 in the 
skin epithelium induces the interfollicular expression of transcription factors 
normally restricted to the hair follicle bulge.  (A) Newborn skin sections from 
K14-Lhx2  transgenic (TG) and wild-type (WT) littermates were grafted for 4 days 
and immunofluorescence stained with antibodies as color-coded and 
counterstained with DAPI in blue.  Scale bar, 40μm.  (B) Semi-quantitative RT-
PCR on mRNA isolated from epidermal cells of day 4 post-graft skin confirms the 
increased expression of bulge stem cell markers in the transgenic epidermis.
 If Lhx2 is required for hair follicle stem cell maintenance, then its absence 
could alter the ability of follicles to form.  In support of this notion, E16 Lhx2 null 
embryos displayed an ~40% reduction in the overall density of P-cadherin positive 
hair follicles, with no noticeable defect in the epidermis or embryo size (Figure 
3.9).  A marked reduction in follicle density is a feature of other mouse mutants in 
key hair follicle morphogenetic genes (Botchkarev et al., 1999; Foitzik et al., 
1999; van Genderen et al., 1994).  Although Lhx2 knockout follicle density was 
reduced, Shh, Wnt10b, Bmp2, Bmp4 and Lef1 expression appeared unaffected in 
those hair placodes and germs that developed independently of Lhx2 (Figure 
3.10A).  To follow hair follicle development beyond E16 in the Lhx2 null mutants, 
skin engraftments were performed.  Hair follicles from Lhx2 null grafts appeared 
morphologically and biochemically indistinguishable from their wild-type 
counterparts as judged by various markers of the companion layer, inner root 
sheath and hair shaft (Figure 3.10B).  Taken together, the gain- and loss-of-
function studies suggest that Lhx2, reflecting its expression pattern, functions to 




Figure 3.9  Loss of Lhx2 reduces hair follicle morphogenesis.  As reported, 
Lhx2 knockout (KO) embryos are noticeably paler than wild-type (WT) 
littermates, lack eyes, and have a slightly flattened forehead by gross morphology 
(Porter et al., 1997).  Pictured embryos are at E15.5.  Representative back skin 
sections from E16 Lhx2 KO and WT littermates show comparable epidermal 
differentiation but fewer follicles at all stages of development in Lhx2 null 
embryos.  The graph provides quantification from multiple sections of three 
embryos.  Abbreviations: Pc, placode; HG, hair germ; Peg, hair peg.  Scale bar, 
40μm.
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Figure 3.10  Development and differentiation of Lhx2 null hair follicles.  (A) 
Key signals regulating hair morphogenesis are expressed normally in follicles 
induced independently of Lhx2.  In situ hybridizations of E16 Lhx2 knockout 
(KO) and wild-type (WT) littermates were pseudo-colored and overlayed with an 
immunofluorescence image of β4-integrin.  (B) Hair differentiation is normal in 
Lhx2 null follicles.  Immunofluorescence staining with indicated antibodies of 
Lhx2 KO and WT skin grafts at mid-anagen show typical expression patterns of 
K6 (companion layer), AE15 (inner root sheath and medulla), AE13 (hair cortex), 
Gata3 (precursors of IRS), and Lef1 (precursors of cortex).
Lhx2 maintains follicle stem cells in a quiescent state
 If Lhx2 maintains the undifferentiated state of embryonic and adult follicle 
stem cells, then Lhx2 null follicles might exhibit alterations in the transition of 
stem cells from the resting (telogen) to the growing (anagen) phase of the 
postnatal hair cycle.  Using skin grafts taken from E15.5 embryos, the hair cycles 
of wild-type and Lhx2 knockout follicles were compared.  The initial 
morphogenetic and first postnatal Lhx2  knockout hair cycles progressed similarly 
to those in the wild-type and by 8 weeks, knockout follicles had returned to 
telogen (Figure 3.11).  By contrast, at 11 weeks when most wild-type follicles 
were still in this extended telogen, knockout follicles had precociously entered the 
next hair cycle (Figure 3.12A).  Moreover, when follicles were shaved at 8 weeks, 
most wild-type hairs remained in telogen whereas knockout hairs consistently and 
uniformly grew back within 3 weeks, confirming their shortened resting phase 
(Figure 3.12B-C).  Relative to non-grafted skin, there was an approximately one 
week delay in the overall hair cycle of wild-type grafts, but this was anticipated 
considering that embryonic skin was grafted and allowing for a few days of 
healing.  The length of the hair cycle and the timing of anagen initiation remained 
the same.  Thus, follicles in the skin grafts follow an intrinsic hair cycle clock and 
the defects in the Lhx2 null follicles are likely autonomous and not secondary to 
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grafting.  Furthermore, all grafts analyzed from wild-type and knockout littermates 
were placed on the same recipient to control for any systemic effects.
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Figure 3.11  Hair cycle of Lhx2 null hair follicles.  Histological analysis of Lhx2 
knockout (KO) and wild-type (WT) hair follicles at various ages post-engraftment. 
During the initial morphogenetic and first postnatal hair cycles, follicles behave 
largely synchronously and proceed with similar kinetics in WT and KO skin 
grafts.  After 8 weeks, WT hair follicles are in their second telogen stage, which in 
contrast to the short (1-2 days) first telogen, is prolonged for well over 3 weeks 
(Muller-Rover et al., 2001).  Lhx2 KO follicles are unable to hold this resting 
phase and precociously enter anagen by 11 weeks (Figure 3.12).
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Figure 3.12  Precocious anagen entry of Lhx2 null hair follicles.  (A) Histology 
of wild-type (WT) and Lhx2 knockout (KO) skins at 11 weeks post-engraftment. 
WT follicles are still in telogen, but KO follicles have prematurely entered anagen. 
Scale bar, 80μm.  (B) Upon shaving the grafted hair follicles at 8 weeks, WT hairs 
do not grow back, confirming their resting state, while hair growth is evident in the 
KO graft.  A small portion (*) of the WT graft grew hairs due to a wound response. 
(C) Another example of a shaving experiment demonstrating the regrowth of hair 
follicles in the KO graft after shaving while the WT graft remained at rest.  The 
edges of the WT graft adjacent to the nude skin grew back hairs probably due to a 
non-autonomous effect.
 The precocious activation of anagen in Lhx2 knockout hair follicles 
suggested a defect in the bulge stem cells.  Immunofluorescence and flow 
cytometry analyses revealed that knockout follicles exhibited diminished 
expression of CD34, a surface marker of bulge stem cells (Figure 3.13) (Trempus 
et al., 2003; Blanpain et al., 2004).  This reduction in CD34 was observed 
irrespective of hair cycle number or stage.  On the other hand, other stem cell 
markers examined were comparably expressed in wild-type and knockout hair 
follicle bulges (Figure 3.14).
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Figure 3.13  Diminished expression of CD34 in Lhx2 null hair follicles. 
Irrespective of the hair cycle stage, CD34 expression is dramatically reduced in 
Lhx2 knockout (KO) follicle bulges relative to wild-type (WT).  Shown are 
representative immunofluorescence images and flow cytometry profiles of telogen 
follicles at 8 weeks and anagen follicles at 40 days post-engraftment.  A summary 
of the percentage of α6-integrin positive cells that are also CD34 positive in each 
of the hair follicle stages was determined by flow cytometry.  Scale bar, 40μm.
 Although CD34 marks the normally quiescent adult stem cells, it is not 
found in the more proliferative embryonic skin progenitors, suggesting that its 
reduction could be an indication of enhanced proliferative activity within Lhx2 
knockout hair follicle stem cells.  This hypothesis was supported by 
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Figure 3.14  Expression of bulge markers in Lhx2 null hair follicles.  Although 
CD34 expression is dramatically reduced in Lhx2 null hair follicles, the expression 
of other bulge markers, Tenascin C and S100A6, appear to be normal in both 
telogen and anagen hair follicles.  Skin sections from Lhx2 knockout (KO) and 
wild-type (WT) grafts were immunofluorescence stained with antibodies as color-
coded and counterstained with DAPI in blue.
bromodeoxyuridine (BrdU) pulse-chase experiments conducted prior to marked 
deviations in hair cycling (Figure 3.15).  After a three day pulse period at the onset 
of anagen, both the wild-type and knockout hair follicles were equally labeled 
with BrdU, but only the wild-type follicle bulge retained appreciable label after a 4 
week chase (Blanpain et al., 2004; Taylor et al., 2000).  By contrast, knockout hair 
follicles displayed very few label retaining cells (LRCs), as confirmed and 
quantified by flow cytometry.
 The reduction in label retention was accompanied by enhanced proliferation 
within the Lhx2 null bulge.  After a 4-hour BrdU pulse during full anagen, the 
percentage of S-phase labeled bulge cells was twice as high as normal (Figure 
3.16).  By contrast, the number of S-phase cells in the interfollicular epidermis and 
outer root sheath of wild-type and knockout skins was comparable, underscoring 
the specificity of this hyperproliferation.  A similar result was observed in telogen 
follicles.  The elevated proliferative activity of the knockout bulge did not appear 
to alter the overall size of the stem cell niche.  Therefore without Lhx2, follicle 
stem cells are more readily activated to proliferate and differentiate along the hair 
lineage.  On the other hand, Lhx2 is not sufficient to induce quiescence, because 




Figure 3.15  Loss of BrdU label retention in Lhx2 null follicle stem cells.  Lhx2 
knockout (KO) and wild-type (WT) skin grafts were pulsed with BrdU for 3 days 
at the onset of anagen between days 26 to 28, then chased for 4 weeks when hair 
follicles reentered telogen.  Analysis of BrdU staining indicates that label retaining 
cells (LRCs) concentrated in the infrequently dividing bulge stem cells of WT 
follicles, but were diminished in Lhx2 KO follicles.  Shown are representative skin 
sections stained with antibodies to BrdU and flow cytometry profiles of BrdU 
incorporation in the α6-integrin, CD34 positive bulge cells.  Results of 
quantification by flow cytometry is provided.  BrdU incorporation after the 3 day 
pulse period was also analyzed by flow cytometry and shows equivalent labeling 
in both WT and KO grafts.  Scale bar, 20μm.
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Figure 3.16  Increased BrdU incorporation in Lhx2 null follicle stem cells. 
Lhx2 knockout (KO) and wild-type (WT) skin grafts were pulsed with BrdU for 4 
hours at day 40 (anagen) or at 8 weeks (telogen) before cells were isolated and 
analyzed for BrdU incorporation by flow cytometry.  Proliferation was enhanced 
in Lhx2 KO hair follicle bulges relative to WT.  Shown are representative profiles 
of cells gated on α6-integrin (red) and analyzed for CD34 expression and BrdU 
incorporation.  Results of quantification by flow cytometry is provided.
Discussion
 Characterization of Lhx2 in hair follicles has revealed its role in regulating 
the status of progenitor cells in the skin (Figure 3.17).  Initially expressed in the 
embryonic hair placode, Lhx2 contributes to the specification and possible 
expansion of these early hair follicle progenitors.  Lhx2 is not expressed in the 
absence of hair follicle induction and is dramatically diminished in arrested hair 
follicles that are unable to proliferate and undergo further morphogenesis.  In 
addition, targeted loss of Lhx2 reduces the overall number of initiated hair 
follicles.  Although hair morphogenesis can proceed without Lhx2, null follicles 
that do form are unable to hold a resting state and precociously enter new hair 
growth cycles.  This is a result of Lhx2 expression in the hair follicle bulge where 
it functions to maintain stem cells in a quiescent and undifferentiated state.  The 
precocious activation of bulge stem cells is accompanied by enhanced 
proliferation and loss of label retaining cells in Lhx2  null hair follicles.  Once 
committed, cells exiting the bulge no longer require or express Lhx2 and proceed 
along a normal program of terminal differentiation by receiving additional 
signaling cues and altering gene expression.  Progenitor cells incapable of 
responding to these cues continue to express Lhx2 and remain undifferentiated. 
The sufficiency of Lhx2 to maintain the undifferentiated state of epithelial cells is 
supported by the forced expression of Lhx2 in the epidermis and tongue, where it 
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can inhibit all signs of differentiation.  Thus, Lhx2 appears to function as a 
molecular brake in regulating the switch between hair follicle stem cell 
maintenance and their activation to terminally differentiate.
 Although not sufficient to induce de novo hair morphogenesis, Lhx2 can 
also change the fate of epidermal cells and induce the expression of key hair 
follicle stem cell genes.  Two of these genes, Tcf3 and Sox9, have been described 
to functionally regulate hair follicle stem cell lineages (Merrill et al, 2001; Vidal et 
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Figure 3.17  Model for Lhx2 during hair follicle development.  Lhx2 is present 
in the early embryonic hair progenitors of the placode where it contributes to the 
specification of hair follicles.  As morphogenesis proceeds, Lhx2 becomes 
restricted to the presumptive bulge cells, and postnatally it remains as a faithful 
bulge stem cell marker, where it functions to maintain cells in an undifferentiated, 
quiescent state.  As stem cells become activated and embark upon different follicle 
lineages within the hair matrix, they down-regulate Lhx2 expression and induce 
expression of other transcription factors required for cell fate determination.  In 
response to external signaling cues, the precursors become further committed to 
terminally differentiate.
al., 2005).  Interestingly, several lines of evidence suggest that Lhx2 may function 
upstream of these factors in orchestrating hair follicle development.  Similar to 
Lhx2, transgenic expression of Tcf3 also suppresses terminal epidermal 
differentiation and promotes features of the outer root sheath and bulge (Merrill et 
al., 2001).  However unlike transgenic expression of Lhx2, early suprabasal 
markers of differentiation are normal and stratification of the epidermis seems to 
occur in Tcf3 transgenics.  Although this discrepancy could be attributable to 
developmental differences in the timing of when the skins are analyzed, a recent 
study which conditionally induces Tcf3 for extended periods of time at various 
ages corroborates the initial findings in the Tcf3 transgenic mice (Nguyen et al., 
2006).  In addition, induction of Tcf3 did not give rise to Lhx2 expression in the 
epidermis (data not shown).  Thus the greater severity of the Lhx2 transgenic 
phenotype which induces Tcf3 combined with the lack of Lhx2 induction in the 
Tcf3 transgenic suggests that Lhx2 can promote Tcf3 activity, but not vice versa. 
Furthermore, while the endogenous expression pattern of Lhx2 is largely restricted 
to the bulge, Tcf3 expression extends throughout the lower outer root sheath, 
considered to be the immediate progeny of bulge stem cells.  Although sustaining 
Tcf3 expression in the outer root sheath is likely independent of Lhx2, it is 
fascinating to speculate that Lhx2 may induce Tcf3 expression in the bulge to 
regulate the outer root sheath lineage during hair growth.
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 Similarly, the expression of Sox9 is also broader than Lhx2 in the hair 
follicle.  Along with its expression in the bulge, Sox9 is present throughout the 
outer root sheath like Tcf3.  However during early hair morphogenesis, Sox9 
expression appears to trail Lhx2 expression at the leading edge of invaginating 
hair follicles, and while Lhx2 becomes concentrated at the presumptive bulge, 
Sox9 continues to be expressed in the lower outer root sheath (data not shown). 
This difference in expression pattern is reflected in the distinct hair follicle 
phenotypes of the Lhx2 null and Sox9 conditional null mice.  Although both 
mutant mice lack expression of the bulge specific marker CD34, the basis for this 
loss are completely different.  In the Lhx2 null, loss of CD34 is likely a 
consequence of the enhanced proliferative state of follicle stem cells.  However in 
the absence of Sox9, the outer root sheath, and with it the bulge and entire hair 
structure, completely degenerates around the time developing follicles begin to 
penetrate the skin surface (Vidal et al., 2005).  Thus reflecting their different 
expression patterns, Lhx2 and Sox9 regulate distinct cell types in the hair follicle, 
with Sox9 affecting the differentiation of a more downstream lineage than Lhx2. 
Although these genes seem to co-localize within the bulge, further studies are 
necessary to address if Lhx2 can directly regulate the transcription of Sox9 and 
Tcf3.  Assessment of their expression in Lhx2 null bulges has been difficult in the 
absence of a definitive stem cell marker like CD34, but both Sox9 and Tcf3 appear 
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to be normally expressed in the outer root sheath of Lhx2 independent hair 
follicles (data not shown).  This suggests that their induction by Lhx2 is likely 
indirect even though the promoter regions of both Sox9 and Tcf3 contain putative 
homeodomain regulatory elements.
 Precedence for Lhx2 functioning in an indirect or cell non-autonomous 
mechanism to govern progenitor status is found in several developmental contexts, 
particularly in the hematopoietic system.  Absence of Lhx2 impairs definitive 
erythropoiesis and consistent with this phenotype, colony forming assays of cells 
isolated from mutant fetal livers demonstrate a dramatic reduction in the number 
of progenitor cells of the erythroid lineage (Porter et al., 1997).  However Lhx2 
null cells are still able to contribute significantly to erythrocytes in chimeric mice 
as well as engraft lethally irradiated mice.  Thus a defective hepatic environment, 
mediated by Lhx2 target genes, is responsible for the loss and abnormal 
development of progenitor cells.  Similarly, hematopoietic stem cells immortalized 
by expressing Lhx2 in embryonic stem cells are only able to self-renew either in 
high density cultures with the presence of steel factor (also known as stem cell 
factor or c-kit ligand) or on stromal feeder cell layers (Pinto do O et al., 2001). 
Growth and renewal of these cells is strictly contingent on Lhx2 expression, but 
their dependency on extrinsic elements further suggests that Lhx2 regulates 
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soluble factors involved in stem cell maintenance.  The specific identity of these 
factors is presently unknown.
 Lhx2 also regulates progenitor cells during neural development.  Without 
functional Lhx2, progenitors of the cerebral cortex are unable to proliferate 
leading to cortical hypoplasia (Porter et al., 1997).  Accompanying this defect is an 
expansion of the cortical hem, a signaling-rich band of tissue that guides dorsal 
neural development adjacent to the Lhx2 expressing ventricular zone.  Since Lhx2 
is not expressed in the cortical hem, a cell non-autonomous mechanism must exist 
to restrict this region for the forebrain to develop.  Notably, the cortical hem is 
marked by the expression of several Wnt and Bmp ligands, suggesting that Lhx2 
may regulate the specification and growth of cortical progenitors by limiting the 
extent of these key ligands (Bulchand et al., 2001; Monuki et al., 2001).
 Interestingly, loss of Lhx2 in hair follicles is reminiscent of enhanced 
epithelial Wnt signaling, whereby bulge stem cells prematurely activate and enter 
new hair cycles.  Similar to Lhx2 null hair follicles, constitutive expression of a 
stabilized form of β-catenin in the skin epithelium results in precocious anagen 
entry upon reaching the extended telogen phase after the first postnatal hair cycle 
(Lowry et al., 2005).  This parallel suggests the possibility that Lhx2 can 
negatively regulate Wnt activity in hair follicle progenitors, but further studies are 
necessary to determine if Wnt signaling is indeed elevated in Lhx2 null hair 
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follicles.  Recently, another LIM-HD factor Lhx5 was found to promote forebrain 
development by activating the transcription of secreted Wnt antagonists (Peng and 
Westerfield, 2006).  Whether Lhx2 can also modulate a Wnt-inhibited 
microenvironment in the hair follicle bulge to maintain the undifferentiated and 
quiescent state of stem cells awaits the identification of target genes regulated by 
Lhx2.  Nonetheless, expression of Lhx2 appears to underlie a conserved means of 




 The following mice were generous gifts: Lhx2-/- (H. Westphal, NIH); β-
cateninfl/fl (R. Kemler, Max Plank, Freiburg); Shh-/- (A. McMahon, Harvard); 
BmpR1afl/fl (Y. Mishina, NIH).  Lhx2 transgenic mice were generated by cloning 
full length murine Lhx2 cDNA (gift from J. Hirota, Rockefeller) into a vector 
driving expression from a human keratin 14 promoter faithfully expressed in the 
interfollicular epidermis and outer root sheath of hair follicles (Vasioukhin et al., 
1999).  For timed pregnancies, the morning of a vaginal plug was considered 
embryonic day E0.5.
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Histology, immunofluorescence, and in situ hybridizations
 Tissues were embedded in OCT (Tissue-Tek) and immediately frozen on 
dry ice.  Sections of 10μm were cut with a cryostat onto glass slides, fixed in 4% 
paraformaldehyde for 8 minutes, and subjected to immunofluorescence 
microscopy or hematoxylin/eosin staining.  When applicable, the MOM Basic Kit 
(Vector Labs) was used to prevent non-specific binding of mouse monoclonal 
antibodies.  Otherwise, stainings were performed in phosphate buffered saline 
(PBS) with 0.1% Triton X-100, 2.5% normal donkey serum, and 2.5% normal goat 
serum.  BrdU unmasking involved treatment with 1M HCl at 37°C for 45 minutes 
prior to blocking.  Primary antibodies were incubated overnight at 4°C and 
secondary antibodies at room temperature for 1 hour.  Slides were washed after 
antibody incubations with PBS for 5 minutes, three times.  Antibodies and 
dilutions used: Lhx2 (rabbit, 1:2500; T. Jessell, Columbia); P- and E-cadherins 
(rat, 1:100; M. Takeichi, Riken, Kobe); α6-integrin (rat, 1:100; Pharmingen); K5 
(rabbit, 1:500; Fuchs lab); K1 (rabbit, 1:500; Fuchs lab); K17 (rabbit, 1:5000; P. 
Coulombe, Johns Hopkins); Filaggrin (rabbit, 1:500; Covance); β4-integrin (rat, 
1:100; Pharmingen); CD34 (rat, 1:100; Pharmingen); Tenascin C (mouse, 1:500; 
IBL); S100A6 (rabbit, 1:100; Lab Vision); BrdU (rat, 1:500; Abcam); Tcf3 (guinea 
pig, 1:300; Fuchs lab); Sox9 (rabbit, 1:100; Santa Cruz); Nfatc1 (mouse, 1:100; 
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Santa Cruz); Lef1 (rabbit, 1:250; Fuchs lab); Gata3 (mouse, 1:100; Santa Cruz); 
K6 (rabbit, 1:500; Fuchs lab); AE13 and AE15 (mouse, 1:50; T.T. Sun, NYU); HA 
(rat, 1:100; Roche); FITC (1:100; Jackson) or Alexa594 (1:1000; Molecular 
Probes) conjugated secondary antibodies.  Nuclei were stained with 4’6’-
diamidino-2-phenylindole (DAPI; 1:10000) in a single wash step after staining. 
Slides were mounted with antifade.  Imaging was performed using Zeiss Axioskop 
and Axiophot microscopes equipped with Spot RT (Diagnostic Instruments) and 
Axiocam (Zeiss) digital cameras, respectively.
Engraftment and BrdU experiments
 Full thickness skins were removed from the torsos of sex-matched wild 
type and Lhx2 null E15.5 embryos, and placed onto the backs of anesthetized 
female nude recipient mice, with each recipient receiving a wild-type and 
knockout graft.  Grafts were secured by sterile gauze and cloth bandages, which 
were removed after healing (12-13 days).  Hairs typically appeared within 1 week 
after grafting.  A total of forty grafts were placed (20 wild-type and 20 knockout) 
and each showed a consistent phenotype dependent on the presence or absence of 
Lhx2 in the donor skin.  Newborn back skins were similarly grafted for the K14-
Lhx2 transgenic mice.  The day of engraftment was considered day 0. 
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 5’-bromo-2’-deoxyuridine (BrdU, Sigma) pulse-chase experiments were 
performed as described.  For BrdU pulse-chase experiments, intra-peritoneal 
injections of 50μg/g BrdU were carried out twice a day for 3 days at day 26 to 28 
post-graft and analyzed 4 weeks later for label retention.  For cell cycle analysis, 
mice were injected once with 50μg/g BrdU at day 40 or 8 weeks post-graft and 
analyzed 4 hours later for BrdU incorporation.  A minimum of 4 grafts (two wild-
type and two knockout) were used for each BrdU experiment.
Flow cytometry analysis
 For grafted skin, single cell suspensions of total skin were prepared by 
dissecting the graft, removing subcutaneous fat, mincing into small pieces, and 
sequential treatment with collagenase (Sigma, 2.5mg/mL) in Hanks’ balanced salt 
solution (Cambrex) for 1 hour and trypsin with EDTA (Gibco, 0.25%) for 15 
minutes at 37°C.  Between treatments, the tissue was triturated with PBS using a 
pipet and spun down.  Cells were neutralized with culture media (E high calcium) 
and strained (40μM pores; BD Biosciences).  Single cells were resuspended in 
PBS containing 5% fetal bovine serum at a maximum concentration of 107 cells/
mL and minimum volume of 100μL, and stained with primary antibodies coupled 
to biotin for 30 minutes on ice.  After washing once with PBS, cells were stained 
with streptavidin and antibodies directly conjugated to specific fluorophores for 30 
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minutes on ice.  Cells were washed once in PBS and resuspended in 300ng/mL 
propidium iodide for dead cell exclusion.  All centrifugation steps were performed 
at 300xg for 5 minutes at 4°C.  BrdU detection was subsequently performed using 
BrdU Flow Kit (Pharmingen).  Flow cytometry analysis was performed on a 
FACSort equipped with CellQuest (BD Biosciences).  Antibodies used for FACS: 
CD34 conjugated to biotin (1:50, Pharmingen), α6-integrin coupled to PE (1:100, 
Pharmingen); streptavidin-APC (1:200, Pharmingen).
Barrier function assay
 After dissection, the grafted skin exterior was exposed for 4 hours at 37°C 
in a solution of 100mM NaPO4, 1.3mM MgCl2, 3mM K3Fe(CN)6, 3mM K4Fe(CN)
6, 0.01% sodium deoxycholate, 0.01% sodium dodecyl sulfate, and 1mg/mL X-gal 
(Eppendorf), which was adjusted to a pH of 4.5 with HCl.  At this pH in the 
absence of an epidermal barrier, the solution will penetrate the epidermis causing 
endogenous β-galactosidase activity to catalyze X-gal into a blue precipitate.  The 
dermal interior was placed on PBS to prevent drying out.
RNA isolation and semi-quantitative RT-PCR
 Total RNA from FACS sorted cells was isolated using the Absolutely RNA 
Microprep kit (Stratagene) and quantified using Ribogreen (Molecular Probes). 
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Normalized RNA quantities were reverse transcribed with Superscript III using 
oligo-dT primers (Invitrogen).  Typically, 30ng of total RNA was reverse 
transcribed into a 20μL volume of cDNA, which was then diluted 12-fold.  One 
microliter of this working stock was used as template for PCR reactions: 2.5μL of 
10X PCR buffer with MgCl2, 0.5μL of 10mM dNTPs, 0.25μL of AmpliTaq DNA 
polymerase (Applied Biosystems), 0.5μL each of forward and reverse primers at 
20mM, 1μL of template DNA, and 19.75μL of H2O.  PCR amplification of 
selected genes of interest was performed using primers designed to produce a 
product spanning exon/intron boundaries.  Primers were designed using 
PrimerSelect of Lasergene (DNAStar) to work at the following settings: initial 
denaturing at 94°C for 3 minutes; 27-36 cycles of 20 seconds at 94°C denaturing, 
30 seconds at 60°C annealing, and 45 seconds at 72°C extension.  Primers used:
 gapdh: 5’-cgtagacaaaatggtgaaggtcgg-3’; 5’-aagcagttggtggtgcaggatg-3’
 lhx2: 5’-gcccgggccaagttcag-3’; 5’-gggggtggcgagtcattaga-3’
 lhx9: 5’-ctccggaccatgaaatcctacttt-3’; 5’-ctcgctcttttgttaaaccacacg-3’
 tcf3: 5’-tctcaagccggttcccacac-3’; 5’-tttccgggcaagctcatagtattt-3’
 sox9: 5’-cggcggaggaagtcggtgaagaac-3’; 5’-ggtgggtgcggtgctgctgatg-3’
 K5: 5’-aacattttggggtctgggtcac-3’; 5’-ggcccacagagactgcttcttt-3’
 β4: 5’-tcgtgggtagagcagcagaggaa-3’; ccactggtgttcactgccctaagc-3’
Transient transfections and western blots
 Murine keratinoctyes were cultured in E low calcium media.  At 
approximately 40% confluence, cells were transfected with FuGene 6 reagent 
(Roche) at a 3:1 FuGene:DNA ratio and harvested after two days.  For 
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immunofluorescence, cells in a 24-well plate on glass coverslips were transfected 
with 0.3μg of total DNA and processed as described above.  For immunoblotting, 
cells in a 6-well plate were transfected with 1.5μg of total DNA.  Cells were 
directly lysed in 2X sample buffer (250mM Tris pH 6.8, 4% sodium dodecyl 
sulfate, 10% glycerol, 0.1% bromophenol blue, 2% β-mercaptoethanol), scraped, 
and boiled for 5 minutes.  Proteins were resolved using SDS-polyacrylamide gel 
electrophoresis, semi-dry transferred onto nitrocellulose membrane, probed with 
antibodies in 5% non-fat dry milk, and detected by ECL (Amersham Biosciences). 
Primary antibodies were incubated overnight at 4°C and secondary antibodies at 
room temperature for 1 hour.  Blots were washed after antibody incubations with 
PBS-T (0.1% Tween-20 in PBS) for 10 minutes, three times.  Antibodies and 
dilutions used: Lhx2/Lhx9 (rabbit, 1:8000; T. Jessell, Columbia); anti-HA (rat, 




 During development, genetically identical cells acquire specific 
characteristics unique to its function through the activation and repression of 
genes.  To investigate the molecular regulation of hair follicle morphogenesis, 
early hair progenitors and basal epidermal keratinocytes were selectively isolated 
from embryonic skin using cell surface markers by exploiting their differential 
expression of P-cadherin.  Comparing the gene expression profiles of these 
isolated cell populations revealed transcriptional differences that occur as hair 
follicles are specified from the epithelium and undergo subsequent development. 
In addition to expressing signaling molecules already implicated in hair 
morphogenesis, embryonic hair progenitors adopted a distinct set of transcriptional 
regulators and repressed other regulators of epidermal differentiation.  These 
functionally significant genes validate and lay the foundation to probe into the 
roles of the many other uncharacterized genes in hair follicle and epidermal 
development.
Origins of hair follicle stem cells
 Most notably, the embryonic hair progenitors displayed a strong molecular 
resemblance to adult follicle stem cells, indicating functional similarities between 
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the two cell types.  This is not too surprising considering that embryonic hair 
progenitors and adult stem cells share many common features with each other. 
Both cell types are undifferentiated, yet capable of differentiating into lineages of 
the entire follicle.  The induction of hair morphogenesis from embryonic ectoderm 
also parallels the activation of adult stem cells during initiation of hair renewal. 
Both processes rely on a dermal component and utilize the same signaling 
pathways to mediate their epithelial-mesenchymal interactions.  These similarities 
suggest the possibility that embryonic hair progenitors are counterparts to adult 
follicle stem cells, and that the commonly expressed genes regulate attributes 
shared by both cell types.  However, the best characterized and most specific 
marker of hair follicle stem cells, CD34, only becomes apparent upon completion 
of the initial morphogenetic hair cycle at approximately three weeks of age in 
mice.  Stem cells should theoretically exist prior to this time to supply the growing 
hair and contribute to epidermal wound healing, but the lack of molecular markers 
to identify these putative cells has precluded studies to trace the origins of the hair 
follicle stem cell niche.  Thus, questions have remained as to when and how, if at 
all, stem cells are specified and set aside during development.
 This study provides two lines of direct evidence, in addition to their 
similarities in gene expression, that demonstrate that stem cells exist during hair 
follicle morphogenesis and are likely specified upon embryonic hair induction. 
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First, label retaining cells were identified in a presumptive bulge compartment of 
developing hair follicles which later became CD34 positive stem cells in adult 
follicles.  Since embryonic skin was pulse-labeled before this compartment 
formed, the label retaining cells, a hallmark of adult stem cells, probably 
originated from early hair progenitors.  Second, expression of Lhx2, which was 
identified in the PCAD+ cells of the microarray screen, was also localized to the 
same presumptive bulge compartment.  Present in both embryonic hair progenitors 
and adult stem cells, Lhx2 expression is lost in the absence of hair induction but is 
expanded when stem cells are unable to differentiate.  Thus Lhx2’s initial 
expression in hair placodes, concentration to the presumptive bulges of developing 
follicles, and final localization in adult follicle bulges, lend support to the 
specification of stem cells upon embryonic hair induction and the existence of a 
stem cell niche during hair morphogenesis.
 Furthermore, Lhx2 was functionally demonstrated to regulate 
characteristics of hair follicle stem cells.  Without Lhx2, fewer hair follicles are 
induced during embryogenesis and those that do form prematurely activate bulge 
stem cells and differentiate when hair follicles normally should be at rest.  Leading 
up to this stem cell defect, Lhx2 null hair follicles have diminished CD34 
expression and lose label retaining abilities.  Thus, loss of Lhx2 results in loss of 
stem cell character, whereby fewer stem cells are specified to initiate hair 
112
morphogenesis and become more susceptible to differentiate.  On the other hand, 
gain of Lhx2 expression inhibits terminal differentiation and promotes the 
acquisition of hair stem cell markers.  Lhx2 therefore maintains hair follicle stem 
cell character by keeping them in a undifferentiated, quiescent state.
 Although Lhx2 appears to link the specification of embryonic hair 
progenitors to the maintenance of adult follicle stem cells, more functional studies 
are needed to conclusively show that stem cells directly arise from the induction of 
hair follicle morphogenesis.  With the ability to isolate and purify embryonic hair 
progenitors, many of the assays used to establish the proliferative potential and 
multipotency of adult bulge stem cells can now be applied to hair placode cells. 
For example, isolated embryonic hair progenitors can be cultured in vitro to assess 
their clonogenicity and self-renewal capacity through serial passage.  Although 
lineage analysis from the Shh promoter clearly indicates that the entire hair follicle 
and bulge are derived from the hair placode (Levy et al., 2005), the multipotency 
of embryonic hair progenitors can be evaluated at the single cell level through 
transplantation experiments of isolated cells.  These experiments will not only 
demonstrate that embryonic hair progenitors possess fundamental stem cell 
characteristics, but also support the notion for the hair placode as the embryonic 
origin of bulge stem cells.
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Regulation of hair follicle stem cells
 Elucidating molecular details by which Lhx2 acquires and maintains stem 
cell character will also further our understanding into the specification and 
development of the stem cell niche.  Identifying genes directly regulated by Lhx2 
will be important in this regard.  The ability of transgenic Lhx2 expression to alter 
the genetic program of epidermal cells into a hair follicle stem cell lineage 
supports the possibility that Lhx2 could act as a master regulator of hair follicle 
determination through target genes.  Additionally, identifying interacting proteins 
with Lhx2 will also be useful in analyzing its regulatory mechanisms.  Through 
their LIM domains, LIM-HD transcription factors are well known to interact with 
a variety of transcriptional regulators to direct the fate of progenitor cells during 
development, especially of the nervous system (Curtiss and Heilig, 1998; Bach, 
2000).  In this combinatorial manner, distinct complexes of LIM-HD factors 
determine the unique identity of cells through the activation of transcriptional 
targets.  Interestingly, Lhx2 is the only LIM-HD family member expressed at 
significant levels in the skin by microarray analysis.  This suggests that Lhx2 may 
play a primary role in specifying the hair follicle stem cell lineage and 
distinguishing it from the surrounding embryonic ectoderm during induction of 
hair morphogenesis.
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 However, Lhx2 also functions in postnatal stem cells by maintaining their 
quiescence during the resting phase of the hair cycle.  Although the specification 
of stem cells during embryogenesis appears to be distinct from the maintenance of 
adult stem cell quiescence, both functions of Lhx2 can be reconciled considering 
the co-localization of label retaining cells and Lhx2 expression in the developing 
stem cell niche.  Nucleotide label retention is an indication of slow-cycling cells 
and the correlation of these cells with Lhx2 expression in both developing and 
mature hair follicle bulges suggests that maintaining quiescence and hence stem 
cell character may be a fundamental function of Lhx2 in hair follicles. 
Unfortunately, testing the label retaining ability of developing bulges in Lhx2 null 
hair follicles was difficult given the need to graft the skin, and preliminary results 
were inconclusive.  Additional studies are also needed to evaluate the long-term 
consequences of Lhx2 loss in hair follicles.  Although stem cells precociously 
activate new rounds of hair growth even beyond the second telogen stage, it 
remains unknown if Lhx2 null stem cells have defects in self-renewal resulting in 
niche depletion and progressive loss of hair follicles.  Currently, the oldest skin 
graft is approximately one year old and the Lhx2 knockout shows a thinner hair 
coat relative to wild-type.  Despite the need for more conclusive studies, the 
embryonic and postnatal phenotypes of the Lhx2 null mice can be explained by a 
loss in hair follicle stem cell character, particularly in their quiescent properties. 
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Identifying Lhx2 interacting proteins and their transcriptional targets within the 
embryonic hair progenitors and adult stem cells will determine how Lhx2 can 
modulate this critical function to maintain the stem cell niche.  An attractive 
hypothesis is whether Lhx2 can sustain a Wnt-inhibited microenvironment in the 
bulge, since increased Wnt signaling also leads to precocious stem cell activation. 
Interestingly, both embryonic hair progenitors and adult bulge stem cells express 
several secreted Wnt antagonists, including at least two in common, Dkk3 and 
Wif1.
 Characterizing other signature genes shared by embryonic hair progenitors 
and adult bulge stem cells will undoubtedly reveal additional insights into 
fundamental features of hair follicle stem cells.  Together these genes may 
cooperatively regulate the specification and maintenance of hair follicle stem cells 
during development.  Along with their similarities, there obviously are molecular 
differences between embryonic hair progenitors and adult stem cells, which could 
be a reflection of the distinct morphological environment in which these two cell 
types function.  For instance, embryonic hair progenitors are specified from a layer 
of ectoderm lacking a defined niche, while adult stem cells are in contact with 
mature dermal papillae cells in a well innervated and vascularized niche.  In some 
respect, embryonic hair progenitors may actually be a more primitive cell since 
they must organize into a functional stem cell niche before differentiating into 
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more mature hair lineages.  Thus, the genes shared in common such as Lhx2 are 
most likely to be directly involved in the specification and maintenance of hair 
follicle stem cells throughout morphogenesis and postnatal life.
 Aside from their similarities in gene expression, the same signaling 
pathways also regulate the specification of embryonic hair progenitors and the 
activation of follicle stem cells.  Determining how these signals affect the 
expression and activity of intrinsic factors required for the maintenance of stem 
cells like Lhx2 is essential in understanding their mechanisms to govern stem cell 
behavior.  One goal of this study was to discover genetic targets of the multiple 
signals that converge to regulate hair follicle morphogenesis, but their co-
expression in the transcriptional profile of embryonic hair progenitors makes it 
difficult to discern any candidate genes without secondary screens.  However the 
molecular mechanisms of these pathways can begin to be dissected by applying 
the techniques developed here on various genetic mutants of signaling pathways 
that affect hair morphogenesis.  By isolating and transcriptionally profiling 
embryonic hair progenitors of Shh, Noggin, and Tgf-β2 null mice, one can 
evaluate genes regulated by specific signaling pathways and their impact on hair 
follicle development.  Combining this expression data with genome-wide 
chromatin immunoprecipitation using antibodies against transcriptional mediators 
of these pathways will be powerful in determining genes directly regulated by 
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these signals during hair follicle morphogenesis.  Furthermore, the hierarchy of 
signaling events can be organized to analyze the sequential or convergent 
molecular controls during induction and morphogenesis of hair follicles.
Implications beyond hair follicles
 In addition to the hair follicle, a variety of other stem cell systems utilize 
the same signaling pathways to regulate self-renewal and lineage commitment 
(Fuchs et al., 2004; Moore and Lemischka, 2006).  Even more remarkable is the 
recurrence of these signals in guiding the development of tissues and organs which 
employ the formation of placodes.  From as early as neural induction to the 
formation of nearly every ectodermally derived appendage, these conserved 
developmental pathways drive analogous cellular processes during morphogenesis 
(Hogan, 1999; Pispa and Thesleff, 2003).  This begs the question of when and how 
unique cell fates are determined to favor the formation of one structure instead of 
another.  The answer may lie in the local balance of competing transcriptional 
regulators which integrate spatial and temporal cues to direct a distinct genetic 
program for different lineages.  This appears to be the case in the induction and 
differentiation of cranial sensory placodes where gene regulatory networks 
composed of transcription factors activate sets of “placode-specific” enhancers 
(Baker and Bronner-Fraser, 2001; Bhattacharyya and Bronner-Fraser, 2004). 
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Isolating the placodes of these other organs, particularly of appendages of the skin 
such as sweat and mammary glands, and comparing their expression profiles to 
those of the hair follicle placode will discern both common themes and unique 
aspects of individual morphogenetic processes downstream of shared signaling 
pathways.
 A complete understanding of the molecular events in the development of 
these tissues and organs have therapeutic implications, particularly if they involve 
the specification of stem cells.  Knowledge of normal morphogenesis and stem cell 
function will also aid in diagnosis and treatment when this process goes awry in 
disease.  Much more work lies ahead, but the hope of manipulating stem cells to 




 The following is a comprehensive list of the 1394 differentially expressed 
genes in the sorted cell populations.  Signal values of Affymetrix probe sets and 
their annotated genes upregulated ≥2-fold in either the PCAD+ hair progenitors or 
PCAD− interfollicular keratinocytes relative to the other is provided.  The Mean 





Probe Set ID UniGene Name UniGene Symbol Mean Log2 
Ratio
PCAD+ Signal PCAD- Signal
1 2 1 2
1425425_a_at Wnt inhibitory factor 1 Wif1 6.02 2731 2330 51 27
1455280_at Fras1 related extracellular matrix protein 1 Frem1 5.15 1325 1213 40 32
1416846_a_at PDZ domain containing RING finger 3 Pdzrn3 4.91 9934 7866 361 227
1427053_at RIKEN cDNA 5033411B22 gene 5033411B22Rik 4.79 473 473 18 17
1449530_at trichorhinophalangeal syndrome I (human) Trps1 4.39 1266 1344 70 54
1427054_s_at RIKEN cDNA 5033411B22 gene 5033411B22Rik 4.36 2064 2325 103 111
1416561_at glutamic acid decarboxylase 1 Gad1 4.32 397 288 19 14
1434286_at trichorhinophalangeal syndrome I (human) Trps1 4.27 608 597 39 23
1418317_at LIM homeobox protein 2 Lhx2 4.18 7738 5952 450 300
1435349_at neuropilin 2 Nrp2 4.10 7272 5570 456 284
1446929_at BTB and CNC homology 2 (Bach2), mRNA Bach2 4.05 3820 2920 204 198
1437667_a_at BTB and CNC homology 2 Bach2 4.03 8000 5534 411 401
1434195_at protease, serine, 35 Prss35 3.96 2667 2887 233 124
1457445_at trichorhinophalangeal syndrome I (human) Trps1 3.90 2800 3173 249 151
1436869_at sonic hedgehog Shh 3.89 13860 12748 1084 707
1440304_at RIKEN cDNA E030004N02 gene E030004N02Rik 3.80 4028 3243 267 250
1450065_at adenylate cyclase 7 Adcy7 3.79 1727 1276 132 83
1427168_a_at procollagen, type XIV, alpha 1 Col14a1 3.79 8956 7752 763 438
1436515_at RIKEN cDNA E030004N02 gene E030004N02Rik 3.74 9455 6722 619 576
1448870_at latent transforming growth factor beta binding p Ltbp1 3.73 556 432 41 33
1438214_at trichorhinophalangeal syndrome I (human) Trps1 3.73 3737 3386 362 174
1447343_at neuropilin 2 Nrp2 3.72 1214 987 96 71
1420753_at tolloid-like Tll 3.70 1560 1563 149 91
1456307_s_at adenylate cyclase 7 Adcy7 3.69 9337 6953 840 406
1426528_at neuropilin 2 Nrp2 3.68 9358 8642 808 597
1455961_at membrane metallo endopeptidase Mme 3.64 1849 1346 133 121
1443161_at Trichorhinophalangeal syndrome I (human) Trps1 3.62 2186 1934 245 91
1442605_at BTB and CNC homology 2 (Bach2), mRNA Bach2 3.60 1923 1725 173 128
1438532_at Similar to hemicentin; fibulin 6 (LOC240793), NA 3.59 744 709 73 47
1440339_at RIKEN cDNA 4833416E15 gene 4833416E15Rik 3.55 3635 4031 273 378
1440026_at Trichorhinophalangeal syndrome I (human) Trps1 3.55 1705 1858 190 115
1450922_a_at transforming growth factor, beta 2 Tgfb2 3.52 928 750 95 51
1441657_at BTB and CNC homology 2 (Bach2), mRNA Bach2 3.51 745 563 61 53
1456778_at neuropilin 2 Nrp2 3.50 2668 2498 267 191
1426640_s_at tribbles homolog 2 (Drosophila) Trib2 3.49 4357 5099 560 278
1428347_at cytoplasmic FMR1 interacting protein 2 Cyfip2 3.41 404 338 34 35
1450923_at transforming growth factor, beta 2 Tgfb2 3.41 4148 3313 433 263
1416967_at SRY-box containing gene 2 Sox2 3.36 258 216 28 18
1436002_at RIKEN cDNA C230013L11 gene C230013L11Rik 3.34 2083 1526 170 183
1417155_at neuroblastoma myc-related oncogene 1 Nmyc1 3.32 5929 4936 614 469
1426766_at RIKEN cDNA 6330403K07 gene 6330403K07Rik 3.30 1930 1940 238 154
1447174_at Dachshund 1 (Drosophila) Dach1 3.28 632 742 86 56
1455865_at insulinoma-associated 1 Insm1 3.28 253 137 18 20
1434881_s_at potassium channel tetramerisation domain con Kctd12 3.28 1536 1697 174 158
1435399_at RIKEN cDNA 2310068J10 gene 2310068J10Rik 3.27 859 845 104 72
1436555_at expressed sequence AI158848 AI158848 3.23 6564 7114 772 688
1433743_at dachshund 1 (Drosophila) Dach1 3.22 1037 703 122 62
1455277_at Hedgehog-interacting protein Hhip 3.17 317 430 43 39
1417336_a_at synaptotagmin-like 4 Sytl4 3.15 812 906 90 103
1423250_a_at transforming growth factor, beta 2 Tgfb2 3.14 1030 770 108 94
1454613_at Dihydropyrimidinase-like 3 Dpysl3 3.11 1836 2828 303 227
1436173_at deleted in liver cancer 1 Dlc1 3.06 2681 2534 326 299
1440177_at hypothetical protein 9630027E11 9.63E+17 3.02 140 94 12 16
1425874_at homeo box C13 Hoxc13 2.95 1027 857 130 113
1460602_at deleted in liver cancer 1 Dlc1 2.94 2334 1762 290 238
1447227_at Solute carrier family 40 (iron-regulated transpo Slc40a1 2.94 890 766 133 82
1424683_at RIKEN cDNA 1810015C04 gene 1810015C04Rik 2.91 3977 3785 552 482
1450988_at G protein-coupled receptor 49 Gpr49 2.86 1064 1260 174 146
1437218_at fibronectin 1 Fn1 2.84 741 662 103 93
1435396_at expressed sequence C85317 C85317 2.81 2237 2387 351 309
1437360_at Protocadherin 19 Pcdh19 2.81 435 464 62 66
1457042_at Transcribed sequences NA 2.81 293 258 33 45
1436329_at early growth response 3 Egr3 2.79 4346 3845 718 464
1456901_at A disintegrin-like and metalloprotease (reprolysi Adamts20 2.78 196 140 22 26
1429088_at limb-bud and heart Lbh 2.76 677 545 105 74
1450770_at RIKEN cDNA 3632451O06 gene 3632451O06Rik 2.72 776 680 118 102
1436759_x_at calponin 3, acidic Cnn3 2.71 2928 3178 535 398
1456611_at RIKEN cDNA D430015B01 gene D430015B01Rik 2.69 2088 1979 322 306
1443263_at BTB and CNC homology 2 (Bach2), mRNA Bach2 2.69 1530 1052 221 172
1447831_s_at myotubularin related protein 7 Mtmr7 2.66 163 109 20 22
1441956_s_at Cut-like 1 (Drosophila), transcript variant 2, mR Cutl1 2.65 1100 797 141 156
1424704_at runt related transcription factor 2 Runx2 2.65 1095 1177 170 191











1458220_at deleted in liver cancer 1 Dlc1 2.63 1151 662 157 126
1423259_at inhibitor of DNA binding 4 Idb4 2.61 1195 1271 190 214
1446141_at Transforming growth factor, beta 2 Tgfb2 2.60 1670 1023 251 182
1436836_x_at calponin 3, acidic Cnn3 2.58 2657 3000 564 380
1428572_at brain abundant, membrane attached signal pro Basp1 2.56 9068 8067 1426 1479
1443044_at hypothetical A830091E24 A830091E24 2.54 257 181 38 36
1425749_at syntaxin binding protein 6 (amisyn) Stxbp6 2.54 1370 1419 260 219
1426642_at fibronectin 1 Fn1 2.53 10050 9975 1833 1630
1437385_at Transcribed sequences NA 2.53 830 458 105 109
1419276_at ectonucleotide pyrophosphatase/phosphodiest Enpp1 2.52 344 367 58 65
1458739_at Latent transforming growth factor beta binding Ltbp1 2.51 1254 646 176 140
1438303_at transforming growth factor, beta 2 Tgfb2 2.51 302 253 60 37
1460578_at FYVE, RhoGEF and PH domain containing 5 Fgd5 2.50 308 448 69 62
1436218_at leucine-rich repeat-containing G protein-coupled Lgr6 2.49 3471 3647 692 577
1454830_at fibrillin 2 Fbn2 2.48 335 235 56 44
1455570_x_at calponin 3, acidic Cnn3 2.47 2850 3066 616 450
1429549_at procollagen, type XXVII, alpha 1 Col27a1 2.47 3756 3479 651 656
1429506_at naked cuticle 1 homolog (Drosophila) Nkd1 2.46 514 544 77 116
1450627_at progressive ankylosis ank 2.46 5382 4562 1191 614
1420425_at PR domain containing 1, with ZNF domain Prdm1 2.45 1034 1068 246 138
1419724_at ectodysplasin-A receptor Edar 2.44 3788 3830 763 636
1456380_x_at calponin 3, acidic Cnn3 2.42 1253 1417 273 225
1433490_s_at erythrocyte protein band 4.1-like 2 Epb4.1l2 2.42 2222 2427 454 415
1428896_at platelet-derived growth factor receptor-like Pdgfrl 2.42 225 174 34 40
1428209_at brain expressed X-linked 4 Bex4 2.42 548 335 94 66
1440465_at Cut-like 1 (Drosophila), transcript variant 2, mR Cutl1 2.42 465 561 84 106
1419485_at forkhead box C1 Foxc1 2.41 271 292 62 44
1456211_at NACHT, leucine rich repeat and PYD containin Nalp10 2.41 254 249 52 43
1456292_a_at vimentin Vim 2.39 113 160 21 30
1455145_at 14, 17 days embryo head cDNA, RIKEN full-le NA 2.38 671 710 135 131
1450928_at inhibitor of DNA binding 4 Idb4 2.38 6461 6145 1307 1115
1454890_at angiomotin Amot 2.37 741 748 164 123
1459546_s_at ectonucleotide pyrophosphatase/phosphodiest Enpp1 2.37 368 383 56 89
1423260_at inhibitor of DNA binding 4 Idb4 2.37 882 924 153 198
1444780_at RIKEN cDNA 5330421F07 gene 5330421F07Rik 2.37 701 528 124 112
1434909_at Ras-related GTP binding D Rragd 2.36 3334 3492 747 587
1422869_at c-mer proto-oncogene tyrosine kinase Mertk 2.35 547 401 113 71
1455256_at TRAF2 and NCK interacting kinase Tnik 2.34 1048 1026 257 152
1456111_at hypothetical protein C130036J11 C130036J11 2.33 1287 1224 269 229
1423607_at lumican Lum 2.27 366 299 83 55
1434325_x_at protein kinase, cAMP dependent regulatory, ty Prkar1b 2.27 411 315 78 71
1454742_at RasGEF domain family, member 1B Rasgef1b 2.27 919 983 178 216
1439852_at Transcribed sequences NA 2.27 2154 1808 368 450
1433583_at zinc finger protein 365 Zfp365 2.26 470 511 101 104
1416776_at crystallin, mu Crym 2.25 138 135 30 27
1417061_at solute carrier family 40 (iron-regulated transport Slc40a1 2.25 5078 4173 1130 802
1443544_at Transcribed sequences NA 2.25 347 316 58 81
1416221_at follistatin-like 1 Fstl1 2.24 1843 1895 429 359
1417359_at microfibrillar-associated protein 2 Mfap2 2.24 1855 1644 412 327
1440593_at 12 days embryo eyeball cDNA, RIKEN full-lengt NA 2.23 4632 4444 1035 901
1438354_x_at calponin 3, acidic Cnn3 2.23 205 199 53 33
1438894_at Transcribed sequences NA 2.23 260 259 72 39
1457859_at ADP-ribosylation factor related protein 2 Arfrp2 2.22 869 689 177 155
1434172_at cannabinoid receptor 1 (brain) Cnr1 2.22 363 212 54 65
1450505_a_at RIKEN cDNA 1810015C04 gene 1810015C04Rik 2.22 405 277 81 63
1439468_at BTB and CNC homology 2 (Bach2), mRNA Bach2 2.22 1008 730 179 188
1418028_at dopachrome tautomerase Dct 2.20 704 1011 122 244
1418723_at endothelial differentiation, lysophosphatidic aci Edg7 2.20 458 548 127 91
1448259_at follistatin-like 1 Fstl1 2.20 3740 3911 900 767
1438306_at ring finger protein 180 Rnf180 2.20 2510 2007 509 469
1422912_at bone morphogenetic protein 4 Bmp4 2.19 880 661 158 177
1422643_at monooxygenase, DBH-like 1 Moxd1 2.18 5488 5646 1396 1069
1446525_at Glypican 3, mRNA (cDNA clone MGC:35964 I Gpc3 2.17 694 570 154 126
1439766_x_at vascular endothelial growth factor C Vegfc 2.17 85 109 21 21
1459619_at erythrocyte protein band 4.1-like 2 Epb4.1l2 2.16 1170 1263 248 296
1417111_at mannosidase 1, alpha Man1a 2.16 3026 2592 655 601
1438118_x_at vimentin Vim 2.16 165 239 37 52
1428455_at procollagen, type XIV, alpha 1 Col14a1 2.15 724 606 140 158
1449822_at atonal homolog 1 (Drosophila) Atoh1 2.14 339 234 75 52
1422655_at patched homolog 2 Ptch2 2.14 4094 4103 942 921
1434136_at RIKEN cDNA 6332401O19 gene 6332401O19Rik 2.14 88 62 17 17
1441539_at 0 day neonate lung cDNA, RIKEN full-length e NA 2.12 659 645 152 148
1460604_at cytochrome b reductase 1 Cybrd1 2.12 132 89 22 28
1417377_at immunoglobulin superfamily, member 4A Igsf4a 2.12 5125 4096 1076 1026











1429178_at odd Oz/ten-m homolog 3 (Drosophila) Odz3 2.12 2293 2463 573 524
1434683_at Cut-like 1 (Drosophila), transcript variant 2, mR Cutl1 2.12 1134 1005 244 249
1443240_at Glypican 3, mRNA (cDNA clone MGC:35964 I Gpc3 2.12 3607 4188 879 908
1437347_at endothelin receptor type B Ednrb 2.11 387 726 72 175
1458205_at Mannosidase 1, alpha, mRNA (cDNA clone M Man1a 2.10 522 477 128 105
1452309_at cingulin-like 1 Cgnl1 2.10 2572 2532 602 592
1438441_at Inhibitor of DNA binding 4 Idb4 2.10 137 175 33 39
1422592_at catenin delta 2 Catnd2 2.09 274 314 68 70
1455180_at expressed sequence AA407270 AA407270 2.09 187 180 40 46
1425447_at dickkopf homolog 4 (Xenopus laevis) Dkk4 2.08 267 517 98 78
1427025_at myotubularin related protein 7 Mtmr7 2.08 425 405 106 91
1455262_at Transcribed sequences NA 2.08 408 385 113 74
1453851_a_at growth arrest and DNA-damage-inducible 45 g Gadd45g 2.07 1080 912 283 189
1446088_at RIKEN cDNA 9430081I23 gene 9430081I23Rik 2.07 1665 1433 475 261
1423274_at DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptid Ddx26 2.06 1887 1836 449 446
1423278_at protein tyrosine phosphatase, receptor type, K Ptprk 2.05 2663 2570 681 583
1439060_s_at DNA segment, Chr 11, ERATO Doi 498, expre D11Ertd498e 2.04 480 413 107 109
1422864_at runt related transcription factor 1 Runx1 2.04 608 447 145 110
1418176_at vitamin D receptor Vdr 2.04 802 732 193 179
1427086_at CDNA clone IMAGE:5028619, partial cds NA 2.03 399 323 89 86
1435280_at expressed sequence AI452195 AI452195 2.03 1261 1100 268 306
1441779_at RIKEN cDNA 9530006C21 gene 9530006C21Rik 2.03 295 474 85 98
1433471_at transcription factor 7, T-cell specific Tcf7 2.03 541 565 138 133
1455843_at fucosyltransferase 4 Fut4 2.02 194 139 40 41
1429870_at RIKEN cDNA C630040K21 gene C630040K21Rik 2.02 211 193 57 43
1459136_at BTB and CNC homology 2 (Bach2), mRNA Bach2 2.01 75 29 10 13
1424098_at ELOVL family member 7, elongation of long ch Elovl7 2.00 1708 1503 501 301
1417411_at nucleosome assembly protein 1-like 5 Nap1l5 2.00 310 252 71 69
1417600_at solute carrier family 15 (H+/peptide transporter Slc15a2 2.00 5339 5490 1534 1182
1435720_at Potassium voltage-gated channel, Shal-related Kcnd3 2.00 161 245 45 54
1438619_x_at zinc finger, DHHC domain containing 14 Zdhhc14 2.00 359 348 84 93
1446720_at Activated leukocyte cell adhesion molecule Alcam 1.99 1793 1577 491 355
1415949_at carboxypeptidase E Cpe 1.99 538 544 157 116
1436076_at discs, large (Drosophila) homolog-associated pr Dlgap1 1.99 142 387 60 58
1447567_at Odd Oz/ten-m homolog 3 (Drosophila) Odz3 1.99 213 157 50 42
1444432_at RIKEN cDNA D330040H18 gene D330040H18Rik 1.99 338 302 94 67
1452583_s_at galactose mutarotase Galm 1.98 447 715 136 151
1423091_a_at glycoprotein m6b Gpm6b 1.98 4945 5300 1555 1048
1450723_at ISL1 transcription factor, LIM/homeodomain (isl Isl1 1.98 239 181 59 46
1415834_at dual specificity phosphatase 6 Dusp6 1.97 4312 4387 1235 986
1436551_at fibroblast growth factor receptor 1 Fgfr1 1.97 860 1015 262 213
1460431_at glucosaminyl (N-acetyl) transferase 1, core 2 Gcnt1 1.97 360 348 94 87
1422648_at solute carrier family 7 (cationic amino acid tran Slc7a2 1.97 245 256 63 65
1436791_at wingless-related MMTV integration site 5A Wnt5a 1.97 242 100 45 34
1440372_at ADP-ribosylation factor related protein 2 Arfrp2 1.96 5712 5079 1601 1176
1425779_a_at T-box 1 Tbx1 1.96 143 231 44 50
1416632_at malic enzyme, supernatant Mod1 1.95 2176 2295 636 524
1458249_at Transcribed sequence with weak  similarity to p NA 1.95 158 174 46 40
1445711_at expressed sequence BB163080 BB163080 1.94 137 132 38 32
1424050_s_at fibroblast growth factor receptor 1 Fgfr1 1.94 489 653 152 143
1442740_at PR domain containing 5 Prdm5 1.93 249 217 67 54
1446247_at a disintegrin-like and metalloprotease (reprolysi Adamts18 1.92 727 879 221 202
1458605_at ADP-ribosylation factor related protein 2 Arfrp2 1.92 1005 880 275 223
1417376_a_at immunoglobulin superfamily, member 4A Igsf4a 1.92 1864 1726 473 473
1417400_at retinoic acid induced 14 Rai14 1.92 2729 2775 779 671
1448502_at solute carrier family 16 (monocarboxylic acid tr Slc16a7 1.92 482 451 134 112
1437466_at activated leukocyte cell adhesion molecule Alcam 1.91 4667 4243 1312 1054
1439554_at sex comb on midleg homolog 1 Scmh1 1.91 898 707 227 198
1430264_at RIKEN cDNA 2610030P05 gene 2610030P05Rik 1.91 5092 4606 1356 1220
1446609_at Transcribed sequences NA 1.91 675 562 201 127
1442504_at 0 day neonate thymus cDNA, RIKEN full-length NA 1.90 129 220 46 44
1448765_at Fyn proto-oncogene Fyn 1.90 202 192 56 49
1439753_x_at sine oculis-related homeobox 4 homolog (Dros Six4 1.89 39 38 11 10
1426724_at calponin 3, acidic Cnn3 1.88 579 733 163 191
1449273_at cytoplasmic FMR1 interacting protein 2 Cyfip2 1.88 415 269 91 91
1431118_at RIKEN cDNA 6720427H10 gene 6720427H10Rik 1.88 993 939 284 243
1444646_at RIKEN cDNA 8430420F16 gene 8430420F16Rik 1.88 831 774 239 197
1423584_at insulin-like growth factor binding protein 7 Igfbp7 1.87 872 847 227 244
1456621_at RIKEN cDNA D430015B01 gene D430015B01Rik 1.86 220 168 57 49
1437614_x_at zinc finger, DHHC domain containing 14 Zdhhc14 1.86 370 348 96 102
1438861_at basonuclin 2 Bnc2 1.85 4881 4243 1191 1329
1441972_at RIKEN cDNA 6230424C14 gene 6230424C14Rik 1.85 122 70 28 24
1420965_a_at ectodermal-neural cortex 1 Enc1 1.84 2745 2245 630 760
1417378_at immunoglobulin superfamily, member 4A Igsf4a 1.84 9455 8839 2666 2442














1437431_at Cut-like 1 (Drosophila), transcript variant 2, mR Cutl1 1.84 672 577 181 166
1440878_at runt related transcription factor 1 Runx1 1.84 610 504 177 134
1416688_at synaptosomal-associated protein 91 Snap91 1.84 137 147 45 34
1440312_at ELOVL family member 7, elongation of long ch Elovl7 1.83 1827 1779 654 357
1440586_at RIKEN cDNA B430203I24 gene B430203I24Rik 1.83 2036 2093 605 553
1448415_a_at sema domain, immunoglobulin domain (Ig), sh Sema3b 1.83 336 389 102 102
1417455_at transforming growth factor, beta 3 Tgfb3 1.82 2397 2805 766 706
1449315_at odd Oz/ten-m homolog 3 (Drosophila) Odz3 1.81 872 938 297 220
1455447_at RIKEN cDNA D430019H16 gene D430019H16Rik 1.81 516 473 143 139
1443158_at Sex comb on midleg homolog 1 Scmh1 1.81 600 658 185 174
1441206_at synaptopodin 2 Synpo2 1.81 166 98 36 37
1443222_at Thymoma viral proto-oncogene 3 Akt3 1.81 395 402 100 127
1435832_at leucine rich repeat containing 4 Lrrc4 1.80 743 901 201 269
1428902_at carbohydrate sulfotransferase 11 Chst11 1.80 1465 1354 387 423
1436864_at ADP-ribosylation factor related protein 2 Arfrp2 1.79 771 714 239 191
1428479_at nuclear factor of activated T-cells, cytoplasmic, Nfatc1 1.79 293 324 91 87
1429359_s_at RNA binding protein gene with multiple splicing Rbpms 1.79 110 121 33 34
1444992_at expressed sequence AI120166 AI120166 1.78 1850 1773 469 588
1436223_at PREDICTED: integrin beta 8 [Mus musculus], Itgb8 1.77 1055 1174 404 248
1447040_at Activated leukocyte cell adhesion molecule Alcam 1.77 964 818 324 197
1438896_at DnaJ (Hsp40) homolog, subfamily C, member Dnajc6 1.77 148 116 43 34
1439895_at expressed sequence AU021025 AU021025 1.77 4635 4341 1359 1277
1434073_at G protein-coupled receptor associated sorting Gprasp2 1.77 527 551 159 157
1439556_at neural cell adhesion molecule 1 Ncam1 1.77 1112 964 370 238
1434180_at pleckstrin homology domain containing, family Plekhc1 1.77 862 993 284 258
1441644_at Protein tyrosine phosphatase, receptor type, K Ptprk 1.76 204 183 64 51
1423341_at chondroitin sulfate proteoglycan 4 Cspg4 1.75 2352 2353 695 703
1420667_at double C2, beta Doc2b 1.75 315 300 92 91
1417110_at mannosidase 1, alpha Man1a 1.75 835 861 256 249
1422552_at reprimo, TP53 dependant G2 arrest mediator c Reprimo 1.75 189 260 73 59
1436279_at solute carrier family 26, member 7 Slc26a7 1.75 86 207 32 48
1453003_at sortilin-related receptor, LDLR class A repeats-c Sorl1 1.75 2992 2132 847 660
1440770_at B-cell leukemia/lymphoma 2 Bcl2 1.74 4115 3926 1266 1134
1455333_at tensin 3 Tns3 1.74 2795 2704 897 747
1420731_a_at cysteine and glycine-rich protein 2 Csrp2 1.74 337 253 92 83
1420589_at hyaluronan synthase 3 Has3 1.73 8226 8337 2524 2479
1450191_a_at SRY-box containing gene 13 Sox13 1.73 848 890 256 269
1421694_a_at chondroitin sulfate proteoglycan 2 Cspg2 1.72 988 1271 316 362
1422824_s_at epidermal growth factor receptor pathway subst Eps8 1.72 827 875 267 248
1419486_at forkhead box C1 Foxc1 1.72 462 417 137 130
1456862_at sine oculis-related homeobox 4 homolog (Dros Six4 1.72 39 47 13 13
1438473_at ADP-ribosylation factor related protein 2 Arfrp2 1.71 306 393 104 108
1417307_at dystrophin, muscular dystrophy Dmd 1.71 1785 1806 589 509
1441891_x_at ELOVL family member 7, elongation of long ch Elovl7 1.71 2190 2294 879 487
1421598_at per-hexamer repeat gene 3 Phxr3 1.71 657 538 187 177
1429671_at RIKEN cDNA 2410018M08 gene 2410018M08Rik 1.71 513 486 153 152
1455535_at RIKEN cDNA A730017D01 gene A730017D01Rik 1.71 233 190 52 77
1447204_at Fibronectin leucine rich transmembrane protein Flrt2 1.70 3666 3905 1073 1252
1419700_a_at prominin 1 Prom1 1.70 1976 2187 704 577
1416165_at RAB31, member RAS oncogene family Rab31 1.70 771 578 230 180
1440840_at RIKEN cDNA D630004K10 gene D630004K10Rik 1.70 1849 1505 547 478
1416617_at acetyl-Coenzyme A synthetase 2 (AMP formin Acas2l 1.69 770 728 234 231
1424097_at ELOVL family member 7, elongation of long ch Elovl7 1.69 1977 2227 807 496
1422831_at fibrillin 2 Fbn2 1.69 261 337 81 102
1442467_at RIKEN cDNA 5330421F07 gene 5330421F07Rik 1.69 483 405 135 140
1441573_at sex comb on midleg homolog 1 Scmh1 1.69 1887 1625 618 471
1423858_a_at 3-hydroxy-3-methylglutaryl-Coenzyme A synth Hmgcs2 1.68 389 389 125 117
1418847_at arginase type II Arg2 1.68 496 350 140 119
1434557_at huntingtin interacting protein 1 Hip1 1.68 729 692 222 223
1417585_at nucleoporin 210 Nup210 1.68 2193 1948 622 668
1449033_at tumor necrosis factor receptor superfamily, me Tnfrsf11b 1.68 39 27 11 9
1438975_x_at zinc finger, DHHC domain containing 14 Zdhhc14 1.68 346 327 98 111
1458324_x_at 16 days embryo head cDNA, RIKEN full-length NA 1.67 422 336 136 100
1439191_at follistatin-like 1 Fstl1 1.67 718 511 217 164
1435941_at rhomboid, veinlet-like 4 (Drosophila) Rhbdl4 1.67 997 1024 297 338
1441091_at Transcribed sequences NA 1.67 635 653 234 170
1433699_at tumor necrosis factor, alpha-induced protein 3 Tnfaip3 1.67 1548 1457 539 405
1433642_at ADP-ribosylation factor related protein 2 Arfrp2 1.66 1876 2861 686 779
1423407_a_at fibulin 2 Fbln2 1.66 575 738 201 212
1454799_at Transcribed sequences NA 1.65 515 456 161 149
1427256_at chondroitin sulfate proteoglycan 2 Cspg2 1.64 8514 8533 2892 2594
1453514_at glycoprotein m6b Gpm6b 1.64 203 293 77 79
1446196_at high mobility group AT-hook 2 Hmga2 1.64 332 216 106 66
1452366_at RIKEN cDNA 4732435N03 gene 4732435N03Rik 1.64 1732 1706 583 519








1420377_at sialyltransferase 8 (alpha-2, 8-sialyltransferase Siat8b 1.64 1021 954 301 334
1437967_at Titin Ttn 1.64 192 66 42 30
1418210_at profilin 2 Pfn2 1.63 7565 9001 3149 2194
1443086_at activated leukocyte cell adhesion molecule Alcam 1.63 2251 1778 783 508
1438841_s_at arginase type II Arg2 1.62 218 173 77 49
1427257_at chondroitin sulfate proteoglycan 2 Cspg2 1.62 1208 1548 483 406
1440354_at ELOVL family member 7, elongation of long ch Elovl7 1.62 415 428 162 113
1422823_at epidermal growth factor receptor pathway subst Eps8 1.62 663 623 208 211
1440678_at Latent transforming growth factor beta binding Ltbp1 1.62 292 216 81 83
1430307_a_at malic enzyme, supernatant Mod1 1.62 1013 1193 368 350
1442680_at Neural cell adhesion molecule 1 Ncam1 1.62 290 299 116 75
1453041_at Trp53 inducible protein 5 Trp53i5 1.62 645 628 228 187
1443837_x_at B-cell leukemia/lymphoma 2 Bcl2 1.61 1182 1375 370 468
1423277_at protein tyrosine phosphatase, receptor type, K Ptprk 1.61 674 769 255 217
1448566_at solute carrier family 40 (iron-regulated transport Slc40a1 1.61 1002 789 323 261
1440758_at 7 days neonate cerebellum cDNA, RIKEN full-l NA 1.60 359 344 115 117
1457275_at desmuslin Dmn 1.60 122 86 38 29
1447491_at Leucine rich repeat containing 5 Lrrc5 1.60 2338 1952 785 624
1426865_a_at neural cell adhesion molecule 1 Ncam1 1.60 893 1015 348 280
1429893_at RIKEN cDNA 2810004A10 gene 2810004A10Rik 1.60 812 821 274 267
1433776_at lipoma HMGIC fusion partner Lhfp 1.60 138 119 38 47
1443394_at RIKEN cDNA 9230105E05 gene 9230105E05Rik 1.60 889 859 312 263
1450061_at ectodermal-neural cortex 1 Enc1 1.59 1985 1975 649 665
1453102_at fibronectin leucine rich transmembrane protein 3 Flrt3 1.59 3583 3475 1265 1079
1417505_s_at interleukin 11 receptor, alpha chain 1 Il11ra1 1.59 1243 1032 376 377
1443018_at Neural cell adhesion molecule 1 Ncam1 1.59 1199 1122 498 275
1453191_at procollagen, type XXVII, alpha 1 Col27a1 1.59 720 592 193 239
1416041_at serum/glucocorticoid regulated kinase Sgk 1.59 1011 1211 467 268
1426301_at activated leukocyte cell adhesion molecule Alcam 1.58 5975 5097 1967 1712
1419044_at contactin associated protein 4 Cntnap4 1.58 269 305 103 89
1427182_s_at DNA segment, Chr 18, ERATO Doi 653, expre D18Ertd653e 1.58 91 77 33 23
1442174_at tetraspanin 18 Tspan18 1.58 581 631 203 202
1450781_at high mobility group AT-hook 2 Hmga2 1.57 2443 2222 715 850
1452287_at Musashi homolog 1(Drosophila) Msi1h 1.57 1289 1071 407 386
1417621_at nuclear factor of activated T-cells, cytoplasmic, Nfatc1 1.57 1000 733 363 214
1425761_a_at nuclear factor of activated T-cells, cytoplasmic, Nfatc1 1.57 750 1250 294 359
1417520_at nuclear factor, erythroid derived 2, like 3 Nfe2l3 1.57 159 100 47 39
1437760_at UDP-N-acetyl-alpha-D-galactosamine:polypepti Galnt12 1.57 516 482 143 194
1441769_at ADP-ribosylation factor related protein 2 Arfrp2 1.56 10510 8762 3542 2981
1448788_at antigen identified by monoclonal antibody MRC Mox2 1.56 622 597 217 196
1457687_at B-cell leukemia/lymphoma 2 Bcl2 1.56 2072 2141 723 701
1421818_at B-cell leukemia/lymphoma 6 Bcl6 1.56 1436 1278 498 419
1420928_at beta galactoside alpha 2,6 sialyltransferase 1 St6gal1 1.55 2503 2666 844 919
1436501_at mitochondrial tumor suppressor 1 Mtus1 1.55 170 184 64 56
1445211_at Sex comb on midleg homolog 1 Scmh1 1.55 2221 2021 792 660
1451359_at cDNA sequence BC005662 BC005662 1.54 311 328 109 111
1419468_at C-type lectin domain family 14, member a Clec14a 1.54 39 49 15 15
1448877_at distal-less homeobox 2 Dlx2 1.54 142 131 41 53
1458113_at RIKEN cDNA 9530019H20 gene 9530019H20Rik 1.54 669 635 255 192
1456404_at a disintegrin-like and metalloprotease (reprolysi Adamts5 1.53 115 188 64 38
1451435_at cut-like 1 (Drosophila) Cutl1 1.53 1278 1286 418 468
1433596_at DnaJ (Hsp40) homolog, subfamily C, member Dnajc6 1.53 987 862 330 306
1424114_s_at laminin B1 subunit 1 Lamb1-1 1.53 2068 1721 670 637
1418175_at vitamin D receptor Vdr 1.53 400 292 115 122
1457434_s_at protein tyrosine phosphatase-like (proline inste Ptpla 1.52 3249 3247 1114 1145
1460595_at 16 days embryo head cDNA, RIKEN full-length NA 1.51 1269 929 422 339
1417780_at longevity assurance homolog 4 (S. cerevisiae) Lass4 1.51 232 179 84 59
1436959_x_at nasal embryonic LHRH factor Nelf 1.51 1320 1095 416 430
1426864_a_at neural cell adhesion molecule 1 Ncam1 1.51 10025 9716 4194 2742
1417319_at poliovirus receptor-related 3 Pvrl3 1.51 867 824 283 311
1444993_at Ring finger protein 32 Rnf32 1.51 304 279 107 97
1417673_at growth factor receptor bound protein 14 Grb14 1.50 556 713 246 198
1424113_at laminin B1 subunit 1 Lamb1-1 1.50 144 123 47 48
1442625_at Transcribed sequence with weak  similarity to p NA 1.50 116 113 44 37
1426300_at activated leukocyte cell adhesion molecule Alcam 1.49 1304 1247 499 411
1436512_at ADP-ribosylation factor-like 7 Arl7 1.49 5319 4995 1950 1707
1424890_at basonuclin 1 Bnc1 1.49 6659 6733 2259 2513
1455096_at fibronectin leucine rich transmembrane protein 2 Flrt2 1.49 3069 3322 1120 1149
1441391_at Guanine nucleotide binding protein (G protein), Gnb1l 1.49 1377 1335 463 502
1428387_at acyl-CoA synthetase long-chain family member Acsl3 1.48 673 817 240 291
1448323_a_at biglycan Bgn 1.48 2110 2127 729 789
1460070_at Carbohydrate sulfotransferase 2 Chst2 1.48 353 431 141 138
1430320_at dystrophin, muscular dystrophy Dmd 1.48 269 132 71 64
1450990_at glypican 3 Gpc3 1.48 1034 902 380 315












1447547_at latent transforming growth factor beta binding p Ltbp1 1.47 50 37 16 15
1423331_a_at poliovirus receptor-related 3 Pvrl3 1.47 468 525 171 185
1441509_at RIKEN cDNA A130009I22 gene A130009I22Rik 1.47 590 609 222 211
1439341_at Transcribed sequences NA 1.47 379 469 164 141
1459420_at Transcribed sequences NA 1.47 1611 1742 674 537
1425007_at zinc finger protein 566 Zfp566 1.47 780 755 295 258
1429310_at fibronectin leucine rich transmembrane protein 3 Flrt3 1.46 4189 4586 1658 1520
1450044_at frizzled homolog 7 (Drosophila) Fzd7 1.46 4010 3666 1445 1350
1434848_at G protein-coupled receptor 27 Gpr27 1.46 273 288 106 99
1449286_at netrin G1 Ntng1 1.46 240 224 84 84
1433626_at phospholipid scramblase 4 Plscr4 1.46 84 93 35 29
1418835_at pleckstrin homology-like domain, family A, me Phlda1 1.46 2031 1759 696 674
1448673_at poliovirus receptor-related 3 Pvrl3 1.46 1609 1608 571 600
1440555_at Ras-related GTP binding D Rragd 1.46 308 228 97 95
1436419_a_at RIKEN cDNA 1700097N02 gene 1700097N02Rik 1.46 728 451 276 140
1416405_at biglycan Bgn 1.45 2055 2057 742 760
1436917_s_at G-protein signalling modulator 1 (AGS3-like, C. Gpsm1 1.45 340 269 115 107
1440506_at Solute carrier family 7 (cationic amino acid trans Slc7a2 1.45 200 222 72 83
1451835_at SRY-box containing gene 21 Sox21 1.45 969 908 375 312
1443870_at ATP-binding cassette, sub-family C (CFTR/MR Abcc4 1.44 950 948 351 351
1456811_at CXXC finger 4 Cxxc4 1.44 34 32 12 12
1455995_at DNA segment, Chr 10, Brigham & Women's G D10Bwg1379e 1.44 42 29 14 11
1450064_at formin 2 Fmn2 1.44 135 167 53 58
1419470_at guanine nucleotide binding protein, beta 4 Gnb4 1.44 495 528 191 186
1422708_at phosphoinositide-3-kinase, catalytic, gamma p Pik3cg 1.44 100 69 31 30
1447295_at Cut-like 1 (Drosophila), transcript variant 2, mR Cutl1 1.44 638 705 236 260
1446380_at RIKEN cDNA 9430076C15 gene 9430076C15Rik 1.44 747 761 272 285
1439793_at Gap junction membrane channel protein alpha 3 Gja3 1.44 108 129 42 45
1420872_at guanylate cyclase 1, soluble, beta 3 Gucy1b3 1.43 49 86 22 26
1430876_at RIKEN cDNA 2610312I10 gene 2610312I10Rik 1.43 148 88 46 39
1453545_at RIKEN cDNA 5730492I20 gene 5730492I20Rik 1.43 724 871 297 294
1443194_at RIKEN cDNA 5930430O07 gene 5930430O07Rik 1.43 816 551 276 220
1435701_at 10 days neonate medulla oblongata cDNA, RI NA 1.42 556 584 241 184
1442411_at Glucocorticoid induced transcript 1 Glcci1 1.42 644 581 216 241
1454824_s_at mitochondrial tumor suppressor 1 Mtus1 1.42 1208 1106 453 410
1426258_at sortilin-related receptor, LDLR class A repeats-c Sorl1 1.42 1959 2057 670 828
1437122_at B-cell leukemia/lymphoma 2 Bcl2 1.41 342 384 138 136
1437422_at sema domain, seven thrombospondin repeats ( Sema5a 1.41 2601 2236 863 952
1454866_s_at chloride intracellular channel 6 Clic6 1.40 133 109 51 40
1422851_at high mobility group AT-hook 2 Hmga2 1.40 8339 8585 3150 3249
1442992_at hypothetical LOC403343 130004C03 1.40 985 940 385 343
1446583_at NA NA 1.40 98 50 27 26
1444763_at protein tyrosine phosphatase, receptor type, K Ptprk 1.40 245 322 110 103
1448557_at RIKEN cDNA 1200015N20 gene 1200015N20Rik 1.40 148 215 69 67
1437492_at RIKEN cDNA 9430023B20 gene 9430023B20Rik 1.40 69 80 26 30
1443827_x_at cDNA sequence BC004044 BC004044 1.39 196 212 80 76
1435207_at DIX domain containing 1 Dixdc1 1.39 1477 1565 646 512
1437403_at RIKEN cDNA E130306M17 gene E130306M17Rik 1.39 2199 2874 939 979
1434776_at sema domain, seven thrombospondin repeats ( Sema5a 1.39 2159 2086 796 819
1456315_a_at protein tyrosine phosphatase-like (proline inste Ptpla 1.38 2054 2111 781 821
1416892_s_at RIKEN cDNA 3110001A13 gene 3110001A13Rik 1.38 1514 1486 594 560
1438989_s_at RIKEN cDNA B130021B11 gene B130021B11Rik 1.38 116 137 44 53
1418608_at calmodulin-like 3 Calml3 1.37 311 312 148 93
1451899_a_at general transcription factor II I repeat domain-c Gtf2ird1 1.37 1724 1874 734 657
1426858_at inhibin beta-B Inhbb 1.37 357 441 172 135
1433779_at cancer susceptibility candidate 4 Casc4 1.37 1122 1127 446 427
1445697_at Similar to development- and differentiation-enh --- 1.37 705 717 272 279
1456095_at Tyrosinase (Tyr), mRNA Tyr 1.37 65 133 27 45
1437574_at a disintegrin-like and metalloprotease (reprolysi Adamts18 1.36 312 327 132 117
1441947_x_at cDNA sequence BC033915 BC033915 1.36 1144 1115 403 476
1427579_at rhomboid, veinlet-like 4 (Drosophila) Rhbdl4 1.36 202 220 74 90
1429987_at RIKEN cDNA 9930013L23 gene 9930013L23Rik 1.36 325 225 126 84
1435892_at RIKEN cDNA D430002O22 gene D430002O22Rik 1.36 191 214 92 66
1446772_at Transcribed sequences NA 1.36 954 903 388 335
1448698_at cyclin D1 Ccnd1 1.35 3260 3274 1292 1277
1448665_at dystrophin, muscular dystrophy Dmd 1.35 6501 5439 2439 2226
1439795_at G protein-coupled receptor 64 Gpr64 1.35 2475 2656 955 1063
1460364_at general transcription factor II I repeat domain-c Gtf2ird1 1.35 3782 3439 1508 1316
1423110_at procollagen, type I, alpha 2 Col1a2 1.35 451 553 190 202
1448669_at dickkopf homolog 3 (Xenopus laevis) Dkk3 1.34 594 599 231 239
1417937_at dapper homolog 1, antagonist of beta-catenin ( Dact1 1.33 335 243 125 102
1426008_a_at solute carrier family 7 (cationic amino acid tran Slc7a2 1.33 114 113 45 45
1456515_s_at transcription factor-like 5 (basic helix-loop-helix) Tcfl5 1.33 225 218 104 72
1455436_at DIRAS family, GTP-binding RAS-like 2 Diras2 1.32 203 251 94 87





1438702_at fibronectin leucine rich transmembrane protein 2 Flrt2 1.32 5637 6152 2253 2473
1452106_at nephronectin Npnt 1.32 2856 2624 1056 1144
1436993_x_at profilin 2 Pfn2 1.32 8822 9628 4227 3166
1423635_at bone morphogenetic protein 2 Bmp2 1.31 3129 2528 1275 998
1448901_at carboxypeptidase X 1 (M14 family) Cpxm1 1.31 172 205 72 79
1417782_at longevity assurance homolog 4 (S. cerevisiae) Lass4 1.31 48 53 20 21
1444306_at Musashi homolog 1(Drosophila) Msi1h 1.31 213 160 79 70
1429001_at pirin Pir 1.31 115 130 54 45
1454788_at ADP-ribosylation factor-like 7 Arl7 1.30 7089 5997 3031 2267
1436181_at development and differentiation enhancing fact Ddef2 1.30 760 783 326 299
1458947_at Fanconi anemia, complementation group C Fancc 1.30 6368 5673 2672 2212
1429053_at RIKEN cDNA 1110012J17 gene 1110012J17Rik 1.30 1528 1542 593 652
1453595_at RIKEN cDNA 2900064B18 gene 2900064B18Rik 1.30 95 85 34 39
1455325_at RIKEN cDNA A230057G18 gene A230057G18Rik 1.30 1982 1444 694 683
1434709_at RIKEN cDNA C130076O07 gene C130076O07Rik 1.30 202 203 85 80
1429285_at serine (or cysteine) proteinase inhibitor, clade Serpina9 1.30 211 151 78 68
1437889_x_at biglycan Bgn 1.29 778 798 312 334
1434628_a_at rhophilin, Rho GTPase binding protein 2 Rhpn2 1.29 326 471 162 158
1436761_s_at RIKEN cDNA 1200015N20 gene 1200015N20Rik 1.29 36 39 19 12
1424625_a_at DENN/MADD domain containing 1A Dennd1a 1.29 241 258 100 105
1432103_a_at SH3-domain GRB2-like 3 Sh3gl3 1.29 527 571 214 235
1431202_at hect domain and RLD 3 Herc3 1.28 346 306 119 150
1452771_s_at acyl-CoA synthetase long-chain family member Acsl3 1.27 1146 1160 447 507
1451972_at glucocorticoid induced transcript 1 Glcci1 1.27 2044 1653 737 791
1416842_at glutathione S-transferase, mu 5 Gstm5 1.27 545 555 247 209
1423885_at laminin, gamma 1 Lamc1 1.27 932 893 373 381
1429514_at phosphatidic acid phosphatase type 2B Ppap2b 1.27 553 641 249 244
1431049_at amyotrophic lateral sclerosis 2 (juvenile) chromo Als2cr15 1.27 76 43 24 24
1416257_at calpain 2 Capn2 1.26 1132 1198 442 531
1421317_x_at myeloblastosis oncogene Myb 1.26 1667 1470 692 616
1450194_a_at myeloblastosis oncogene Myb 1.26 619 536 262 220
1428259_at RIKEN cDNA 2310075M15 gene 2310075M15Rik 1.26 4243 4545 1776 1896
1431300_at RIKEN cDNA 3110007P09 gene 3110007P09Rik 1.26 139 98 55 43
1455549_at SEC14 and spectrin domains 1 Sestd1 1.26 3533 3005 1263 1450
1454764_s_at solute carrier family 38, member 1 Slc38a1 1.26 67 130 29 49
1434496_at polo-like kinase 3 (Drosophila) Plk3 1.25 311 335 144 127
1452365_at RIKEN cDNA 4732435N03 gene 4732435N03Rik 1.25 286 289 132 110
1417686_at lectin, galactose binding, soluble 12 Lgals12 1.24 664 527 274 225
1418209_a_at profilin 2 Pfn2 1.24 14379 15533 7097 5580
1441463_at RIKEN cDNA C230079D11 gene C230079D11Rik 1.24 166 212 85 73
1455250_at SH3-domain binding protein 4 Sh3bp4 1.24 482 591 218 233
1434429_at synaptotagmin 14-like Syt14l 1.24 25 28 9 13
1450857_a_at procollagen, type I, alpha 2 Col1a2 1.23 1099 1347 515 522
1436508_at RIKEN cDNA 2410014A08 gene 2410014A08Rik 1.23 3995 4345 1820 1738
1456874_at fibronectin leucine rich transmembrane protein 2 Flrt2 1.22 308 315 127 140
1436509_at RIKEN cDNA 2410014A08 gene 2410014A08Rik 1.22 2334 2720 1055 1113
1455818_at RIKEN cDNA 4930427A07 gene 4930427A07Rik 1.22 1566 2273 687 937
1454576_at RIKEN cDNA A230102O21 gene A230102O21Rik 1.22 193 227 75 105
1452214_at SKI-like Skil 1.22 4739 4351 1970 1928
1458140_at slit homolog 2 (Drosophila) Slit2 1.22 121 139 65 46
1426317_at StAR-related lipid transfer (START) domain co Stard6 1.22 464 459 219 178
1441927_at synaptotagmin 7 Syt7 1.22 199 198 79 91
1433043_at chondroitin sulfate proteoglycan 2 Cspg2 1.21 140 119 58 54
1426218_at glucocorticoid induced transcript 1 Glcci1 1.21 1924 1382 682 732
1459868_x_at interleukin 11 receptor, alpha chain 1 Il11ra1 1.21 109 91 42 44
1450860_at leucine aminopeptidase 3 Lap3 1.21 2970 3036 1417 1174
1452107_s_at nephronectin Npnt 1.21 1238 1034 446 531
1417420_at cyclin D1 Ccnd1 1.20 9402 8926 3856 4102
1449630_s_at MAP/microtubule affinity-regulating kinase 1 Mark1 1.20 2261 2573 958 1137
1430934_at RIKEN cDNA 2810043G22 gene 2810043G22Rik 1.20 125 123 58 50
1454877_at SERTA domain containing 4 Sertad4 1.20 6165 5585 2505 2587
1421052_a_at spermine synthase Sms 1.20 3674 4151 1789 1616
1445178_at SH3 multiple domains 2 Sh3md2 1.20 573 574 239 261
1448569_at CD8 antigen, beta chain Cd8b 1.19 3142 3800 1489 1534
1417311_at cysteine rich protein 2 Crip2 1.19 798 792 309 386
1457113_at nuclear autoantigenic sperm protein (histone-bin Nasp 1.19 1849 1314 800 563
1443589_at DNA segment, Chr X, ERATO Doi 242, expres DXErtd242e 1.19 89 105 47 37
1425942_a_at glycoprotein m6b Gpm6b 1.19 291 332 144 129
1450780_s_at high mobility group AT-hook 2 Hmga2 1.19 7972 8281 3444 3664
1446850_at Phosphatidic acid phosphatase type 2B Ppap2b 1.19 209 241 109 87
1442845_at RIKEN cDNA C130075A20 gene C130075A20Rik 1.19 171 130 62 69
1454268_a_at cytochrome b-245, alpha polypeptide Cyba 1.18 276 305 135 121
1455214_at microphthalmia-associated transcription factor Mitf 1.18 438 572 228 215
1416489_at phosphatidylinositol 4-kinase type 2 beta Pi4k2b 1.18 1025 1098 519 416







1435363_at pleckstrin homology domain containing, family Plekhg1 1.18 1503 1397 733 550
1452666_a_at transmembrane and coiled-coil domains 2 Tmcc2 1.18 161 172 67 80
1441038_at Utrophin Utrn 1.18 713 720 324 309
1444253_at a disintegrin-like and metalloprotease (reprolysi Adamts18 1.17 89 81 43 33
1455437_at cDNA sequence BC033915 BC033915 1.17 3577 2945 1465 1430
1440952_at MAD homolog 7 (Drosophila) Smad7 1.17 368 197 133 106
1451679_at RIKEN cDNA 6530401D17 gene 6530401D17Rik 1.17 707 623 344 247
1440513_at expressed sequence C80258 C80258 1.16 690 698 300 319
1423680_at fatty acid desaturase 1 Fads1 1.16 929 799 426 347
1449455_at hemopoietic cell kinase Hck 1.16 275 323 127 139
1460693_a_at procollagen, type IX, alpha 3 Col9a3 1.16 61 60 29 25
1458942_at RIKEN cDNA C230037E05 gene C230037E05Rik 1.16 287 263 124 123
1426241_a_at sex comb on midleg homolog 1 Scmh1 1.16 596 656 236 325
1445918_at transmembrane protein 2 Tmem2 1.16 297 229 115 120
1416953_at connective tissue growth factor Ctgf 1.15 774 994 423 369
1433491_at erythrocyte protein band 4.1-like 2 Epb4.1l2 1.15 96 116 50 45
1456072_at protein phosphatase 1, regulatory (inhibitor) su Ppp1r9a 1.15 426 408 194 183
1452226_at regulator of chromosome condensation 2 Rcc2 1.15 1072 988 488 439
1454701_at RIKEN cDNA 4930503L19 gene 4930503L19Rik 1.15 643 493 333 176
1424824_at RIKEN cDNA 9630044O09 gene 9630044O09Rik 1.15 47 39 19 20
1436977_at Transcribed sequences NA 1.15 376 322 153 160
1440284_at Transcribed sequences NA 1.15 26 26 13 11
1416579_a_at tumor-associated calcium signal transducer 1 Tacstd1 1.15 5810 5848 2899 2340
1459144_at Fibronectin type III domain containing 3a Fndc3 1.14 692 781 328 340
1431226_a_at fibronectin type III domain containing 4 Fndc4 1.14 294 271 132 124
1427028_at leucine-rich repeat-containing G protein-coupled Lgr6 1.14 397 394 181 179
1456648_at Mannosidase 1, alpha Man1a 1.14 385 521 194 212
1451516_at Ras homolog enriched in brain like 1 Rhebl1 1.14 1024 1005 482 441
1419798_at RIKEN cDNA 2610019E17 gene 2610019E17Rik 1.14 99 103 53 39
1434307_at transmembrane protein 64 Tmem64 1.14 947 988 462 417
1442175_at RIKEN cDNA C030027H14 gene C030027H14Rik 1.14 593 538 272 243
1438783_at Transmembrane, prostate androgen induced RN Tmepai 1.14 572 562 243 271
1447043_at V-erb-a erythroblastic leukemia viral oncogene Erbb4 1.14 214 157 77 89
1437785_at a disintegrin-like and metalloprotease (reprolysi Adamts9 1.13 5519 5115 2230 2633
1433894_at expressed sequence AI591476 AI591476 1.13 119 134 54 61
1453416_at growth arrest-specific 2 like 3 Gas2l3 1.13 2651 2126 1086 1087
1429896_at RIKEN cDNA 5830408B19 gene 5830408B19Rik 1.13 8103 9049 4003 3817
1446461_at SRY-box containing gene 5 Sox5 1.13 224 179 94 88
1437467_at activated leukocyte cell adhesion molecule Alcam 1.12 15907 14868 7572 6622
1448919_at CD302 antigen Cd302 1.12 125 132 63 55
1439568_at gene regulated by estrogen in breast cancer pr Greb1 1.12 371 468 183 200
1424367_a_at homer homolog 2 (Drosophila) Homer2 1.12 719 817 318 386
1430033_at RIKEN cDNA 5330431K02 gene 5330431K02Rik 1.12 349 269 143 138
1437059_at SRY-box containing gene 21 Sox21 1.12 3230 2585 1364 1302
1423499_at synuclein, alpha interacting protein (synphilin) Sncaip 1.12 131 144 64 63
1446653_at Transcribed sequences NA 1.12 444 368 179 192
1435083_at cortexin Ctxn 1.11 547 515 220 273
1433590_at hect domain and RLD 3 Herc3 1.11 1081 1043 471 516
1459493_at SET binding protein 1 (Setbp1), mRNA Setbp1 1.11 495 522 231 241
1435176_a_at inhibitor of DNA binding 2 Idb2 1.11 370 437 182 189
1431402_at kin of IRRE like 3 (Drosophila) Kirrel3 1.11 439 439 205 202
1430352_at RIKEN cDNA 8430417A20 gene 8430417A20Rik 1.11 3978 3771 1608 1968
1430083_at RIKEN cDNA 2610307P16 gene 2610307P16Rik 1.10 125 109 58 52
1440739_at vascular endothelial growth factor C Vegfc 1.10 202 190 103 79
1438866_at glutamate receptor ionotropic, NMDA3A Grin3a 1.09 55 36 20 22
1420411_a_at phosphatidylinositol 4-kinase type 2 beta Pi4k2b 1.09 542 213 241 78
1435977_at hepatoma-derived growth factor, related protei Hdgfrp3 1.09 780 728 354 353
1434797_at RIKEN cDNA 6720469N11 gene 6720469N11Rik 1.09 583 528 255 267
1458241_at RIKEN cDNA 9230105E05 gene 9230105E05Rik 1.09 658 464 248 271
1448024_at RIKEN cDNA B430320C24 gene B430320C24Rik 1.09 504 618 286 237
1435050_at RIKEN cDNA B930094H20 gene B930094H20Rik 1.09 52 40 22 21
1434645_at RIKEN cDNA C530008M17 gene C530008M17Rik 1.09 56 51 26 24
1422865_at runt related transcription factor 1 Runx1 1.09 74 65 30 35
1446897_at Transcribed sequences NA 1.09 256 307 137 126
1460559_at ankyrin repeat domain 25 Ankrd25 1.08 1151 1377 575 612
1435387_at expressed sequence AI505012 AI505012 1.08 375 433 195 187
1449058_at GLI-Kruppel family member GLI Gli 1.08 587 668 265 329
1449471_at potassium large conductance calcium-activate Kcnmb4 1.08 512 588 248 273
1447818_x_at Ras homolog enriched in brain like 1 Rhebl1 1.08 1503 1344 769 576
1456377_x_at RIKEN cDNA 0610025L06 gene 0610025L06Rik 1.08 2107 2327 1021 1068
1419829_a_at Transcribed sequence with weak  similarity to p NA 1.08 286 248 144 107
1433531_at acyl-CoA synthetase long-chain family member Acsl4 1.07 980 887 525 364
1417312_at dickkopf homolog 3 (Xenopus laevis) Dkk3 1.07 378 388 198 168
1420342_at ganglioside-induced differentiation-associated- Gdap10 1.07 1925 2086 958 947











1440067_at Neural cell adhesion molecule 1 Ncam1 1.07 157 124 79 54
1426934_at NHS-like 1 Nhsl1 1.07 1721 1737 788 865
1418711_at platelet derived growth factor, alpha Pdgfa 1.07 1668 1864 685 990
1424250_a_at Rho guanine nucleotide exchange factor (GEF) Arhgef3 1.07 559 567 283 253
1422462_at ubiquitin-conjugating enzyme E2T (putative) Ube2t 1.07 379 323 161 171
1434982_at Transcribed sequence with weak  similarity to p NA 1.07 160 208 90 84
1425510_at MAP/microtubule affinity-regulating kinase 1 Mark1 1.06 181 180 80 93
1452740_at myosin heavy chain 10, non-muscle Myh10 1.06 2847 2468 1344 1197
1457256_x_at patched homolog 2 Ptch2 1.06 7113 6632 3415 3192
1424051_at procollagen, type IV, alpha 2 Col4a2 1.06 1217 1241 600 578
1425452_s_at protein tyrosine phosphatase, receptor type, J //Ptprj /// AW12575 1.06 3005 3130 1710 1241
1426541_a_at RIKEN cDNA 2310067E08 gene 2310067E08Rik 1.06 38 39 18 19
1435184_at RIKEN cDNA B430320C24 gene B430320C24Rik 1.06 886 939 495 381
1434592_at solute carrier family 16 (monocarboxylic acid tr Slc16a10 1.06 615 517 258 283
1424950_at SRY-box containing gene 9 Sox9 1.06 1393 1265 724 553
1452205_x_at T-cell receptor beta, variable 13 Tcrb-V13 1.06 128 144 64 66
1418884_x_at tubulin, alpha 1 Tuba1 1.06 8478 7906 4029 3798
1435913_at cDNA sequence BC038881 BC038881 1.05 287 260 137 127
1427683_at early growth response 2 Egr2 1.05 863 915 583 277
1417558_at Fyn proto-oncogene Fyn 1.05 153 171 65 92
1417101_at heat shock protein 2 Hspa2 1.05 458 382 214 191
1454671_at insulin induced gene 1 Insig1 1.05 443 596 226 269
1422771_at MAD homolog 6 (Drosophila) Smad6 1.05 57 71 30 31
1416505_at nuclear receptor subfamily 4, group A, member Nr4a1 1.05 1322 1300 675 591
1460627_at RIKEN cDNA D130067I03 gene D130067I03Rik 1.05 73 46 28 27
1429114_at SEC14 and spectrin domains 1 Sestd1 1.05 393 394 182 198
1421943_at transforming growth factor alpha Tgfa 1.05 426 348 196 176
1417978_at eukaryotic translation initiation factor 4E memb Eif4e3 1.04 360 448 182 208
1435308_at fucosyltransferase 9 Fut9 1.04 83 74 40 36
1444519_at G protein-coupled receptor 49 Gpr49 1.04 70 184 51 59
1458575_at SET binding protein 1 (Setbp1), mRNA Setbp1 1.04 1105 1001 511 509
1417612_at immediate early response 5 Ier5 1.04 1886 1662 965 753
1424594_at lectin, galactose binding, soluble 7 Lgals7 1.04 426 372 172 215
1448416_at matrix gamma-carboxyglutamate (gla) protein Mglap 1.04 202 160 89 87
1434700_at RIKEN cDNA 6030408C04 gene 6030408C04Rik 1.04 1446 1395 692 688
1455820_x_at scavenger receptor class B, member 1 Scarb1 1.04 1084 1125 552 523
1439926_at hypothetical protein 4632417D23 4632417D23 1.03 335 319 155 165
1455881_at immediate early response 5-like Ier5l 1.03 438 382 195 205
1415806_at plasminogen activator, tissue Plat 1.03 179 149 91 69
1435461_at membrane associated guanylate kinase, WW a Magi3 1.03 714 714 355 342
1434008_at sodium channel, type IV, beta polypeptide Scn4b 1.03 229 211 102 113
1436368_at solute carrier family 16 (monocarboxylic acid tr Slc16a10 1.03 2087 1700 896 943
1451152_a_at ATPase, Na+/K+ transporting, beta 1 polypepti Atp1b1 1.02 988 1043 501 497
1417688_at cDNA sequence BC004044 BC004044 1.02 329 367 157 187
1437540_at mucolipin 3 Mcoln3 1.02 174 306 101 127
1444583_at Nuclear autoantigenic sperm protein (histone-bi Nasp 1.02 1249 1296 757 502
1456475_s_at protein kinase, cAMP dependent regulatory, ty Prkar2b 1.02 2551 2090 1165 1118
1448509_at SH3-domain GRB2-like (endophilin) interacting Sgip1 1.02 369 379 204 166
1432746_at RIKEN cDNA 6030442H21 gene 6030442H21Rik 1.02 266 219 129 109
1455149_at SH3 multiple domains 2 Sh3md2 1.02 641 596 288 322
1415964_at stearoyl-Coenzyme A desaturase 1 Scd1 1.02 2508 3322 1443 1395
1417749_a_at tight junction protein 1 Tjp1 1.02 8251 7217 4086 3533
1459054_at cDNA sequence BC035954 BC035954 1.01 146 129 58 78
1416326_at cysteine-rich protein 1 (intestinal) Crip1 1.01 803 813 389 411
1433770_at dihydropyrimidinase-like 2 Dpysl2 1.01 2010 2294 1045 1091
1419593_at gene regulated by estrogen in breast cancer pr Greb1 1.01 169 201 92 91
1457229_at G-protein coupled receptor 173 Gpr173 1.01 337 346 164 175
1455687_at intestinal cell kinase Ick 1.01 2803 2305 1193 1331
1441995_at Neural cell adhesion molecule 1 Ncam1 1.01 571 420 272 212
1417928_at PDZ and LIM domain 4 Pdlim4 1.01 371 285 197 127
1448908_at phosphatidic acid phosphatase type 2B Ppap2b 1.01 377 410 201 190
1455980_a_at PREDICTED: similar to growth arrest-specific 2 Gas2l3 1.01 449 292 174 186
1433571_at serine incorporator 5 Serinc5 1.01 728 553 350 278
1446326_at procollagen, type I, alpha 2 Col1a2 1.00 61 68 31 33
1437894_at prospero-related homeobox 1 Prox1 1.00 57 41 23 25
1438664_at protein kinase, cAMP dependent regulatory, ty Prkar2b 1.00 1136 1010 565 506
1428749_at Dmx-like 2 Dmxl2 1.00 572 598 296 290
1453523_at RIKEN cDNA A030006P16 gene A030006P16Rik 1.00 185 158 79 91
1449198_a_at sialyltransferase 9 (CMP-NeuAc:lactosylceramid Siat9 1.00 456 569 261 247
1426712_at solute carrier family 6 (neurotransmitter transp Slc6a15 1.00 58 50 29 25
1429581_at acyl-Coenzyme A dehydrogenase family, mem Acad9 -1.00 1908 1711 3811 3429
1451243_at arginyl aminopeptidase (aminopeptidase B) Rnpep -1.00 252 183 454 407
1428549_at coiled-coil domain containing 3 Ccdc3 -1.00 565 599 1084 1241












1429021_at Eph receptor A4 Epha4 -1.00 925 798 1904 1535
1419309_at glycoprotein 38 Gp38 -1.00 197 200 345 450
1445897_s_at interferon-induced protein 35 Ifi35 -1.00 190 192 410 354
1419161_a_at NADPH oxidase 4 Nox4 -1.00 43 47 99 80
1430191_at RIKEN cDNA 9130004J05 gene 9130004J05Rik -1.00 524 498 1052 988
1439731_at RIKEN cDNA E130309F12 gene E130309F12Rik -1.00 64 42 102 105
1426584_a_at sorbitol dehydrogenase 1 Sdh1 -1.00 188 160 343 353
1416137_at annexin A7 Anxa7 -1.01 193 197 413 374
1422470_at BCL2/adenovirus E1B 19kDa-interacting protei Bnip3 -1.01 2059 1348 4148 2581
1452434_s_at DiGeorge syndrome critical region gene 6 Dgcr6 -1.01 260 253 565 471
1427510_at guanine nucleotide binding protein, alpha inhibit Gnai1 -1.01 101 91 168 216
1424172_at hydroxyacyl glutathione hydrolase Hagh -1.01 445 394 856 825
1416401_at kangai 1 (suppression of tumorigenicity 6, pros Kai1 -1.01 259 231 513 474
1417701_at protein phosphatase 1, regulatory (inhibitor) su Ppp1r14c -1.01 1841 2267 4441 3780
1430286_s_at protein phosphatase 1, regulatory (inhibitor) su Ppp1r14c -1.01 221 230 483 427
1449256_a_at RAB11a, member RAS oncogene family Rab11a -1.01 1041 1168 2267 2184
1453261_at RIKEN cDNA 2610035D17 gene 2610035D17Rik -1.01 151 101 252 246
1452519_a_at zinc finger protein 36 Zfp36 -1.01 821 944 2074 1484
1423420_at adrenergic receptor, beta 1 Adrb1 -1.02 43 54 109 87
1438764_at annexin A7 Anxa7 -1.02 370 376 837 672
1417649_at cyclin-dependent kinase inhibitor 1C (P57) Cdkn1c -1.02 131 161 291 299
1417195_at DNA segment, Chr 8, ERATO Doi 594, expres D8Ertd594e -1.02 191 204 368 435
1416021_a_at fatty acid binding protein 5, epidermal Fabp5 -1.02 7649 6955 15545 14020
1426873_s_at junction plakoglobin Jup -1.02 242 237 479 492
1422743_at phosphorylase kinase alpha 1 Phka1 -1.02 97 99 184 213
1423909_at RIKEN cDNA 0610011I04 gene 0610011I04Rik -1.02 313 324 618 669
1420150_at splA/ryanodine receptor domain and SOCS bo Spsb1 -1.02 165 159 284 373
1457883_at Adult male aorta and vein cDNA, RIKEN full-le NA -1.03 215 247 431 512
1438093_x_at diazepam binding inhibitor Dbi -1.03 3129 2925 6563 5766
1442606_at dynamin binding protein Dnmbp -1.03 116 106 242 211
1455994_x_at elongation of very long chain fatty acids (FEN1 Elovl1 -1.03 598 668 1295 1294
1459948_at Growth hormone receptor Ghr -1.03 70 65 136 138
1419052_at OVO homolog-like 1 (Drosophila) Ovol1 -1.03 70 62 152 117
1435571_at RIKEN cDNA A530065I17 gene A530065I17Rik -1.03 175 210 412 372
1435205_at transcription factor AP-2, epsilon Tcfap2e -1.03 822 903 1612 1909
1425645_s_at cytochrome P450, family 2, subfamily b, polype Cyp2b20 -1.04 64 74 160 123
1449852_a_at EH-domain containing 4 Ehd4 -1.04 387 287 837 532
1418517_at Iroquois related homeobox 3 (Drosophila) Irx3 -1.04 122 126 264 243
1421106_at jagged 1 Jag1 -1.04 288 176 616 313
1441547_at Nuclear factor I/A Nfia -1.04 1102 1117 2179 2389
1430483_a_at RIKEN cDNA 2310042N02 gene 2310042N02Rik -1.04 99 100 203 207
1430655_at RIKEN cDNA 4631405K08 gene 4631405K08Rik -1.04 496 421 843 1029
1446281_at RIKEN cDNA C530008M07 gene C530008M07Rik -1.04 134 111 291 211
1424530_at SEC14-like 2 (S. cerevisiae) Sec14l2 -1.04 130 139 288 265
1430724_at abhydrolase domain containing 9 Abhd9 -1.05 138 106 256 247
1432018_at achaete-scute complex homolog-like 2 (Drosop Ascl2 -1.05 15 13 30 28
1451210_at phosphatidic acid phosphatase type 2c Ppap2c -1.05 842 1019 1931 1909
1428400_at RIKEN cDNA 2200002K05 gene 2200002K05Rik -1.05 83 90 202 154
1423494_at RIKEN cDNA 2310042E22 gene 2310042E22Rik -1.05 90 108 207 203
1433943_at RIKEN cDNA 4930463G05 gene 4930463G05Rik -1.05 97 94 200 195
1450034_at signal transducer and activator of transcription Stat1 -1.05 310 340 688 656
1448529_at thrombomodulin Thbd -1.05 28 39 90 47
1417196_s_at DNA segment, Chr 8, ERATO Doi 594, expres D8Ertd594e -1.06 604 544 1160 1237
1448194_a_at H19 fetal liver mRNA H19 -1.06 14012 11770 27644 25780
1417047_at prominin 2 Prom2 -1.06 194 184 462 329
1425603_at RIKEN cDNA 0610011I04 gene 0610011I04Rik -1.06 381 416 787 877
1453511_at RIKEN cDNA 2310007B03 gene 2310007B03Rik -1.06 52 51 116 98
1458578_at RNA binding motif, single stranded interacting Rbms1 -1.06 274 258 503 606
1438937_x_at angiogenin, ribonuclease A family, member 1 Ang1 -1.07 61 38 101 101
1448985_at dual specificity phosphatase 22 Dusp22 -1.07 687 706 1523 1412
1425918_at EGL nine homolog 3 (C. elegans) Egln3 -1.07 678 715 1592 1338
1417301_at frizzled homolog 6 (Drosophila) Fzd6 -1.07 1540 1441 3208 3058
1422784_at keratin complex 2, basic, gene 6a Krt2-6a -1.07 123 144 312 245
1450626_at mannosidase, beta A, lysosomal Manba -1.07 255 297 511 648
1453593_at RIKEN cDNA 1700110N18 gene 1700110N18Rik -1.07 434 394 851 880
1424308_at solute carrier family 24 (sodium/potassium/calci Slc24a3 -1.07 193 245 407 506
1443720_s_at bone morphogenetic protein receptor, type 1B Bmpr1b -1.08 17 14 31 34
1437057_at EGF-like-domain, multiple 3 Egfl3 -1.08 444 487 937 1026
1439757_s_at Eph receptor A4 Epha4 -1.08 246 212 475 493
1424400_a_at formyltetrahydrofolate dehydrogenase Fthfd -1.08 78 123 174 241
1417395_at Kruppel-like factor 4 (gut) Klf4 -1.08 586 590 1223 1270
1445929_at Potassium channel, subfamily K, member 2 Kcnk2 -1.08 68 62 137 139
1440693_at RIKEN cDNA 2410003B16 gene 2410003B16Rik -1.08 94 86 194 188
1428450_at RIKEN cDNA 2610034B18 gene 2610034B18Rik -1.08 196 243 477 446










1437245_at RIKEN cDNA 9930117H01 gene 9930117H01Rik -1.08 22 22 58 35
1420614_at t-complex-associated-testis-expressed 1-like Tcte1l -1.08 628 733 1465 1401
1416431_at tubulin, beta 6 Tubb6 -1.08 164 171 374 335
1423126_at ATPase, Na+/K+ transporting, beta 3 polypepti Atp1b3 -1.09 4489 4920 10040 9992
1436346_at CD109 antigen Cd109 -1.09 1370 1430 3341 2638
1420498_a_at disabled homolog 2 (Drosophila) Dab2 -1.09 109 66 142 219
1418648_at EGL nine homolog 3 (C. elegans) Egln3 -1.09 269 216 578 445
1418483_a_at glycoprotein galactosyltransferase alpha 1, 3 Ggta1 -1.09 450 473 946 1014
1434440_at guanine nucleotide binding protein, alpha inhibit Gnai1 -1.09 4199 4308 8972 9096
1417777_at leukotriene B4 12-hydroxydehydrogenase Ltb4dh -1.09 742 923 1850 1666
1441163_at mediator of RNA polymerase II transcription, s Med12l -1.09 35 46 76 94
1448954_at nuclear receptor interacting protein 3 Nrip3 -1.09 180 206 331 487
1422293_a_at potassium channel tetramerisation domain con Kctd1 -1.09 143 152 317 310
1424507_at Ras and Rab interactor 1 Rin1 -1.09 26 18 39 53
1415850_at RAS p21 protein activator 3 Rasa3 -1.09 362 397 791 819
1440283_at RIKEN cDNA 1810059H22 gene 1810059H22Rik -1.09 126 99 239 236
1450947_at RIKEN cDNA 2610528J11 gene 2610528J11Rik -1.09 123 95 234 226
1434725_at RIKEN cDNA 4921521N14 gene 4921521N14Rik -1.09 239 303 561 585
1447655_x_at SRY-box containing gene 6 Sox6 -1.09 798 744 1639 1646
1449929_at t-complex-associated-testis-expressed 1-like Tcte1l -1.09 2975 2957 6576 6068
1444974_at expressed sequence AU023617 AU023617 -1.10 257 266 493 626
1437874_s_at hexosaminidase B Hexb -1.10 202 141 415 308
1424942_a_at myelocytomatosis oncogene Myc -1.10 63 73 172 118
1434534_at NA NA -1.10 5518 4035 11594 8601
1429284_at RIKEN cDNA 8430436F23 gene 8430436F23Rik -1.10 725 744 1737 1419
1451594_s_at serine (or cysteine) proteinase inhibitor, clade Serpinb6c -1.10 55 66 137 121
1416528_at SH3 domain binding glutamic acid-rich protein-l Sh3bgrl3 -1.10 533 551 1084 1247
1424030_at grainyhead-like 1 (Drosophila) Grhl1 -1.10 690 780 1811 1324
1454862_at pleckstrin homology-like domain, family B, me Phldb2 -1.11 934 1036 1988 2245
1438882_at Rho GTPase activating protein 18 Arhgap18 -1.11 424 308 871 694
1427677_a_at SRY-box containing gene 6 Sox6 -1.11 1167 1221 2598 2555
1416564_at SRY-box containing gene 7 Sox7 -1.11 85 70 190 143
1436651_at Transcribed sequences NA -1.11 257 218 498 522
1439352_at tripartite motif protein 7 Trim7 -1.11 51 52 111 110
1419572_a_at ATP-binding cassette, sub-family D (ALD), me Abcd4 -1.12 143 118 326 238
1425108_a_at cDNA sequence BC004728 BC004728 -1.12 72 65 162 135
1424303_at expressed sequence AV216087 AV216087 -1.12 371 420 843 878
1443997_at RIKEN cDNA C130040D06 gene C130040D06Rik -1.12 129 92 292 180
1426908_at UDP-N-acetyl-alpha-D-galactosamine: polypept Galnt7 -1.12 168 184 410 352
1441153_at Utrophin Utrn -1.12 619 540 1369 1145
1417122_at vav 3 oncogene Vav3 -1.12 925 1131 2282 2169
1437302_at adrenergic receptor, beta 2 Adrb2 -1.13 51 53 126 101
1451446_at anthrax toxin receptor 1 Antxr1 -1.13 1492 1509 3214 3363
1448359_a_at hypoxia induced gene 1 Hig1 -1.13 272 284 683 535
1417813_at inhibitor of kappaB kinase epsilon Ikbke -1.13 142 134 313 290
1451775_s_at interleukin 13 receptor, alpha 1 Il13ra1 -1.13 171 184 394 385
1434070_at jagged 1 Jag1 -1.13 1758 1383 3955 2887
1421163_a_at nuclear factor I/A Nfia -1.13 557 490 1078 1203
1440491_at solute carrier family 1 (glial high affinity glutam Slc1a3 -1.13 34 25 69 57
1438183_x_at sorbitol dehydrogenase 1 Sdh1 -1.13 72 63 145 148
1416008_at special AT-rich sequence binding protein 1 Satb1 -1.13 3483 3307 7376 7483
1433819_s_at 1-acylglycerol-3-phosphate O-acyltransferase Agpat3 -1.14 156 155 380 307
1417566_at abhydrolase domain containing 5 Abhd5 -1.14 203 233 543 415
1422678_at diacylglycerol O-acyltransferase 2 Dgat2 -1.14 219 223 604 374
1416855_at growth arrest specific 1 Gas1 -1.14 6714 5863 14228 13385
1447173_at NA NA -1.14 25 26 60 53
1426952_at Rho GTPase activating protein 18 Arhgap18 -1.14 140 138 320 293
1423824_at RIKEN cDNA 5031439A09 gene 5031439A09Rik -1.14 1106 1177 2475 2560
1420915_at signal transducer and activator of transcription Stat1 -1.14 177 162 411 333
1450618_a_at small proline-rich protein 2A Sprr2a -1.14 649 777 1707 1419
1417639_at solute carrier family 22 (organic cation transport Slc22a4 -1.14 238 222 540 474
1444479_at Transcribed sequences NA -1.14 2794 3662 6420 7713
1434486_x_at UDP-glucose pyrophosphorylase 2 Ugp2 -1.14 579 616 1374 1257
1437932_a_at claudin 1 Cldn1 -1.15 1061 947 2637 1810
1437458_x_at clusterin Clu -1.15 329 313 773 655
1453072_at G protein-coupled receptor 160 Gpr160 -1.15 177 225 490 396
1423062_at insulin-like growth factor binding protein 3 Igfbp3 -1.15 94 75 190 184
1451690_a_at poliovirus receptor-related 4 Pvrl4 -1.15 137 73 277 166
1448312_at proprotein convertase subtilisin/kexin type 2 Pcsk2 -1.15 150 191 307 446
1435842_at RIKEN cDNA 1110038O08 gene 1110038O08Rik -1.15 111 130 226 306
1456321_at RIKEN cDNA 3830408G10 gene 3830408G10Rik -1.15 28 26 77 45
1423844_s_at cystathionine beta-synthase Cbs -1.16 94 81 168 221
1421365_at follistatin Fst -1.16 1925 1790 3610 4709
1455872_at hypothetical protein A030013D21 A030013D21 -1.16 95 114 230 235











1416481_s_at hypoxia induced gene 1 Hig1 -1.16 1348 1560 3770 2729
1460236_at kallikrein 10 Klk10 -1.16 52 57 128 115
1439847_s_at Kruppel-like factor 12 Klf12 -1.16 122 117 290 241
1421217_a_at lectin, galactose binding, soluble 9 Lgals9 -1.16 91 100 193 235
1450976_at N-myc downstream regulated gene 1 Ndrg1 -1.16 237 172 606 299
1439148_a_at phosphofructokinase, liver, B-type Pfkl -1.16 940 734 2055 1648
1415943_at syndecan 1 Sdc1 -1.16 2465 3026 6493 5739
1437279_x_at syndecan 1 Sdc1 -1.16 1817 1817 4034 4073
1444274_at Transcribed sequence with moderate similarity NA -1.16 116 102 214 270
1451546_s_at transmembrane protein 40 Tmem40 -1.16 131 115 290 259
1426911_at desmocollin 2 Dsc2 -1.17 437 355 1102 677
1431777_a_at high mobility group nucleosomal binding domain Hmgn3 -1.17 867 987 2091 2062
1426604_at ribonuclease L (2', 5'-oligoisoadenylate synthet Rnasel -1.17 53 54 148 94
1433266_at RIKEN cDNA 2810416A17 gene 2810416A17Rik -1.17 170 202 490 345
1452092_at RIKEN cDNA 4631426J05 gene 4631426J05Rik -1.17 1797 2081 4056 4623
1441971_at Transcribed sequences NA -1.17 721 691 1796 1379
1451742_a_at UDP-glucose pyrophosphorylase 2 Ugp2 -1.17 949 995 2305 2069
1459009_at Utrophin Utrn -1.17 255 236 613 488
1422941_at wingless-related MMTV integration site 16 Wnt16 -1.17 101 101 214 240
1442348_at 2 days pregnant adult female oviduct cDNA, RIK NA -1.18 125 96 251 247
1441242_at Dipeptidylpeptidase 4 Dpp4 -1.18 256 252 638 513
1417143_at endothelial differentiation, lysophosphatidic aci Edg2 -1.18 157 166 341 389
1438251_x_at protease, serine, 11 (Igf binding) Prss11 -1.18 1231 1020 2442 2636
1445710_x_at RIKEN cDNA 1110051B16 gene 1110051B16Rik -1.18 413 253 793 669
1455915_at UDP-N-acetyl-alpha-D-galactosamine:polypepti Galnt4 -1.18 304 343 738 723
1446480_at Adult male corpora quadrigemina cDNA, RIKE NA -1.19 44 55 116 108
1416455_a_at crystallin, alpha B Cryab -1.19 33 29 65 78
1418497_at fibroblast growth factor 13 Fgf13 -1.19 340 368 698 920
1418135_at homolog of human MLLT2 unidentified gene Mllt2h -1.19 813 880 1808 2064
1434059_at RIKEN cDNA B230312A22 gene B230312A22Rik -1.19 457 425 1074 939
1425560_a_at S100 calcium binding protein A16 S100a16 -1.19 2352 2726 5872 5718
1420822_s_at sphingosine-1-phosphate phosphatase 1 Sgpp1 -1.19 1212 1001 2971 2058
1452138_a_at angiotensin I converting enzyme (peptidyl-dipe Ace2 -1.20 59 85 187 137
1429582_at BTB (POZ) domain containing 14A Btbd14a -1.20 88 124 261 220
1435059_at development and differentiation enhancing Ddef1 -1.20 556 515 1186 1267
1435283_s_at expressed sequence AI414343 AI414343 -1.20 122 108 240 288
1452388_at heat shock protein 1A Hspa1a -1.20 436 937 1141 1800
1436994_a_at histone 1, H1c Hist1h1c -1.20 568 508 1603 866
1421045_at mannose receptor, C type 2 Mrc2 -1.20 101 104 209 262
1419663_at osteoglycin Ogn -1.20 24 22 54 51
1430114_at RIKEN cDNA 5430420C16 gene 5430420C16Rik -1.20 58 43 146 83
1447676_x_at S100 calcium binding protein A16 S100a16 -1.20 4183 4279 9787 9710
1415906_at thymosin, beta 4, X chromosome Tmsb4x -1.20 4175 4965 10107 10783
1445421_at Transcribed sequences NA -1.20 90 84 216 186
1437868_at cDNA sequence BC023892 BC023892 -1.21 229 251 603 508
1417795_at cell adhesion molecule with homology to L1CA Chl1 -1.21 164 204 378 467
1443906_at decay accelerating factor 1 Daf1 -1.21 61 66 142 152
1448499_a_at epoxide hydrolase 2, cytoplasmic Ephx2 -1.21 89 80 190 199
1416101_a_at histone 1, H1c Hist1h1c -1.21 827 866 2301 1599
1458127_at NA NA -1.21 295 220 631 549
1425284_a_at RAB27A, member RAS oncogene family Rab27a -1.21 12 14 35 24
1439184_s_at thioredoxin-like 5 Txnl5 -1.21 1718 1693 3802 4074
1419239_at zinc finger protein 54 Zfp54 -1.21 104 102 287 189
1433971_at calmodulin binding transcription activator 1 Camta1 -1.22 181 170 389 427
1439203_at Special AT-rich sequence binding protein 1 Satb1 -1.22 117 95 247 245
1424359_at 5-oxoprolinase (ATP-hydrolysing) Oplah -1.23 83 76 197 175
1432418_a_at creatine kinase, mitochondrial 1, ubiquitous Ckmt1 -1.23 60 58 144 135
1447299_at NA NA -1.23 65 32 146 70
1452160_at TCDD-inducible poly(ADP-ribose) polymerase Tiparp -1.23 909 813 2105 1933
1434485_a_at UDP-glucose pyrophosphorylase 2 Ugp2 -1.23 535 567 1377 1209
1418073_at acyl-Coenzyme A thioesterase 2, mitochondria Acate2 -1.24 2208 2195 5417 4991
1455372_at cytoplasmic polyadenylation element binding p Cpeb3 -1.24 97 102 251 218
1449773_s_at growth arrest and DNA-damage-inducible 45 b Gadd45b -1.24 95 81 212 201
1436633_at LOC380741 (LOC380741), mRNA NA -1.24 83 75 184 188
1416749_at protease, serine, 11 (Igf binding) Prss11 -1.24 1487 1133 2924 3208
1437869_at RIKEN cDNA 3222402P14 gene 3222402P14Rik -1.24 1196 961 2670 2404
1436183_at RIKEN cDNA 9830115L13 gene 9830115L13Rik -1.24 1010 1040 2335 2521
1456891_at DENN/MADD domain containing 2C Dennd2c -1.24 627 713 1614 1551
1438115_a_at solute carrier family 9 (sodium/hydrogen excha Slc9a3r1 -1.24 396 362 866 923
1427477_at transmembrane protease, serine 13 Tmprss13 -1.24 243 271 664 545
1449968_s_at acyl-Coenzyme A thioesterase 2, mitochondria Acate2 -1.25 1362 1593 3655 3360
1459823_at EH-domain containing 2 Ehd2 -1.25 363 377 917 844
1434575_at erythrocyte protein band 4.1-like 1 Epb4.1l1 -1.25 217 221 484 560
1434802_s_at neurotrophin 3 Ntf3 -1.25 520 427 1065 1169










1438588_at pleiomorphic adenoma gene-like 1 Plagl1 -1.25 104 118 276 249
1435354_at potassium inwardly-rectifying channel, subfamil Kcnj15 -1.25 419 395 1017 925
1455786_at RIKEN cDNA 2610036F08 gene 2610036F08Rik -1.25 114 118 295 256
1437434_a_at RIKEN cDNA 5031439A09 gene 5031439A09Rik -1.25 978 955 2352 2243
1437469_at RIKEN cDNA A030007D23 gene A030007D23Rik -1.25 148 131 370 292
1430567_at serine protease inhibitor, Kazal type 5 Spink5 -1.25 35 31 88 68
1453377_at SH2 domain containing 4A Sh2d4a -1.25 136 100 333 224
1456003_a_at solute carrier family 1 (glutamate/neutral amino Slc1a4 -1.25 394 420 843 1086
1420821_at sphingosine-1-phosphate phosphatase 1 Sgpp1 -1.25 427 377 1127 783
1434738_at threonyl-tRNA synthetase-like 2 Tarsl2 -1.25 145 155 385 327
1436293_x_at DNA segment, Chr 1, ERATO Doi 471, expres D1Ertd471e -1.26 242 205 494 576
1419133_at envoplakin Evpl -1.26 174 161 400 405
1416343_a_at lysosomal membrane glycoprotein 2 Lamp2 -1.26 210 240 578 492
1448233_at prion protein Prnp -1.26 1734 1515 4009 3736
1418890_a_at RAB3D, member RAS oncogene family Rab3d -1.26 170 208 505 398
1451201_s_at ribonuclease/angiogenin inhibitor 1 Rnh1 -1.26 728 815 2042 1649
1429637_at RIKEN cDNA 2210419I08 gene 2210419I08Rik -1.26 186 202 546 385
1436122_at Zinc finger protein 667 (Zfp667), mRNA A830025F02Rik -1.26 276 270 716 590
1460351_at S100 calcium binding protein A11 (calizzarin) S100a11 -1.26 2296 2561 5515 6105
1455304_at Similar to Munc13-3 (LOC235480), mRNA NA -1.26 68 64 122 195
1416921_x_at aldolase 1, A isoform Aldo1 -1.27 3017 2143 6834 5430
1424877_a_at aminolevulinate, delta-, dehydratase Alad -1.27 244 240 619 549
1437058_at EGF-like-domain, multiple 3 Egfl3 -1.27 324 292 705 777
1433481_at FK506 binding protein 14 Fkbp14 -1.27 194 231 539 480
1434815_a_at mitogen-activated protein kinase-activated prot Mapkapk3 -1.27 467 422 1108 1028
1443122_at NA NA -1.27 59 49 155 104
1451508_at RIKEN cDNA 1700108L22 gene 1700108L22Rik -1.27 145 158 349 383
1417580_s_at selenium binding protein 1 Selenbp1 -1.27 98 96 234 234
1438116_x_at solute carrier family 9 (sodium/hydrogen excha Slc9a3r1 -1.27 262 273 589 706
1444441_at Transcribed sequences NA -1.27 246 231 589 561
1449131_s_at CD1d1 antigen Cd1d1 -1.28 397 534 1141 1101
1418267_at macrophage stimulating 1 (hepatocyte growth fa Mst1 -1.28 91 88 221 213
1457358_at Myeloid ecotropic viral integration site-related g Mrg1 -1.28 66 77 157 189
1441793_at Protein phosphatase 1, regulatory (inhibitor) sub Ppp1r11 -1.28 414 327 766 1018
1448786_at RIKEN cDNA 1100001H23 gene 1100001H23Rik -1.28 726 626 1811 1472
1439375_x_at aldolase 1, A isoform Aldo1 -1.29 2011 1447 4330 4032
1416138_at annexin A7 Anxa7 -1.29 358 386 944 868
1416194_at cytochrome P450, family 4, subfamily b, polype Cyp4b1 -1.29 689 627 1529 1675
1448606_at endothelial differentiation, lysophosphatidic aci Edg2 -1.29 287 305 710 734
1424096_at keratin complex 2, basic, gene 5 Krt2-5 -1.29 8392 8994 21358 21270
1455521_at Kruppel-like factor 12 Klf12 -1.29 277 269 743 595
1428922_at RIKEN cDNA 1200009O22 gene 1200009O22Rik -1.29 192 214 540 455
1460407_at Spi-B transcription factor (Spi-1/PU.1 related) Spib -1.29 120 124 304 293
1422822_at StAR-related lipid transfer (START) domain co Stard5 -1.29 381 370 1045 793
1437665_at Transcribed sequences NA -1.29 98 92 259 205
1427553_at Clone IMAGE:4190185, mRNA, partial cds NA -1.30 120 81 253 232
1438407_at RIKEN cDNA 9330132E09 gene 9330132E09Rik -1.30 2138 2354 5406 5666
1417335_at sulfotransferase family, cytosolic, 2B, member Sult2b1 -1.30 526 400 1606 649
1423035_s_at thioredoxin-like 5 Txnl5 -1.30 1691 1992 4117 4950
1445701_at ATPase, Ca++ transporting, plasma membrane Atp2b4 -1.30 252 212 620 515
1460657_at wingless related MMTV integration site 10a Wnt10a -1.30 414 343 803 1049
1419401_at ankyrin repeat and SOCS box-containing protei Asb13 -1.31 295 281 783 647
1449130_at CD1d1 antigen Cd1d1 -1.31 460 520 1226 1202
1437689_x_at clusterin Clu -1.31 248 256 633 618
1435435_at cortactin binding protein 2 Cortbp2 -1.31 57 73 198 121
1448491_at enoyl coenzyme A hydratase 1, peroxisoma Ech1 -1.31 366 453 982 1041
1416554_at PDZ and LIM domain 1 (elfin) Pdlim1 -1.31 1349 1547 3382 3790
1452714_at RIKEN cDNA 1200003E16 gene 1200003E16Rik -1.31 806 834 2220 1847
1420191_s_at DNA segment, Chr 16, Brigham & Women's G D16Bwg1494e -1.32 185 194 471 475
1449770_x_at DNA segment, Chr 16, Brigham & Women's G D16Bwg1494e -1.32 374 384 908 982
1451177_at DnaJ (Hsp40) homolog, subfamily B, member Dnajb4 -1.32 1742 2005 5109 4211
1449036_at ring finger protein 128 Rnf128 -1.32 48 47 100 139
1452246_at osteoclast stimulating factor 1 Ostf1 -1.33 164 187 515 363
1447992_s_at proprotein convertase subtilisin/kexin type 2 Pcsk2 -1.33 31 28 69 80
1459749_s_at FAT tumor suppressor homolog 4 (Drosophila) Fat4 -1.33 50 52 114 141
1425248_a_at TYRO3 protein tyrosine kinase 3 Tyro3 -1.33 38 49 91 125
1455101_at Clone IMAGE:2647821, mRNA NA -1.34 116 132 308 317
1439860_at eukaryotic elongation factor-2 kinase Eef2k -1.34 294 316 799 745
1420565_at homeo box A1 Hoxa1 -1.34 1356 960 3163 2634
1450726_at N-acylsphingosine amidohydrolase 2 Asah2 -1.34 141 114 325 319
1441774_at Rab38, member of RAS oncogene family Rab38 -1.34 184 178 508 405
1416805_at RIKEN cDNA 1110032E23 gene 1110032E23Rik -1.34 67 64 180 149
1433582_at RIKEN cDNA 1190002N15 gene 1190002N15Rik -1.34 703 804 2032 1766
1418951_at taxilin beta Txlnb -1.34 9 14 24 33







1430396_at RIKEN cDNA 5730403I07 gene 5730403I07Rik -1.34 61 56 155 142
1426721_s_at TCDD-inducible poly(ADP-ribose) polymerase Tiparp -1.34 795 899 2030 2258
1445574_at Transcribed sequences NA -1.34 255 290 666 714
1457533_at Transcribed sequences NA -1.34 67 72 200 150
1439429_x_at deltex 2 homolog (Drosophila) Dtx2 -1.35 482 547 1117 1498
1450724_at down-regulated by Ctnnb1, a Drctnnb1a -1.35 1167 1099 2908 2876
1445558_at NA NA -1.35 169 199 512 427
1417738_at RAB25, member RAS oncogene family Rab25 -1.35 325 314 881 745
1420583_a_at RAR-related orphan receptor alpha Rora -1.35 152 111 383 277
1431057_a_at protease, serine, 23 Prss23 -1.35 1091 920 2702 2419
1427228_at RIKEN cDNA 2410003B16 gene 2410003B16Rik -1.35 211 223 553 553
1442791_x_at RIKEN cDNA 6720407P12 gene 6720407P12Rik -1.35 83 71 195 194
1423135_at thymus cell antigen 1, theta Thy1 -1.35 71 90 187 219
1438057_at Transcribed sequence with moderate similarity NA -1.35 36 33 99 77
1442074_at Transcribed sequences NA -1.35 34 38 103 79
1434799_x_at aldolase 1, A isoform Aldo1 -1.36 2521 1837 5999 5047
1422631_at aryl-hydrocarbon receptor Ahr -1.36 2410 2470 6475 6073
1425658_at CD109 antigen Cd109 -1.36 166 155 444 379
1426276_at interferon induced with helicase C domain 1 Ifih1 -1.36 141 159 377 393
1436475_at nuclear receptor subfamily 2, group F, member Nr2f2 -1.36 54 38 123 112
1422637_at Ras association (RalGDS/AF-6) domain family 5 Rassf5 -1.36 69 57 144 178
1422638_s_at Ras association (RalGDS/AF-6) domain family 5 Rassf5 -1.36 333 290 715 885
1432739_at RIKEN cDNA 2900060K15 gene 2900060K15Rik -1.36 55 57 133 153
1415944_at syndecan 1 Sdc1 -1.36 1038 1251 2708 3131
1458706_at Transcribed sequences NA -1.36 387 316 959 830
1419738_a_at tropomyosin 2, beta Tpm2 -1.36 375 426 910 1142
1452411_at leucine rich repeat containing 1 Lrrc1 -1.37 440 467 1247 1099
1418601_at aldehyde dehydrogenase family 1, subfamily A Aldh1a7 -1.38 54 46 156 104
1433604_x_at aldolase 1, A isoform Aldo1 -1.38 1462 1046 3570 2877
1425002_at cDNA sequence BC010462 BC010462 -1.38 24 29 87 52
1417823_at glycine C-acetyltransferase (2-amino-3-ketobuty Gcat -1.38 517 469 1364 1199
1422667_at keratin complex 1, acidic, gene 15 Krt1-15 -1.38 8112 10073 24844 22319
1455091_at male-specific lethal-2 homolog (Drosophila) Msl2 -1.38 262 251 712 625
1442560_at Monoglyceride lipase Mgll -1.38 113 104 255 308
1449459_s_at ankyrin repeat and SOCS box-containing protei Asb13 -1.39 340 334 954 807
1419091_a_at annexin A2 Anxa2 -1.39 3973 3719 10655 9485
1459301_at Myeloid ecotropic viral integration site-related g Mrg1 -1.39 246 236 550 716
1435342_at potassium inwardly-rectifying channel, subfamil Kcnk6 -1.39 380 340 960 928
1418799_a_at procollagen, type XVII, alpha 1 Col17a1 -1.39 1273 1547 3098 4265
1460459_at progestin and adipoQ receptor family member Paqr5 -1.39 162 164 493 362
1433581_at RIKEN cDNA 1190002N15 gene 1190002N15Rik -1.39 733 824 2024 2057
1456317_at RIKEN cDNA 1700055N04 gene 1700055N04Rik -1.39 109 147 348 317
1458055_at Desmocollin 3 Dsc3 -1.40 30 21 82 49
1427318_s_at dysferlin /// fer-1-like 3, myoferlin (C. elegans) Dysf /// Fer1l3 -1.40 76 86 250 177
1418925_at cadherin EGF LAG seven-pass G-type recepto Celsr1 -1.41 466 423 1154 1201
1448792_a_at cytochrome P450, family 2, subfamily f, polype Cyp2f2 -1.41 69 59 182 157
1422662_at lectin, galactose binding, soluble 8 Lgals8 -1.41 557 542 1536 1384
1426941_at mucin 15 Muc15 -1.41 657 590 2163 1145
1423034_at thioredoxin-like 5 Txnl5 -1.41 450 533 1272 1326
1425801_x_at coactosin-like 1 (Dictyostelium) Cotl1 -1.42 760 723 1849 2123
1449013_at eukaryotic elongation factor-2 kinase Eef2k -1.42 294 307 796 808
1449259_at RAB3D, member RAS oncogene family Rab3d -1.42 217 323 750 665
1436733_at RIKEN cDNA E130309F12 gene E130309F12Rik -1.42 60 59 160 157
1437258_at Small proline-rich protein 2B Sprr2a -1.42 13 9 27 30
1448612_at stratifin Sfn -1.42 121 162 368 381
1437927_at discs, large homolog 2 (Drosophila) Dlgh2 -1.43 61 48 143 149
1429779_at eukaryotic translation initiation factor 2C, 4 Eif2c4 -1.43 257 192 614 581
1435551_at formin-family protein FHOS2 FHOS2 -1.43 235 194 530 618
1428083_at RIKEN cDNA 2310043N10 gene 2310043N10Rik -1.43 1158 987 3241 2541
1450699_at selenium binding protein 1 Selenbp1 -1.43 120 150 358 362
1443749_x_at solute carrier family 1 (glial high affinity glutam Slc1a3 -1.43 471 447 1131 1338
1451413_at calpastatin Cast -1.44 542 596 1561 1521
1418944_at cysteinyl leukotriene receptor 1 Cysltr1 -1.44 40 56 118 141
1427183_at epidermal growth factor-containing fibulin-like ex Efemp1 -1.44 880 889 2209 2603
1427165_at interleukin 13 receptor, alpha 1 Il13ra1 -1.44 575 634 1746 1522
1437303_at interleukin 6 signal transducer Il6st -1.44 542 504 1336 1509
1457413_at Receptor tyrosine kinase-like orphan receptor 1 Ror1 -1.44 129 103 320 306
1428891_at RIKEN cDNA 9130213B05 gene 9130213B05Rik -1.44 1361 1263 3634 3468
1428145_at acetyl-Coenzyme A acyltransferase 2 (mitocho Acaa2 -1.45 1229 1415 3882 3336
1435972_at calpastatin Cast -1.45 391 527 1220 1264
1427912_at carbonyl reductase 3 Cbr3 -1.45 204 247 583 645
1460732_a_at periplakin Ppl -1.45 1017 913 2719 2541
1422603_at ribonuclease, RNase A family 4 Rnase4 -1.45 2128 2268 5996 5975
1424214_at RIKEN cDNA 9130213B05 gene 9130213B05Rik -1.45 418 398 992 1236










1436092_at Transcribed sequence with weak  similarity to p NA -1.45 410 456 990 1370
1418091_at transcription factor CP2-like 1 Tcfcp2l1 -1.45 187 159 483 459
1418762_at decay accelerating factor 1 Daf1 -1.46 34 32 103 79
1419086_at fibroblast growth factor binding protein 1 Fgfbp1 -1.46 758 788 2063 2192
1430843_at glutamate decarboxylase-like 1 Gadl1 -1.46 79 85 271 180
1434051_s_at heat shock 70kDa protein 12A Hspa12a -1.46 90 72 243 200
1439153_at IBR domain containing 2 Ibrdc2 -1.46 832 834 2516 2062
1425028_a_at tropomyosin 2, beta Tpm2 -1.46 108 109 263 335
1448213_at annexin A1 Anxa1 -1.47 3908 3893 12052 9581
1436932_at similar to sister-of-mammalian grainyhead prot LOC230824 -1.47 190 141 498 410
1433610_at expressed sequence AA986860 AA986860 -1.48 26 21 72 57
1421492_at prostaglandin D2 synthase 2, hematopoietic Ptgds2 -1.48 115 127 367 306
1423771_at protein kinase C, delta binding protein Prkcdbp -1.48 78 101 241 257
1428146_s_at acetyl-Coenzyme A acyltransferase 2 (mitocho Acaa2 -1.49 1649 1689 4732 4630
1453289_at eukaryotic translation initiation factor 2C, 4 Eif2c4 -1.49 917 1000 2760 2635
1416531_at glutathione S-transferase omega 1 Gsto1 -1.49 994 970 2797 2731
1419027_s_at glycolipid transfer protein Gltp -1.49 4227 3880 11776 10898
1450971_at growth arrest and DNA-damage-inducible 45 b Gadd45b -1.49 149 146 440 386
1417962_s_at growth hormone receptor Ghr -1.49 1525 1663 4426 4504
1457044_at RIKEN cDNA 4732474O15 gene 4732474O15Rik -1.49 131 172 450 395
1452059_at solute carrier family 35, member F5 Slc35f5 -1.49 315 365 1042 867
1422906_at ATP-binding cassette, sub-family G (WHITE), Abcg2 -1.50 1048 1082 2849 3184
1437312_at bone morphogenetic protein receptor, type 1B Bmpr1b -1.50 638 644 1839 1791
1448494_at growth arrest specific 1 Gas1 -1.50 2558 2259 7153 6410
1451385_at RIKEN cDNA 2310056P07 gene 2310056P07Rik -1.50 2407 2246 6901 6232
1431248_at RIKEN cDNA 5031426D15 gene 5031426D15Rik -1.50 98 75 260 225
1449577_x_at tropomyosin 2, beta Tpm2 -1.50 32 34 90 99
1423606_at periostin, osteoblast specific factor Postn -1.51 4069 3972 11291 11576
1453286_at plexin A2 Plxna2 -1.51 352 277 900 876
1421456_at purinergic receptor P2Y, G-protein coupled 1 P2ry1 -1.51 140 152 403 426
1424239_at RIKEN cDNA 2310066E14 gene 2310066E14Rik -1.51 92 90 238 283
1444740_at Transcribed sequences NA -1.51 298 275 871 757
1436702_at cDNA sequence BC034068 BC034068 -1.52 66 51 159 170
1454783_at interleukin 13 receptor, alpha 1 Il13ra1 -1.52 796 795 2373 2188
1425506_at myosin, light polypeptide kinase Mylk -1.52 99 112 284 320
1419201_at RIKEN cDNA 2310015I08 gene 2310015I08Rik -1.52 169 132 431 425
1424612_at NIPA-like domain containing 2 Npal2 -1.52 695 640 2095 1741
1438125_at RIKEN cDNA C230085N15 gene C230085N15Rik -1.52 125 118 344 351
1436365_at zinc finger and BTB domain containing 36 Zbtb36 -1.52 112 108 319 308
1455238_at melanoma associated antigen (mutated) 1-like 1 Mum1l1 -1.53 55 68 182 172
1440635_at Transcribed sequences NA -1.53 155 155 442 454
1451739_at Kruppel-like factor 5 Klf5 -1.54 814 660 2708 1560
1426221_at loss of heterozygosity, 11, chromosomal region Loh11cr2a -1.54 301 522 705 1595
1429274_at RIKEN cDNA 2310010M24 gene 2310010M24Rik -1.54 1049 928 2956 2796
1433719_at solute carrier family 9 (sodium/hydrogen excha Slc9a9 -1.54 60 51 148 171
1450633_at calmodulin 4 Calm4 -1.55 1623 1997 6095 4421
1452843_at interleukin 6 signal transducer Il6st -1.55 260 307 831 822
1435973_at Transcribed sequences NA -1.55 161 120 498 313
1441342_at dipeptidylpeptidase 4 Dpp4 -1.56 44 53 170 115
1456036_x_at glutathione S-transferase omega 1 Gsto1 -1.56 2440 1916 6087 6642
1428680_at CDP-diacylglycerol synthase 1 Cds1 -1.57 207 218 632 632
1435785_at EH-domain containing 2 Ehd2 -1.57 306 318 842 1005
1455140_at expressed sequence AI848332 AI848332 -1.57 395 404 1145 1223
1450769_s_at StAR-related lipid transfer (START) domain co Stard5 -1.57 474 442 1547 1174
1450391_a_at monoglyceride lipase Mgll -1.59 46 45 130 144
1444937_at NA NA -1.59 238 133 600 472
1424130_a_at polymerase I and transcript release factor Ptrf -1.59 1106 891 2929 3043
1450435_at solute carrier family 7 (cationic amino acid tran Slc7a2 -1.59 325 296 942 929
1421844_at interleukin 1 receptor accessory protein Il1rap -1.60 412 397 1244 1202
1442920_at Kruppel-like factor 3 (basic) Klf3 -1.60 77 73 240 214
1426245_s_at microtubule-associated protein, RP/EB family, Mapre2 -1.60 121 110 311 388
1424842_a_at Rho GTPase activating protein 24 Arhgap24 -1.60 398 482 1504 1147
1426397_at transforming growth factor, beta receptor II Tgfbr2 -1.60 830 730 2283 2444
1434957_at cell adhesion molecule-related/down-regulated Cdon -1.61 1615 1699 4426 5656
1427011_a_at LanC (bacterial lantibiotic synthetase compone Lancl1 -1.61 1710 1684 5489 4886
1421690_s_at agouti related protein Agrp -1.62 32 38 101 115
1450981_at calponin 2 Cnn2 -1.62 1235 1216 3736 3815
1434866_x_at carnitine palmitoyltransferase 1a, liver Cpt1a -1.62 83 62 203 237
1416527_at RAB32, member RAS oncogene family Rab32 -1.62 66 98 231 264
1431110_at RIKEN cDNA 5430431D22 gene 5430431D22Rik -1.62 107 95 323 297
1416589_at secreted acidic cysteine rich glycoprotein Sparc -1.62 771 722 2151 2436
1416002_x_at coactosin-like 1 (Dictyostelium) Cotl1 -1.63 232 207 629 727
1451451_at grancalcin Gca -1.63 34 29 123 68
1452614_at hypothetical gene supported by AF014453 LOC229672 -1.63 101 143 352 390
















1439628_x_at Rab38, member of RAS oncogene family Rab38 -1.63 1633 1705 5175 5142
1422573_at AMP deaminase 3 Ampd3 -1.64 403 571 1336 1657
1460406_at expressed sequence AI427122 AI427122 -1.64 224 225 719 681
1456084_x_at fibromodulin Fmod -1.64 15 18 44 59
1427012_at LanC (bacterial lantibiotic synthetase compone Lancl1 -1.64 623 614 1837 2028
1419051_at OVO homolog-like 1 (Drosophila) Ovol1 -1.64 107 82 308 277
1444147_at proprotein convertase subtilisin/kexin type 2 Pcsk2 -1.64 42 23 108 87
1449848_at guanine nucleotide binding protein, alpha 14 Gna14 -1.65 134 132 369 465
1449586_at plakophilin 1 Pkp1 -1.65 4162 3627 13242 11215
1416007_at special AT-rich sequence binding protein 1 Satb1 -1.65 1071 943 2921 3380
1454867_at meningioma 1 Mn1 -1.65 63 95 236 249
1438156_x_at carnitine palmitoyltransferase 1a, liver Cpt1a -1.66 33 22 78 92
1451989_a_at microtubule-associated protein, RP/EB family, Mapre2 -1.66 412 469 1229 1549
1455037_at plexin A2 Plxna2 -1.66 191 161 574 532
1459529_at RIKEN cDNA E230016K23 gene E230016K23Rik -1.66 21 15 49 62
1437231_at SLIT and NTRK-like family, member 6 Slitrk6 -1.66 119 159 408 462
1428650_at tensin Tns -1.66 336 258 813 1045
1435693_at mal, T-cell differentiation protein-like Mall -1.67 622 583 1974 1870
1456114_at CDP-diacylglycerol synthase 1 Cds1 -1.67 259 271 863 820
1420461_at macrophage stimulating 1 receptor (c-met-relate Mst1r -1.67 70 59 200 208
1418318_at ring finger protein 128 Rnf128 -1.67 85 75 252 258
1455061_a_at acetyl-Coenzyme A acyltransferase 2 (mitocho Acaa2 -1.68 101 111 375 303
1433509_s_at DNA segment, Chr 6, ERATO Doi 253, expres D6Ertd253e -1.68 246 203 784 645
1427164_at interleukin 13 receptor, alpha 1 Il13ra1 -1.68 266 263 832 866
1424034_at RAR-related orphan receptor alpha Rora -1.68 457 315 1440 997
1441214_at synaptotagmin-like homologue lacking C2 dom MGI:2443248 -1.68 314 261 958 873
1450005_x_at EGF-like-domain, multiple 9 Egfl9 -1.69 125 126 381 430
1437829_s_at eukaryotic elongation factor-2 kinase Eef2k -1.69 1416 1360 4574 4380
1417394_at Kruppel-like factor 4 (gut) Klf4 -1.69 2460 2128 7689 7115
1455627_at procollagen, type VIII, alpha 1 Col8a1 -1.69 524 399 1528 1433
1434146_at Glutamate receptor, ionotropic, AMPA2 (alpha Gria2 -1.70 11 11 41 32
1436236_x_at coactosin-like 1 (Dictyostelium) Cotl1 -1.70 494 393 1480 1382
1421970_a_at glutamate receptor, ionotropic, AMPA2 (alpha Gria2 -1.70 52 29 152 100
1427537_at epiplakin 1 Eppk1 -1.71 1293 963 3848 3465
1424638_at cyclin-dependent kinase inhibitor 1A (P21) Cdkn1a -1.72 387 369 1558 931
1453345_at RIKEN cDNA 3830408G10 gene 3830408G10Rik -1.72 60 79 296 159
1439675_at RIKEN cDNA 4933429D07 gene 4933429D07Rik -1.72 72 59 200 232
1436119_at aldehyde dehydrogenase 1 family, member L2 Aldh1l2 -1.73 236 271 893 783
1416592_at glutaredoxin 1 (thioltransferase) Glrx1 -1.73 149 130 444 481
1436182_at special AT-rich sequence binding protein 1 Satb1 -1.73 1460 1472 5196 4547
1456741_s_at glycoprotein m6a Gpm6a -1.75 28 26 88 94
1445626_at Lectin, galactose binding, soluble 3 Lgals3 -1.75 67 70 311 150
1420760_s_at N-myc downstream regulated gene 1 Ndrg1 -1.75 1203 740 4082 2280
1436590_at protein phosphatase 1, regulatory (inhibitor) su Ppp1r3b -1.75 594 582 2169 1790
1434773_a_at solute carrier family 2 (facilitated glucose trans Slc2a1 -1.75 1693 959 4707 3889
1442434_at DNA segment, Chr 8, ERATO Doi 82, express D8Ertd82e -1.76 293 270 907 994
1427019_at protein tyrosine phosphatase, receptor type Z, Ptprz1 -1.76 176 197 631 626
1416200_at RIKEN cDNA 9230117N10 gene 9230117N10Rik -1.76 59 58 227 167
1418891_a_at RAB3D, member RAS oncogene family Rab3d -1.77 251 368 1016 1057
1455377_at RIKEN cDNA 4921517B04 gene /// similar to F 17B04Rik /// LOC -1.77 65 57 246 170
1439449_at special AT-rich sequence binding protein 1 Satb1 -1.77 665 755 2154 2679
1418086_at protein phosphatase 1, regulatory (inhibitor) su Ppp1r14a -1.78 35 34 118 119
1424701_at protocadherin 20 Pcdh20 -1.78 338 311 1067 1161
1455288_at RIKEN cDNA 1110036O03 gene 1110036O03Rik -1.78 107 88 362 304
1457656_s_at RIKEN cDNA C230085N15 gene C230085N15Rik -1.78 557 498 1695 1922
1448392_at secreted acidic cysteine rich glycoprotein Sparc -1.78 1084 1030 3542 3740
1426600_at solute carrier family 2 (facilitated glucose trans Slc2a1 -1.79 812 592 2622 2164
1443284_at Special AT-rich sequence binding protein 1 Satb1 -1.79 143 135 470 489
1424698_s_at grancalcin Gca -1.80 42 47 189 122
1422308_a_at lectin, galactose binding, soluble 7 Lgals7 -1.80 2769 3095 11282 9116
1432976_at RIKEN cDNA 2310038E17 gene 2310038E17Rik -1.80 41 37 138 133
1460003_at expressed sequence AI956758 AI956758 -1.81 262 264 1035 812
1458738_at Guanine nucleotide binding protein, alpha 14 Gna14 -1.82 225 192 663 801
1425213_at RIKEN cDNA 6430514L14 gene 6430514L14Rik -1.82 246 249 818 926
1444392_at Leprecan-like 1 Leprel1 -1.83 374 352 1395 1182
1439794_at Netrin 4 (Ntn4), mRNA Ntn4 -1.83 287 236 857 986
1421679_a_at cyclin-dependent kinase inhibitor 1A (P21) Cdkn1a -1.84 1077 948 4377 2845
1429808_at RIKEN cDNA 1110020C03 gene 1110020C03Rik -1.84 65 66 208 260
1420468_at ankyrin repeat and SOCS box-containing protei Asb17 -1.85 31 33 130 101
1417700_at Rab38, member of RAS oncogene family Rab38 -1.85 1158 1182 4230 4223
1426599_a_at solute carrier family 2 (facilitated glucose trans Slc2a1 -1.85 933 604 2948 2460
1437813_at absent in melanoma 1-like Aim1l -1.86 50 57 227 161
1426243_at cystathionase (cystathionine gamma-lyase) Cth -1.86 372 365 1236 1431
1420807_a_at EGF-like-domain, multiple 9 Egfl9 -1.86 142 147 490 554








1460463_at RIKEN cDNA 4632413I24 gene 4632413I24Rik -1.86 945 781 3408 2839
1450782_at wingless-related MMTV integration site 4 Wnt4 -1.86 639 676 2281 2474
1420312_s_at NA NA -1.87 77 73 292 254
1441687_at wingless-related MMTV integration site 4 Wnt4 -1.87 149 149 585 501
1417089_a_at creatine kinase, mitochondrial 1, ubiquitous Ckmt1 -1.88 755 825 2828 2989
1449994_at epithelial mitogen Epgn -1.88 134 160 468 612
1452284_at protein tyrosine phosphatase, receptor type Z, Ptprz1 -1.89 598 612 2274 2205
1431775_at RIKEN cDNA 3100002H09 gene 3100002H09Rik -1.89 91 96 357 335
1455165_at RAR-related orphan receptor alpha, mRNA (cD Rora -1.89 157 115 606 392
1418912_at plexin domain containing 2 Plxdc2 -1.90 97 87 356 331
1449158_at potassium channel, subfamily K, member 2 Kcnk2 -1.90 416 350 1419 1421
1441917_s_at transmembrane protein 40 Tmem40 -1.90 177 231 743 763
1419204_at delta-like 1 (Drosophila) Dll1 -1.91 335 328 1138 1355
1428622_at DEP domain containing 6 Depdc6 -1.91 155 186 730 547
1445638_at Myeloid ecotropic viral integration site-related g Mrg1 -1.91 19 20 77 68
1437019_at RIKEN cDNA 2200001I15 gene 2200001I15Rik -1.91 120 120 482 418
1449816_at sulfotransferase family 5A, member 1 Sult5a1 -1.91 396 336 1356 1380
1429067_at calpain, small subunit 2 Capns2 -1.92 811 869 3616 2754
1456174_x_at N-myc downstream regulated gene 1 Ndrg1 -1.92 923 508 3358 1826
1438570_at Transcribed sequences NA -1.92 681 523 2302 2228
1416022_at fatty acid binding protein 5, epidermal Fabp5 -1.93 2096 2157 9802 6350
1417129_a_at myeloid ecotropic viral integration site-related g Mrg1 -1.94 202 235 730 947
1455200_at p21 (CDKN1A)-activated kinase 6 Pak6 -1.94 394 420 1346 1774
1435595_at RIKEN cDNA 1810011O10 gene 1810011O10Rik -1.94 346 286 1457 951
1433203_at RIKEN cDNA 6030400A10 gene 6030400A10Rik -1.94 506 487 1894 1911
1448987_at acetyl-Coenzyme A dehydrogenase, long-chai Acadl -1.95 351 315 1266 1307
1417346_at apoptosis-associated speck-like protein contain Asc -1.95 404 486 1877 1538
1430550_at lipase-like, ab-hydrolase domain containing 3 Lipl3 -1.95 174 238 988 581
1417185_at lymphocyte antigen 6 complex, locus A Ly6a -1.95 236 163 764 757
1460038_at POU domain, class 3, transcription factor 1 Pou3f1 -1.95 1245 1326 5105 4847
1436325_at RAR-related orphan receptor alpha Rora -1.95 94 74 400 245
1455408_at RIKEN cDNA 4732472I07 gene 4732472I07Rik -1.95 20 18 66 79
1455794_at RIKEN cDNA D130058I21 gene D130058I21Rik -1.95 114 112 532 343
1447791_s_at guanine nucleotide binding protein, alpha 14 Gna14 -1.98 43 54 163 216
1418084_at neuropilin Nrp -1.98 181 184 677 762
1442936_at NA NA -1.99 751 681 2903 2790
1440842_at RIKEN cDNA C230085N15 gene C230085N15Rik -1.99 271 272 1089 1062
1451021_a_at Kruppel-like factor 5 Klf5 -2.00 1244 1077 4930 4322
1416318_at serine (or cysteine) proteinase inhibitor, clade Serpinb1a -2.01 26 37 117 133
1440091_at myeloid ecotropic viral integration site-related g Mrg1 -2.02 182 188 730 773
1434425_at expressed sequence AI597080 AI597080 -2.05 66 66 315 234
1439819_at expressed sequence AU015263 AU015263 -2.05 124 136 677 396
1419905_s_at hydroxyprostaglandin dehydrogenase 15 (NAD) Hpgd -2.05 17 21 77 82
1436178_at leprecan-like 1 Leprel1 -2.05 248 239 969 1053
1426785_s_at monoglyceride lipase Mgll -2.05 117 109 402 533
1437699_at RIKEN cDNA E430014B02 gene E430014B02Rik -2.05 330 356 1485 1357
1452031_at solute carrier family 1 (glial high affinity glutam Slc1a3 -2.05 178 151 647 713
1434025_at Kruppel-like factor 5 Klf5 -2.06 2268 2027 9682 8207
1421964_at Notch gene homolog 3 (Drosophila) Notch3 -2.06 68 81 354 265
1433768_at RIKEN cDNA 2410003B16 gene 2410003B16Rik -2.06 1281 1203 5286 5072
1424852_at myocyte enhancer factor 2C Mef2c -2.07 98 123 544 376
1452232_at UDP-N-acetyl-alpha-D-galactosamine: polypept Galnt7 -2.07 277 342 1512 1073
1418365_at cathepsin H Ctsh -2.08 242 203 997 878
1451308_at elongation of very long chain fatty acids (FEN1 Elovl4 -2.08 44 37 218 125
1417214_at RAB27b, member RAS oncogene family Rab27b -2.08 129 104 522 457
1424976_at ras homolog gene family, member V Rhov -2.08 76 67 349 254
1451415_at RIKEN cDNA 1810011O10 gene 1810011O10Rik -2.08 167 207 979 585
1447861_x_at myeloid ecotropic viral integration site-related g Mrg1 -2.09 44 49 194 198
1448943_at neuropilin Nrp -2.09 211 243 930 999
1424208_at prostaglandin E receptor 4 (subtype EP4) Ptger4 -2.11 286 332 1154 1512
1455186_a_at RIKEN cDNA 1190003J15 gene 1190003J15Rik -2.11 429 466 2029 1841
1436838_x_at coactosin-like 1 (Dictyostelium) Cotl1 -2.12 928 628 3383 3263
1437811_x_at Coactosin-like 1 (Dictyostelium) Cotl1 -2.13 627 427 2289 2227
1415897_a_at microsomal glutathione S-transferase 1 Mgst1 -2.13 218 260 1093 991
1448873_at occludin Ocln -2.14 65 65 336 238
1449938_at placental protein 11 related Pp11r -2.16 300 346 1705 1184
1443579_s_at DEP domain containing 6 Depdc6 -2.17 29 25 161 80
1454666_at Kruppel-like factor 3 (basic) Klf3 -2.17 2420 2262 10926 10119
1426340_at solute carrier family 1 (glial high affinity glutam Slc1a3 -2.17 60 56 255 269
1424966_at transmembrane protein 40 Tmem40 -2.17 311 345 1561 1382
1455573_at keratin complex 1, acidic, gene 14 Krt1-14 -2.18 712 405 2558 2307
1439915_at Myeloid ecotropic viral integration site-related g Mrg1 -2.18 110 114 508 509
1459713_s_at transmembrane protein 16A Tmem16a -2.18 319 341 1689 1308
1419082_at serine (or cysteine) proteinase inhibitor, clade Serpinb2 -2.19 21 18 103 74







1450643_s_at acyl-CoA synthetase long-chain family member Acsl1 -2.20 55 53 303 193
1437232_at bactericidal/permeability-increasing protein-like Bpil2 -2.20 20 19 130 50
1443814_x_at cathepsin H Ctsh -2.20 235 202 1086 910
1451348_at DEP domain containing 6 Depdc6 -2.21 75 60 328 292
1417429_at flavin containing monooxygenase 1 Fmo1 -2.21 363 285 1339 1641
1456815_at forkhead box N1 Foxn1 -2.21 84 83 414 361
1439492_at RIKEN cDNA C130053K05 gene C130053K05Rik -2.21 134 186 834 626
1446764_at Wingless-related MMTV integration site 3A Wnt3a -2.21 217 196 870 1038
1426914_at MARVEL (membrane-associating) domain cont Mrvldc2 -2.22 158 153 800 652
1429503_at RIKEN cDNA 2900024C23 gene 2900024C23Rik -2.22 239 232 1251 950
1450744_at elongation factor RNA polymerase II 2 Ell2 -2.23 1120 1056 5629 4596
1420385_at guanine nucleotide binding protein, alpha 14 Gna14 -2.23 154 150 726 694
1429123_at RAB27A, member RAS oncogene family Rab27a -2.23 131 147 686 616
1418649_at EGL nine homolog 3 (C. elegans) Egln3 -2.24 344 208 1594 930
1448852_at regucalcin Rgn -2.24 72 63 305 333
1443138_at Sulfotransferase family 5A, member 1 Sult5a1 -2.24 231 159 958 853
1439610_at Transcribed sequences NA -2.24 119 92 508 478
1431786_s_at RIKEN cDNA 1190003J15 gene 1190003J15Rik -2.25 230 255 1197 1112
1417942_at Ly6/Plaur domain containing 3 Lypd3 -2.25 129 141 637 647
1419215_at aldehyde oxidase 4 Aox4 -2.26 97 102 507 446
1435076_at RIKEN cDNA 2310047D13 gene 2310047D13Rik -2.26 176 216 1010 861
1434369_a_at crystallin, alpha B Cryab -2.27 33 22 121 137
1419709_at stefin A3 Stfa3 -2.28 2049 2878 11649 11900
1460302_at thrombospondin 1 Thbs1 -2.29 112 109 461 624
1420944_at zinc finger protein 185 Zfp185 -2.29 376 308 2034 1296
1452114_s_at insulin-like growth factor binding protein 5 Igfbp5 -2.31 175 128 760 721
1448944_at neuropilin Nrp -2.31 150 145 794 661
1451716_at v-maf musculoaponeurotic fibrosarcoma oncoge Mafb -2.31 417 368 2247 1655
1434272_at cytoplasmic polyadenylation element binding p Cpeb2 -2.33 333 343 1791 1611
1423856_at popeye domain containing 3 Popdc3 -2.33 297 360 1192 2101
1430551_s_at lipase-like, ab-hydrolase domain containing 3 Lipl3 -2.34 219 235 1552 740
1419591_at melanoma-derived leucine zipper, extra-nuclear Mlze -2.36 202 296 1538 975
1434411_at expressed sequence AW743884 AW743884 -2.37 123 117 537 706
1421811_at thrombospondin 1 Thbs1 -2.37 767 586 3014 3901
1457632_s_at myeloid ecotropic viral integration site-related g Mrg1 -2.38 207 223 1029 1215
1425103_at angiotensin I converting enzyme (peptidyl-dipe Ace2 -2.41 206 205 1312 873
1451798_at interleukin 1 receptor antagonist Il1rn -2.42 95 67 567 287
1435639_at RIKEN cDNA 2610528A11 gene 2610528A11Rik -2.42 36 31 157 198
1439630_x_at suprabasin Sbsn -2.44 638 745 4205 3283
1420364_at G protein-coupled receptor 87 Gpr87 -2.45 158 157 908 813
1449064_at L-threonine dehydrogenase Tdh -2.45 97 107 699 413
1437517_x_at serine (or cysteine) proteinase inhibitor, clade Serpinb3a -2.45 126 131 798 606
1437463_x_at transforming growth factor, beta induced Tgfbi -2.45 270 197 1242 1268
1421604_a_at Kruppel-like factor 3 (basic) Klf3 -2.46 133 136 751 731
1434150_a_at RIKEN cDNA 3300001H21 gene 3300001H21Rik -2.46 107 85 601 446
1453239_a_at ankyrin repeat domain 22 Ankrd22 -2.48 33 47 259 181
1437876_at Hypothetical gene supported by BC030430 (L NA -2.48 76 86 456 447
1449937_at placental protein 11 related Pp11r -2.48 1106 1309 7863 5584
1451006_at xanthine dehydrogenase Xdh -2.48 46 32 260 164
1416697_at dipeptidylpeptidase 4 Dpp4 -2.49 192 176 1178 890
1422588_at keratin complex 2, basic, gene 6b Krt2-6b -2.49 88 106 577 507
1429360_at Kruppel-like factor 3 (basic) Klf3 -2.49 540 476 2769 2935
1442067_at Receptor tyrosine kinase-like orphan receptor 1 Ror1 -2.49 662 425 3277 2673
1448123_s_at transforming growth factor, beta induced Tgfbi -2.49 664 543 3308 3455
1452766_at RIKEN cDNA 2900041A09 gene 2900041A09Rik -2.51 69 74 377 436
1423883_at acyl-CoA synthetase long-chain family member Acsl1 -2.52 495 493 3261 2427
1425789_s_at annexin A8 Anxa8 -2.52 94 93 605 466
1429313_at receptor tyrosine kinase-like orphan receptor 1 Ror1 -2.52 166 136 970 751
1415871_at transforming growth factor, beta induced Tgfbi -2.52 176 159 938 990
1446834_at Cathepsin C Ctsc -2.54 60 77 479 309
1443017_at cytoplasmic polyadenylation element binding p Cpeb2 -2.54 50 81 399 346
1424356_a_at meteorin, glial cell differentiation regulator-like Metrnl -2.54 78 75 538 347
1421965_s_at Notch gene homolog 3 (Drosophila) Notch3 -2.56 308 302 1937 1648
1459897_a_at suprabasin Sbsn -2.56 631 697 4636 3173
1421040_a_at glutathione S-transferase, alpha 2 (Yc2) Gsta2 -2.57 31 45 273 171
1460330_at annexin A3 Anxa3 -2.59 79 74 421 506
1421308_at carbonic anhydrase 13 Car13 -2.59 80 90 609 412
1434295_at RAS guanyl releasing protein 1 Rasgrp1 -2.61 322 224 1870 1404
1454858_x_at RIKEN cDNA 3300001H21 gene 3300001H21Rik -2.62 125 98 785 581
1427957_at RIKEN cDNA 9530008L14 gene 9530008L14Rik -2.65 115 172 929 828
1420955_at visinin-like 1 Vsnl1 -2.65 261 225 1506 1545
1456250_x_at transforming growth factor, beta induced Tgfbi -2.66 871 663 4574 5016
1429076_a_at glycerophosphodiester phosphodiesterase do Gdpd2 -2.68 108 121 753 718
1423414_at prostaglandin-endoperoxide synthase 1 Ptgs1 -2.69 139 135 1001 767








1416382_at cathepsin C Ctsc -2.70 847 870 6502 4688
1441094_at alcohol dehydrogenase 6B (class V) Adh6b -2.70 174 180 1354 955
1452166_a_at keratin complex 1, acidic, gene 10 Krt1-10 -2.73 3442 3963 25956 23170
1454159_a_at insulin-like growth factor binding protein 2 Igfbp2 -2.74 73 55 407 441
1443926_at Myeloid ecotropic viral integration site-related g Mrg1 -2.74 49 40 271 323
1426208_x_at pleiomorphic adenoma gene-like 1 Plagl1 -2.74 1668 1643 10892 11189
1423323_at tumor-associated calcium signal transducer 2 Tacstd2 -2.76 260 222 1740 1520
1417852_x_at chloride channel calcium activated 1 Clca1 -2.79 524 416 3711 2732
1459973_x_at dipeptidylpeptidase 4 Dpp4 -2.80 42 35 322 211
1460591_at estrogen receptor 1 (alpha) Esr1 -2.80 56 66 366 484
1438109_at chloride channel calcium activated 5 Clca5 -2.81 92 67 656 446
1447891_at NA NA -2.81 311 190 1939 1471
1434151_at RIKEN cDNA 3300001H21 gene 3300001H21Rik -2.82 145 168 1166 1044
1421307_at carbonic anhydrase 13 Car13 -2.83 100 107 745 722
1419492_s_at defensin beta 1 Defb1 -2.83 156 116 761 1146
1417702_a_at histamine N-methyltransferase Hnmt -2.83 22 24 169 159
1435761_at stefin A1 Stfa1 -2.83 1452 1288 10084 9335
1425102_a_at angiotensin I converting enzyme (peptidyl-dipe Ace2 -2.87 34 36 313 201
1439528_at RIKEN cDNA 4833423E24 gene 4833423E24Rik -2.88 148 134 1408 658
1426708_at anthrax toxin receptor 2 Antxr2 -2.92 137 203 966 1560
1435436_at Transcribed sequences NA -2.92 133 156 1387 788
1416225_at alcohol dehydrogenase 1 (class I) Adh1 -2.93 191 174 1790 991
1450460_at aquaporin 3 Aqp3 -2.95 193 189 1456 1497
1449500_at serine (or cysteine) proteinase inhibitor, clade Serpinb7 -2.96 434 414 3210 3392
1431211_s_at thioesterase superfamily member 5 Them5 -2.99 64 60 675 309
1424968_at RIKEN cDNA 2210023G05 gene 2210023G05Rik -2.99 112 105 853 867
1456539_at Transcribed sequence with strong similarity to NA -3.02 244 213 2121 1590
1422587_at transmembrane protein 45a Tmem45a -3.09 291 342 3426 1965
1438474_at ankyrin repeat domain 35 Ankrd35 -3.12 26 28 310 162
1419491_at defensin beta 1 Defb1 -3.12 230 177 1662 1852
1434227_at keratinocyte differentiation associated protein Krtdap -3.16 722 673 6328 6098
1436520_at expressed sequence AI450948 AI450948 -3.18 286 196 2525 1767
1441909_s_at RIKEN cDNA 9530066K23 gene 9530066K23Rik -3.20 27 21 252 177
1417853_at chloride channel calcium activated 2 Clca2 -3.26 256 199 2582 1742
1459898_at suprabasin Sbsn -3.31 55 87 885 482
1441341_at Transcribed sequences NA -3.32 109 105 1065 1080
1437939_s_at Cathepsin C Ctsc -3.34 61 56 701 479
1424713_at calmodulin-like 4 Calml4 -3.36 66 63 612 703
1422008_a_at aquaporin 3 Aqp3 -3.38 12 12 136 118
1435760_at cystatin A MGI:3524930 -3.43 168 177 1842 1875
1448932_at keratin complex 1, acidic, gene 16 Krt1-16 -3.44 81 88 1101 735
1417732_at annexin A8 Anxa8 -3.45 243 203 2780 2085
1457025_at RIKEN cDNA 4833413O15 gene 4833413O15Rik -3.46 81 50 998 405
1440523_at retinal short chain dehydrogenase reductase Rdhe2 -3.53 289 260 3978 2367
1441384_at Transcribed sequences NA -3.55 87 101 1318 885
1417408_at coagulation factor III F3 -3.63 44 33 574 376
1448152_at insulin-like growth factor 2 Igf2 -3.64 650 540 7115 7633
1458000_at desmoglein 1 alpha Dsg1a -3.70 317 263 4344 3172
1426808_at lectin, galactose binding, soluble 3 Lgals3 -3.74 312 260 4311 3269
1416930_at lymphocyte antigen 6 complex, locus D Ly6d -3.80 495 434 7376 5495
1419463_at chloride channel calcium activated 1 Clca1 -3.86 592 614 9974 7551
1455519_at desmoglein 1 alpha Dsg1a -3.90 46 44 853 494
1460259_s_at chloride channel calcium activated 1 Clca1 -3.92 351 362 6390 4408
1439620_at carbonic anhydrase 13 Car13 -3.93 19 16 272 266
1422481_at keratin complex 2, basic, gene 1 Krt2-1 -4.06 998 995 18569 14590
1456203_at RIKEN cDNA 1110020A10 gene 1110020A10Rik -4.35 108 75 2497 1172
1424306_at elongation of very long chain fatty acids (FEN1 Elovl4 -4.40 50 42 1254 686
1439183_at N-acylsphingosine amidohydrolase (alkaline cer Asah3 -4.57 16 23 570 323
1424265_at N-acetylneuraminate pyruvate lyase Npl -4.60 260 308 7595 6168
1453801_at thioesterase superfamily member 5 Them5 -4.68 31 25 915 511
1437578_at chloride channel calcium activated 2 Clca2 -4.86 29 20 932 483
1429297_at serine (or cysteine) proteinase inhibitor, clade Serpinb12 -4.97 19 21 815 422
1422939_at serine (or cysteine) proteinase inhibitor, clade Serpinb3b -5.05 74 97 3139 2491
1422940_x_at serine (or cysteine) proteinase inhibitor, clade Serpinb3b -5.07 124 143 4887 4052
1436448_a_at prostaglandin-endoperoxide synthase 1 Ptgs1 -5.11 68 93 3215 2265
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